Category: Guides

  • SMS Marketing for Peptide Brands: Which Platforms Allow It and What to Send

    Peptide SMS marketing is possible for a research-use-only (RUO) brand in a narrow form, and it is controlled by more gatekeepers than any other channel you use. A text passes through your SMS platform, an aggregator and the recipient’s mobile carrier, and each one applies content rules before the message arrives. On top of that sits US telemarketing law, which lets recipients sue per message. This guide is for owners and marketers of RUO peptide stores. It explains how US business texting is registered, what carriers and platforms restrict, what consent you need, and which messages are realistic to send. It is general information, not legal advice.

    Key takeaways
    • No platform policy we read says RUO peptides are allowed. Of fourteen, one names them as prohibited, five have wording that could apply, and eight do not address the category.
    • Registration is mandatory and it describes your real business. Local numbers need 10DLC brand and campaign registration. Toll-free numbers need verification. Reviewers look at your website as well as your sample messages.
    • Consent depends on message type. CTIA’s best practices ask for express consent for informational texts and express written consent for promotional ones. A checkout phone number is not a marketing opt-in.
    • STOP has a legal deadline. The FCC rule requires opt-outs to be honoured within ten business days at most. Your platform should do it at once.
    • The realistic use is service messaging. Order, shipping and account notices, and stock alerts a customer asked for. Not promotional blasts.
    • Do not work around a refusal. Misdescribed registrations and spreading traffic across numbers are named violations in carrier codes and platform policies.

    1. The short answer

    Three separate sets of rules decide whether a text from your store is sent, delivered and lawful.

    • Law. The Telephone Consumer Protection Act (TCPA) and the FCC’s rules under it govern consent, sending hours and opt-outs. Several states add their own rules.
    • Carrier and industry standards. CTIA, the US wireless industry association, publishes messaging best practices. Carriers such as T-Mobile and AT&T publish codes of conduct with lists of disallowed content.
    • Platform policy. The company whose software you use has an acceptable-use policy, and it is often stricter than the carriers.

    None of the carrier or industry documents we read mentions peptides or research chemicals. They restrict nearby categories: illegal drugs, controlled substances, prescription medicines and unlawful content. So the practical question is how a reviewer classifies your store, and that depends on what your website and your messages look like. A store whose product pages read like a pharmacy will be treated as one. If you have not yet cleaned up the site, start there: our RUO website compliance checklist and peptide product page template cover what reviewers look for. Our pages on Google Shopping for peptides and Merchant Center recovery cover the same product-page discipline.

    Set expectations

    SMS will not be a growth channel for an RUO peptide brand in the way it is for a clothing store. Used for service messages to customers who asked for them, it can reduce support tickets and bring back buyers who were waiting on stock. That is the realistic ceiling, and it is worth having only if a provider accepts your business knowing what it sells.

    2. How US business texting works: 10DLC, toll-free, short codes

    Software-sent texts are called application-to-person (A2P) messaging. In the US there are three kinds of sender number, and each has its own approval process. You apply through your SMS platform, not to the carriers directly.

    Number typeWhat it isApprovalWhat reviewers ask for
    10DLCA local ten-digit number used for business textingRegister a brand (your legal business) and a campaign (what you send) with The Campaign Registry, through your providerBusiness identity, use case, sample messages, how people opt in, opt-out and help wording, whether links or age-gated content are involved
    Toll-freeAn 8xx number enabled for textingToll-free verification, submitted by your provider. Twilio states that messages from numbers pending verification have been blocked since 31 January 2024Business details that match the website, use case, opt-in evidence, sample messages
    Short codeA five or six digit number for high-volume programmesLeased, not bought, from the U.S. Short Code Registry, which CTIA administers with iconectiv. Each programme goes through an application and vetting process that takes several weeksA full programme brief. The most scrutiny of the three

    The Campaign Registry’s user guide lists standard campaign use cases that include Marketing, Account Notification, Delivery Notifications, Customer Care, and Mixed or Low Volume Mixed. It also describes itself as a registry and not a compliance reviewer. Content decisions are made by your provider, the aggregators and the carriers.

    Two points matter for an RUO store.

    • The use case has to match what you send. If you will send stock alerts as well as shipping updates, declare both. A campaign registered for delivery notifications that starts carrying offers is out of scope.
    • The registration has to describe the real business. Twilio’s error documentation lists filing under a permitted use case when the underlying business is prohibited as a rejection reason, and says a campaign rejected for prescription-drug or controlled-substance content is not eligible for resubmission. Write the description a reviewer would write after reading your site.

    3. What CTIA and the carriers restrict

    CTIA’s Messaging Principles and Best Practices

    The current edition we could find of CTIA’s Messaging Principles and Best Practices is dated May 2023. It is voluntary guidance, but carriers and platforms build their own rules on it. The parts that matter here:

    • Content. Senders should prevent unlawful, harmful, misleading or illicit content, and content that does not meet age-gating requirements. The document does not list product categories. The acronym “SHAFT” (sex, hate, alcohol, firearms, tobacco) that platforms use does not appear in it, and neither do controlled substances or prescription drugs.
    • Consent by message type. Covered in section 4 below.
    • Opt-out. Standard STOP wording, with plain-language requests honoured too.
    • Snowshoeing. Spreading similar messages across many numbers to dilute volume or avoid filters. CTIA says senders should not do it.
    • Links. Links should not hide the sender’s identity. If you shorten URLs, use a dedicated domain of your own.

    Carrier codes of conduct

    T-Mobile’s Code of Conduct (the copy on T-Mobile’s site is version 2.2, dated November 2020, and we could not confirm whether a later one exists) is more specific. Its disallowed content list includes cannabis, illegal prescriptions and a catch-all for any other illegal content. It bars endorsement of illegal drugs, places controlled substances under additional review, and requires date-of-birth age gates for alcohol, tobacco and similar content. It prohibits snowshoeing, filter evasion, replacement numbers and number cycling, and says unregistered traffic may be suspended.

    AT&T’s 10DLC code of conduct, which we could read only as a 2021 copy hosted by a provider, likewise prohibits snowshoeing, filter evasion and public URL shorteners, and its advertising schedule bars false or unsubstantiated claims.

    What this means for RUO peptides

    No carrier document we read names peptides, research chemicals or SARMs. Whether an RUO product falls under “illegal prescriptions”, “illegal content” or a controlled-substance review is a judgment the carrier or your provider makes, and we will not guess at how often it goes either way. What you control is the evidence: a site with no human-use claims, messages with no promotional drug language, and an honest registration. Carriers can also pass fees to your provider for content violations, and Twilio’s US guidelines say such fees are passed on to the customer.

    4. TCPA consent and opt-out rules

    The TCPA is the federal statute, and the FCC’s rules under it are at 47 CFR 64.1200. This is a summary of the provisions that shape an SMS programme. It is not legal advice, and TCPA litigation turns on details that a lawyer should check for your set-up.

    • Written consent for marketing. Telemarketing sent with an autodialer needs the recipient’s prior express written consent: a signed agreement, which can be electronic, that clearly authorises marketing texts to that number and is not a condition of purchase. Whether a given platform counts as an autodialer is a contested legal question. Do not build on it. CTIA and every platform expect written opt-in for promotional texts anyway.
    • Sending hours. No telephone solicitations before 8 a.m. or after 9 p.m. in the recipient’s local time. The rule applies this to text messages to wireless numbers.
    • Do Not Call. The National Do Not Call Registry rules also extend to texts. Written consent from the recipient is what permits marketing to a registered number.
    • Opt-out. Under paragraph (a)(10), a revocation request must be honoured within a reasonable time, not more than ten business days. In an order released on 1 October 2026 (FCC 26-67), the FCC revised parts of the revocation rules. As we read it, a STOP reply to a marketing text still ends all marketing texts from that sender, a sender may designate a clearly disclosed opt-out method, and the ten-business-day limit stays. Its effective date depends on Federal Register publication, so check the current rule text.
    • One-to-one consent. The FCC’s 2023 “one-to-one” consent rule never took effect. After a federal appeals court vacated it, the FCC restored the earlier definition in July 2025.
    • Damages. 47 U.S.C. 227 gives recipients a private right of action with $500 per violation, and up to three times that for wilful or knowing violations. Counted per message, a small list error becomes a large number.
    State laws

    States add their own rules. Two examples we checked against official sources: Florida’s telemarketing statute, section 501.059, covers text messages and requires prior express written consent for autodialed sales texts. Texas now treats marketing texts as telephone solicitation under Business and Commerce Code chapter 302, which has a registration requirement, although the Secretary of State’s FAQ says a business that texts with the consumer’s prior consent does not have to register. Other states have their own laws. If you sell nationally, have counsel review the programme once.

    Consent levels by message type

    Message type (CTIA)ExampleConsent CTIA expects
    ConversationalA reply to a question the customer texted youImplied by the customer starting the conversation
    InformationalOrder confirmation, shipping update, account noticeExpress consent: the customer gave the number and agreed to receive that kind of message
    PromotionalOffers, new product announcements, stock alertsExpress written consent, given before the first message

    5. What the SMS platforms’ policies say

    We read the published acceptable-use, content or messaging policies of fourteen platforms on 16 November 2026. The matrix reports what each page says and our reading of how it applies to an RUO peptide store. It is not a prediction of what a platform’s review team will decide, and policies change. Where a policy is silent, we say so.

    Infographic: SMS platform policy matrix for RUO peptide stores

    SMS platform policy matrix

    Published policies as read on 16 November 2026. Our reading, not the platform’s decision.

    ALLOWED: policy says yesPROHIBITED: category namedRESTRICTED: nearby wording could applyUNCLEAR: not addressed
    Platform
    Reading
    What the policy says
    Brevo
    Prohibited
    Lists peptide-based products for therapeutic, weight-loss or performance use as not accepted, including those labelled research use only.
    Omnisend
    Restricted
    Prohibits prescription medications, with drugs for research purposes given as an example. Prescription medications are also barred from SMS.
    Klaviyo
    Restricted
    Account-wide: no prescription medications or pharmaceutical products. SMS: no prescription medication that cannot be sold over the counter.
    Telnyx
    Restricted
    Bars messages promoting or facilitating the sale of substances not legally approved for sale, and unauthorised prescription drugs.
    Mailchimp
    Restricted
    Pharmaceutical products are an industry it may not allow. SMS requires an application and approval.
    Textmagic
    Restricted
    Prohibited content includes unlicensed pharmaceuticals and promotion of regulated substances. Neither term is defined.
    Twilio
    Unclear
    Forbids promotional messaging for drugs that cannot be sold over the counter, and controlled substances. Research products not addressed.
    Shopify Messaging
    Unclear
    SMS prohibited content includes prescription medication that cannot be sold over the counter. Research products not addressed.
    Sinch
    Unclear
    Disallows cannabis, CBD, kratom and scheduled drugs, with prescriptions case by case. Research products not addressed.
    Bandwidth
    Unclear
    Will not carry sale or promotion of federally controlled substances. Nothing on prescription or research products.
    Attentive
    Unclear
    Bars content related to anything illegal at state or federal level and endorsement of illicit drugs. No pharmaceutical wording.
    Postscript
    Unclear
    Help pages cover SHAFT, CBD and illicit drugs only. We could not open its terms of service.
    SimpleTexting
    Unclear
    Covers SHAFT, CBD, illicit drugs and controlled substances. May refuse service for any reason.
    EZ Texting
    Unclear
    Prohibits cannabis, CBD and kratom content, and endorsement of illegal drugs or controlled substances. No pharmaceutical wording.
    Allowed: 0  |  Prohibited: 1  |  Restricted: 5  |  Unclear: 8. “Unclear” is not permission. Ask in writing.

    Notes on the matrix

    • Brevo is the only policy that names the category. Its Acceptable Use policy lists peptide products among content not accepted regardless of legality, and says the “research use only” label does not change that. The list is not limited to one channel, so it bears on email as well.
    • Omnisend and Klaviyo are the closest of the rest. Omnisend’s policy (updated 30 April 2026) ties “drugs for research purposes” to prescription medications. Whether a non-prescription RUO compound is inside that phrase is not certain from the text. Klaviyo’s policy (updated 9 April 2026) bars pharmaceutical products across all channels, and its SMS content article says carriers check linked pages as well as the message. If you already use either for email, read the policy before you add SMS.
    • The recurring rule is the over-the-counter test. Twilio, Klaviyo and Shopify Messaging all forbid promoting medication that cannot be sold over the counter. An RUO store selling compounds that are also the active ingredients of prescription medicines should expect a reviewer to consider that rule. The Twilio article we could open is on its older support site and shows a 2023 date.
    • Transactional messages are not exempt. No policy we read carves order or shipping texts out of its content rules. Some rules are worded for promotional messaging only (Twilio’s prescription rule), and some reach the whole business whatever it sends.
    • Evasion is its own violation. Twilio’s Messaging Policy bans snowshoeing and deliberate misspellings. Klaviyo, Attentive, Telnyx and Bandwidth have similar clauses on filter evasion or misleading account information.
    How to ask a platform

    Before you sign up or register a campaign, write to the provider’s compliance or support team. Say that you sell peptides labelled for laboratory research use only, give your URL, and list the message types you intend to send. Ask whether the business is eligible for SMS on their platform and under which use case. Keep the reply. If the answer is no, accept it. A written yes from a provider that has looked at your site is worth more than a quiet approval that a later review reverses.

    6. What to send: realistic message types

    Assuming a provider has accepted the business, these are the message types that fit an RUO store. The further down the table you go, the more a message looks like promotion, and the more consent and care it needs.

    MessageCTIA typeConsent neededNotes
    Order confirmationInformationalExpress: customer opted in to order textsOrder number and a link to the order page. No product pitch
    Shipping and delivery updatesInformationalExpressCarrier, tracking link, delivery exceptions. Useful for temperature-sensitive shipments
    Payment or account noticesInformationalExpressPayment failed, bank-transfer instructions sent, password changed. See peptide payment processing and our guide to peptide chargebacks
    Documentation noticesInformationalExpressThe batch certificate of analysis for an order is available in the account
    Support repliesConversationalImplied when the customer texts firstNever answer use or dosing questions. Reply that products are sold for laboratory research only
    Back-in-stock alertsPromotionalExpress written, for that alertOnly to people who asked for that item. One message per restock
    Offers and announcementsPromotionalExpress writtenHighest risk. Most platform rules on drug content are written for promotional messaging. We suggest leaving these to email

    A stock alert is a marketing message even though the customer requested it, because its purpose is to prompt a purchase. Register it as marketing, collect written consent for it, and keep it within sending hours.

    7. Copy guidelines without human-use claims

    The rule from your website applies to every text: nothing that says, shows or implies use in people or animals. SMS adds a second rule. Because messages are filtered and reviewed by third parties, anything that reads like drug promotion puts the sender number at risk even when you think the wording is defensible.

    • Identify the sender. Start with your brand name. CTIA expects recipients to know who is texting them.
    • State facts about the order or the account. Status, tracking, documents, stock. Not benefits.
    • No dosing, preparation, results or health language. No comparisons with medicines. No before-and-after framing. No testimonials.
    • No urgency built on demand for a drug. “Selling fast” attached to a compound known as a prescription medicine is exactly what the over-the-counter rules target.
    • Use your own domain in links. Carrier codes discourage or prohibit public URL shorteners. The page a link opens is reviewed too, so it must be as clean as the text.
    • Include opt-out wording. “Reply STOP to opt out” on the first message and regularly after, with HELP supported.
    • Write plainly. Odd spellings and spaced-out product names are treated as attempts to evade filters, which is a violation in its own right.

    Examples of acceptable service messages, with a placeholder brand:

    Northlab Research: Order #4821 has shipped. Track it at northlab.example/t/4821 Reply STOP to opt out, HELP for help.
    Northlab Research: The batch certificate of analysis for order #4821 is now in your account: northlab.example/account
    Northlab Research: The item you asked us to notify you about is back in stock. View: northlab.example/notify Reply STOP to opt out.
    Clean wording is not a workaround

    These guidelines are for brands whose provider has accepted the business. They are not a method for getting a prohibited category past a filter. If a platform’s policy bars your store, neutral message text does not make the account compliant, because several policies apply to the business itself and to the linked website.

    8. Building the list with proper consent

    Most TCPA claims and most carrier complaints start with how the number was collected. Use this checklist before the first message goes out.

    Consent checklist
    1. Collect the number yourself. No bought, rented or shared lists, and no numbers passed over by affiliates (see our peptide affiliate program guide). Consent given to someone else is not consent to you.
    2. Separate the opt-ins. One unticked checkbox for order and shipping texts, and a different unticked checkbox for marketing or stock alerts. Never pre-tick either.
    3. Do not make marketing consent a condition of purchase, and say so in the disclosure.
    4. Put the disclosure next to the checkbox. CTIA’s call-to-action list: who is sending, what kind of messages, that message and data rates may apply, how to opt out, how to get help, and a link to the privacy policy. Add message frequency. Do not bury it in the terms and conditions.
    5. Publish a privacy policy that covers mobile numbers and link it from the opt-in. Carriers and platforms commonly expect it to say that opt-in data is not shared with third parties for their marketing.
    6. Send a confirmation text on opt-in that names the brand, states the programme, and gives STOP and HELP instructions. A double opt-in (reply YES) is stronger evidence still.
    7. Keep the record. Number, date and time, the exact wording shown, the page or form, and the IP address if you have it. This is what you produce if consent is ever disputed.
    8. Process STOP automatically and treat plain-language requests (“please stop texting me”) the same way. Send one confirmation and nothing else.
    9. Respect sending hours in the recipient’s time zone, and set a frequency cap you would be comfortable receiving yourself.
    10. Sell to adults and businesses only. If your store requires buyers to confirm they are over 21 or purchasing for a laboratory, keep the SMS opt-in behind the same gate.
    11. Clean the list. Remove numbers that fail repeatedly and numbers of customers who close their accounts. Mobile numbers are reassigned to new people.
    12. Re-check after any change. A new form, popup tool or checkout app can silently drop the disclosure or pre-tick a box.

    Popups that trade a discount for a phone number are standard in e-commerce. For an RUO store they bring in people who have no order with you yet, on a promotional footing, into the channel with the strictest rules. Collecting numbers at checkout and on a back-in-stock form gives you a smaller list that is far easier to defend.

    9. How SMS fits beside email

    Email is the main owned channel for an RUO brand, and SMS is a supplement to it. The division of work is simple.

    EmailSMS
    Best forDetail: documentation, batch and testing information, catalogue updates, policies, offersShort, time-sensitive service notices
    GatekeepersYour email platform and mailbox providersYour SMS platform, aggregators and carriers, with registration before you send
    ConsentOpt-in is best practice. US law centres on accurate headers and a working unsubscribePrior express written consent for marketing, with private lawsuits per message
    Space for contextEnough to include RUO statements and links to documentsVery little. Everything rests on the linked page
    If the account is closedYou can move the list to another providerThe registered number and its approval are lost, and consent may need to be collected again

    In practice: run the welcome series, restock announcements for the whole list, documentation and any offers through email. Use SMS for order and shipping messages and for individual stock alerts. Do not send the same promotion on both channels. Many brands use one platform for both, so remember that a content decision on the SMS side can affect the email account as well. Our peptide email marketing page covers the email side, and Google Ads for peptides covers paid acquisition, where the same site-level review applies. If you measure SMS clicks, our peptide conversion tracking guide covers attribution.

    10. FAQ

    Is peptide SMS marketing allowed in the United States?

    No law we found bans a research-use-only peptide store from texting customers who have consented. The limits come from three places: TCPA consent and opt-out rules, carrier and CTIA content standards, and each SMS platform’s own acceptable-use policy. None of the fourteen platform policies we read says the category is allowed, and one names RUO peptides as prohibited.

    Which SMS platforms allow RUO peptide brands?

    None of the policies we read says so in terms. Brevo’s policy names peptide products, including those labelled research use only, as not accepted. Omnisend, Klaviyo, Telnyx, Mailchimp and Textmagic have wording on pharmaceutical or unapproved products that could apply. The rest do not address the category. Ask the provider in writing before you build on it.

    Do order and shipping texts need consent?

    Yes, though a lower level than marketing. CTIA’s best practices say informational messages need the consumer’s express consent, and promotional messages need express written consent. A phone number typed at checkout for delivery updates does not cover marketing texts. Platform content rules also apply to transactional messages, not only to promotions.

    Do we need 10DLC registration or toll-free verification?

    Yes, one or the other, if you text US customers from an application. A local ten-digit number needs a registered brand and campaign with The Campaign Registry, submitted through your provider. A toll-free number needs verification. Twilio states that messages from toll-free numbers pending verification have been blocked since 31 January 2024.

    Can we register as a general retailer to get approved?

    No. Describe the business, the website and the messages as they are. T-Mobile’s code of conduct prohibits filter evasion, and Twilio lists filing under a permitted use case when the underlying business is prohibited as a reason for rejection. A misdescribed registration risks the number, the account and carrier fees.

    What should a peptide store never put in a text?

    Anything about use in people or animals: dosing, preparation, results, health or body claims, comparisons with medicines, and urgency built on any of those. Keep texts to order facts, account notices and stock status, with your brand name and opt-out wording. Remember that carriers and platforms also review the page a link points to.

    How quickly must we honour a STOP reply?

    The FCC rule at 47 CFR 64.1200(a)(10) requires revocation requests to be honoured within a reasonable time, not more than ten business days. In practice your platform should process STOP at once, and CTIA’s best practices allow one final confirmation message and nothing after it.

    Should an RUO peptide brand use SMS or email?

    Email first. It carries the detail that research buyers need, such as certificates of analysis and batch documentation, and it has fewer gatekeepers. SMS suits short, time-sensitive service messages: order, shipping and account notices, and stock alerts a customer asked for. Treat SMS as a small add-on, not a second promotional channel.

    Thinking about SMS?

    Check the policy and the consent flow before the first text

    Peptide Marketing works only with research-use-only peptide brands. We can review your site and checkout against carrier and platform rules, help you put the eligibility question to providers, and set up service messaging and email that stay within them. We do not write health or use claims, and we do not help brands get around carrier or platform policies.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is general information for businesses selling research-use-only products. It is not legal or regulatory advice. Sources were read on 16 November 2026. Laws, carrier codes and platform policies change, and the matrix records our reading of published text, not any platform’s decision about a particular business. Check the linked pages and take professional advice before you act. Naming a platform here is not an endorsement, and we have no commercial relationship with any platform listed.

  • Peptide Affiliate Programs: Structure, Commissions and Compliance

    A peptide affiliate program looks like the cheapest channel a research-use-only (RUO) brand can open: you pay only when an order arrives. The cost that does not show on the commission report is that every affiliate becomes a person speaking for your brand, in places you do not see, and regulators and platforms treat what they say as your advertising. This guide is for owners and marketers of RUO peptide stores. It covers the software, commission structure and recruitment, and spends most of its length on the part that decides whether the programme is an asset or a liability: the rules you set, how you check them, and what you do when someone breaks them. It is general information, not legal advice.

    Key takeaways
    • You are responsible for what affiliates say. The FTC’s Endorsement Guides make an advertiser liable for misleading or unsubstantiated claims made through endorsements, and for an endorser’s failure to disclose the relationship.
    • An affiliate cannot say what you cannot say. If a human-use, dosing or results claim is off limits on your own product page, it is off limits in an affiliate’s video, caption, email and comment replies.
    • Disclosure is required and it has to be obvious. A commission, a free product and a personal discount code are all connections the audience should be told about, next to the recommendation.
    • Approve people by hand. In this category the question is not how many affiliates you can sign, but whether you would be comfortable with each one’s content being read as your own.
    • A written agreement is the start, not the control. The FTC expects a brand to instruct, monitor and act. Good faith alone is not a defence.
    • Affiliate content travels. Google says it may review third-party sources when enforcing its ads policies, and payment processors prohibit businesses that rely on deceptive testimonials.

    1. Is an affiliate programme right for an RUO brand?

    Affiliate marketing works by borrowing someone else’s audience and trust. That is also the difficulty. Most of the people who have an audience interested in peptides built it by talking about personal use, and an RUO brand cannot be associated with that conversation.

    The reason is how US regulators decide what a product is. Under 21 CFR 201.128, a product’s intended use is the objective intent of the people responsible for it, and it can be shown by labelling claims, advertising matter, and oral or written statements made by those people or their representatives. It can also be shown by the circumstances in which the product is distributed. A “research use only” label is one piece of evidence. It does not outweigh the rest. Our RUO website compliance checklist covers what that means for your own pages.

    FDA has applied this directly. In a warning letter dated 31 March 2026, the agency told a peptide seller that its “research use only” and “not intended for human consumption” statements did not control, because the claims on its product pages showed the products were intended for use in people. That letter relied on the seller’s own website. The regulation, though, is not limited to a seller’s own pages, and a paid affiliate who promotes your products is hard to describe as anything other than someone speaking on your behalf.

    The honest test

    Before building anything, ask one question. Is there a set of partners who would promote your store on the things you are allowed to talk about: documented purity, third-party testing, batch records, storage and shipping standards, service to laboratories? If yes, a small, tightly run programme can work. If the only affiliates available are people whose content is about personal use, the answer is not a cleverer agreement. It is not to run the programme.

    2. The setup flow, with compliance gates

    Most affiliate guides treat setup as a software task. For an RUO brand it is a sequence of decisions with stop points. The diagram shows the order, and the three places where the answer has to be “yes” before you move on.

    Infographic: affiliate programme setup flow

    Affiliate programme setup flow

    Read top to bottom. Black bars are compliance gates. Do not pass a gate on a “no”.

    1
    Write the rules firstClaims policy, disclosure wording, banned content list, affiliate agreement. Have a lawyer review them.
    2
    Choose software and set termsManual approval on. Commission rate, cookie window, payout delay, self-referral blocking.
    3
    Applications come inAsk for every channel the applicant will use, with links.
    Gate A: partner vettingDoes their existing content stay clear of human-use, dosing and results claims? Would you be comfortable if it appeared on your own site?No → decline. Do not approve “with a warning”.
    4
    Sign and onboardAgreement accepted. Content guidelines, approved wording and disclosure examples sent and acknowledged.
    Gate B: first-content reviewHas the affiliate’s first piece of content been checked for a clear disclosure and for banned claims before the link or code is switched on?No → link and code stay inactive.
    5
    Go liveLink and code activated. Orders tracked. Commissions held as pending.
    6
    Monitor on a scheduleSearch each affiliate’s channels, your brand name and your codes. Log what you find.
    Gate C: before every payoutIs the affiliate’s current content compliant, and are the orders genuine and past the refund window?No → hold payout, require a fix by a deadline, or terminate.
    7
    PayApprove commissions and pay on the agreed schedule.
    8
    Review the programmeQuarterly: who is active, what was flagged, what the rules missed. Update the guidelines.
    Back to step 6. Monitoring does not end while an affiliate has a live link or code.

    3. Affiliate software for WooCommerce and Shopify

    The software’s job is narrow: register affiliates, attribute orders to them, calculate commission and record payouts. For an RUO store, four features matter more than the rest. You need manual approval of applicants, the ability to reject or hold commissions before payout, coupon-code attribution alongside links, and self-referral blocking. The table lists what each vendor states on its own pages. It leaves out pricing, which changes, and anything the vendor’s page did not say.

    ToolRuns onAttribution the vendor describesControls the vendor describes
    AffiliateWPWordPress plugin (self-hosted)Referral links and coupon codes. Rates per affiliate or per product, and per category in WooCommerceApplication review and approval. Rejects self-referrals by default. Fraud detection on its Pro tier
    SliceWPWordPress pluginCustom referral links, custom cookie duration. Fixed or percentage rates, per affiliate and per productManual approval, with an optional auto-approve switch
    Solid AffiliateWordPress plugin for WooCommerceLinks, and WooCommerce coupons linked to affiliates. Rates per affiliate, product, group or categoryRegistration form with a pending-approval queue. A fraud prevention suite
    Affiliate for WooCommerceWooCommerce Marketplace extensionCoupon or link tracking. Percentage or flat commission with rules by product, category and affiliateAutomatic or manual approval. Commissions can be approved or rejected by hand. Self-referrals can be blocked
    Shopify CollabsShopify appReferral links and discount codes. Custom and per-product commissionCustom application page, direct invites, or an open-access programme. Payouts through Shopify
    GoAffProShopify app. The vendor also lists WooCommerce and other platformsAffiliate links and discount codes. Product and custom commission, multi-level optionsThe vendor says merchants can review, approve or reject commissions before payout. Fraud protection that the merchant configures
    RefersionStandalone service with Shopify, WooCommerce and BigCommerce integrationsFirst-party tracking links, discount links, attribution rules by code, SKU and emailAutomated or manual payouts with tax forms

    Three practical points before you install anything.

    • Turn off anything “open”. If a tool offers auto-approval or an open-access programme, switch it to application and manual approval before you publish the sign-up page. Check the setting yourself. Do not assume the default.
    • Read the vendor’s terms for your category. None of the feature pages above states a product-category restriction, but a feature page is not the terms of service. Check the terms, and check how the tool pays affiliates. A payout route that runs through a payment provider brings that provider’s rules with it.
    • Avoid multi-level structures. Several tools offer multi-tier commission, where affiliates earn from the people they recruit. It gives you affiliates you never approved. In this category that is the opposite of what you want.

    4. Commission models, cookie windows, and codes versus links

    There is no reliable public benchmark for commission rates in this category, so this section does not quote one. Work it out from your own margin: decide the most you can pay for an order after product cost, shipping, payment fees, refunds and any discount the affiliate’s code gives the buyer, then set the rate below that.

    Commission models

    ModelHow it paysWorks whenWatch for
    Percentage of saleA share of each order’s valueOrder values vary and you want the cost to scale with revenueDecide whether the base includes shipping and tax, and whether it is before or after the discount
    Flat fee per orderA fixed amount per orderOrder values are similar and you want a predictable costInvites many small orders. Set a minimum order value
    Per-product or per-category rateDifferent rates for different productsMargins differ a lot across the catalogueHigher rates push affiliates towards those products. Make sure those are products you want promoted
    First order onlyCommission on a new customer’s first orderYou want to pay for acquisition, not for repeat business you would have had anywayNeeds reliable new-customer detection
    Repeat or lifetimeCommission on later orders from the same customerA partner brings institutional buyers who reorderA long-term cost. It also weakens your leverage to end the relationship cleanly
    Incentives shape content

    Commission design is a compliance decision as well as a financial one. Volume bonuses, leaderboards and short “double commission” pushes reward whoever sells hardest, and in this category the hardest sell is a claim you cannot make. Prefer steady, modest rates. Never pay more for content that performs better because it says more.

    Cookie windows

    The cookie window is how long after a click an order is still credited to the affiliate. Most of the tools above let you set it. There is no correct number. A longer window is more generous to affiliates and credits them for more orders that would have happened anyway. A shorter one is cheaper and will feel unfair to a partner whose audience takes time to order. Pick a window, state it in the agreement, and say which click wins when two affiliates touch the same order.

    Two things reduce what a cookie can see. Where the law requires consent for non-essential cookies, a visitor who declines may not be tracked by a link at all. And buyers who pay later, by bank transfer or crypto, often complete the order outside the session that carried the click. For how that affects attribution in general, see our guide to conversion tracking for peptide stores and our page on peptide payment processing.

    Coupon codes versus links

    Referral linkCoupon code
    How it attributesA click sets a cookie. The order is credited if it happens within the windowThe order is credited when the code is used at checkout
    SurvivesNot a change of device, a cleared browser or declined cookiesDevice changes, delayed payment and declined cookies
    Works inClickable text: articles, emails, link pagesAnywhere, including audio and video where nobody clicks
    Main riskUnder-crediting honest partnersLeakage. Codes get reposted on coupon sites and used by buyers the affiliate never reached
    Cost to youCommission onlyCommission plus the buyer’s discount

    Most programmes use both and credit the order once. Decide which wins when a link and a different affiliate’s code appear on the same order, and block codes from being combined with other offers. Note that a personal code is itself a signal of a relationship. The FTC’s guidance says people given discount codes should disclose that, so a code does not replace a disclosure.

    5. Recruiting the right partners

    Recruit for fit, not reach. The partners who suit an RUO brand are the ones whose audience buys for laboratory and research purposes and whose content can be about supply quality.

    • Likelier fits: publishers and newsletters serving laboratories and life-science researchers, lab-supply directories and comparison sites, procurement and lab-management content, educators covering analytical methods and quality testing.
    • Poor fits, however large: fitness, weight-loss, anti-ageing, biohacking and “wellness” creators, anyone whose content shows or describes personal use, coupon and deal sites, and forums whose threads are about self-administration.

    For every applicant, look before you approve:

    1. Ask for every channel they will promote on, and check each one. The channel they did not list is the one to worry about.
    2. Read or watch their recent content about other peptide sellers. How they promote a competitor is how they will promote you.
    3. Search their name with your product names and with words like “dose”, “results” and “before and after”.
    4. Confirm who they are. You need a real name, a country and a way to reach them, for tax records and for the day you need something taken down.
    5. Ask how they intend to disclose. A partner who has never heard of disclosure will need training, not just a link.

    Do not recruit your own customers as affiliates on the strength of their purchases. A customer endorsement invites a description of what they did with the product, which is the one thing you cannot have attached to your brand.

    6. Who is responsible for affiliate claims: the FTC rules

    In the United States the starting point is the FTC’s Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255, revised in 2023. The Guides define an endorsement broadly: an advertising or promotional message that consumers are likely to believe reflects the views or experience of someone other than the advertiser. An affiliate’s recommendation is one.

    The brand is liable

    Section 255.1 says advertisers are subject to liability for misleading or unsubstantiated statements made through endorsements, and for endorsers failing to disclose their connection to the advertiser. It says advertisers should give guidance, monitor compliance and take action when they find a problem, and it says in terms that good-faith efforts are not a safe harbour. The same section says endorsers can be liable themselves, and so can intermediaries such as agencies.

    The FTC’s plain-language FAQ, “FTC’s Endorsement Guides: What People Are Asking”, describes what a reasonable programme looks like for a brand that uses a network of promoters:

    • explain to members what they can and cannot say about the products;
    • instruct them on their responsibility to disclose their connection to you;
    • periodically search for what they are saying;
    • follow up when you find questionable practices.

    The FAQ adds that handing the programme to an agency or a network does not move the responsibility off the brand, and that the amount of monitoring should reflect the risk. It names health-related products as a case that may need closer oversight.

    Disclosure

    A commission is a material connection, and the audience has to be told. The Guides define “clear and conspicuous” as difficult to miss and easily understandable by ordinary consumers, and say that in interactive media the disclosure should be unavoidable. The FTC’s FAQ and its Disclosures 101 for Social Media Influencers turn that into working rules:

    • Put it with the recommendation. Not on a profile page, not at the end of a caption behind a “more” link, not on a separate disclosures page.
    • Use plain words. The FAQ’s own example is “I get commissions for purchases made through links in this post.” It says the words “affiliate link” on their own, or a “buy now” button, are not enough.
    • In video, say it in the video. A line in the description does not cover it. In a live stream, repeat it.
    • Avoid shorthand. The FTC’s influencer guide warns against “sp”, “spon”, “collab” and a bare “ambassador”.
    • Do not rely on the platform’s tool alone. The FTC says a built-in paid-partnership label is not necessarily sufficient.
    • Free product and discount codes count. Both are connections to disclose.

    Claims

    Disclosure fixes one problem only. It does not make a claim acceptable. Section 255.2 says advertisers must be able to substantiate claims made through endorsements, and that consumer endorsements are not themselves competent and reliable scientific evidence. It also says “results not typical” style disclaimers are not enough. The FTC’s Health Products Compliance Guidance makes the same point about disclaimers generally: a disclosure can clarify an ambiguous claim, but it cannot contradict one. An affiliate who describes a benefit and then says “for research use only” has made the claim.

    Outside the United States

    This section covers US federal rules because that is where most RUO peptide brands sell. Other countries have their own advertising and medicines regulators and their own disclosure rules, and US states have consumer-protection laws of their own. If your affiliates or buyers are elsewhere, take local advice.

    7. What affiliates must never say

    The rule that covers everything: an affiliate may not say, show or imply anything the brand could not say on its own product page. An affiliate programme is not a way to have someone else make the claims you have removed from your site. Regulators look at who benefits and who had the ability to stop it, and using a third party to say it tends to look worse, not better.

    Banned content checklist

    Put this list in the agreement and in the onboarding pack. Each item applies to posts, videos, images, emails, comment replies, direct messages and paid ads.

    1. No human or animal use. No statement or suggestion that a product is for people or pets, however it is worded.
    2. No dosing, preparation or administration content. No amounts, schedules, mixing instructions, calculators or “protocols”.
    3. No health, performance, body-composition or appearance claims. No statements about what a product does in the body.
    4. No before-and-after content. No photos, measurements, timelines or progress stories.
    5. No personal-experience testimonials. Not the affiliate’s own, and not their followers’.
    6. No comparisons with medicines. No brand names of prescription drugs, no “same as”, “alternative to” or “generic”.
    7. No imagery that implies use. No syringes, injection sites, or physique and “transformation” imagery.
    8. No answering use questions. If a follower asks how to use a product, the only acceptable reply is that the products are sold for laboratory research only.
    9. No paid ads without written permission. No bidding on your brand name, no ads using your trademarks, no ads sending traffic to your domain.
    10. No unapproved discounts or urgency. Only the offers you have issued, described accurately.
    11. No email or SMS to lists that did not opt in, and none using your brand name as the sender.
    12. No fake or incentivised reviews, and no posting about your brand without a disclosure.

    Then give affiliates something they can say, or the list will be ignored. Approved material is factual and about the supplier: third-party testing and where the certificates of analysis are published, stated purity and how it is measured, batch traceability, storage and cold-chain handling, shipping times, customer service, and the fact that products are sold strictly for laboratory research. Supply approved wording, approved images and the disclosure line, and require affiliates to use them. The peptide product page template sets out the same facts for your own site. Our Google Shopping for peptides page covers the same product-page discipline from the feed side.

    8. The affiliate agreement and content guidelines

    You need two documents. The agreement is the contract. The content guidelines are the plain-language working rules with examples, which the agreement makes binding. Have a lawyer who knows advertising and FDA-regulated products draft or review both. The outline below is what to bring to that conversation, not a substitute for it.

    ClauseWhat it should settle
    RelationshipIndependent contractor. No authority to speak as the brand or bind it
    Approved channelsThe specific accounts and sites the affiliate may use. New channels need written approval
    Claims and contentThe banned list in section 7, and the rule that only approved wording about the products may be used
    DisclosureRequired on every piece of content, with the exact wording and placement
    Pre-approvalFirst content reviewed before activation. Your right to require review of any later content
    Paid media and trademarksNo paid ads, brand bidding or use of your marks without written permission
    Email and SMSCompliance with applicable law, opt-in lists only, no use of your sender identity
    Commission termsRate, base, cookie window, link-versus-code rule, what is excluded (refunds, chargebacks, self-purchases, cancelled orders)
    PayoutHolding period, minimum, schedule, tax information required
    Monitoring and takedownYour right to review content, and a fixed deadline to edit or remove on request
    Withholding and reversalCommission from non-compliant content is forfeited. Pending commission can be held during a review
    TerminationImmediate for breach of the claims or disclosure rules. Duty to remove content, links and codes afterwards
    ResponsibilityThe affiliate’s responsibility for their own content, as your lawyer advises. This does not remove yours
    ChangesHow you update the guidelines and how affiliates accept the update

    Keep the content guidelines to two or three pages. Show the disclosure line in place on a sample post. Show three examples of acceptable content and three of unacceptable content, with the reason. Record that each affiliate received and accepted them, and keep that record with the date. If a regulator or a platform ever asks what you did to control your affiliates, that record, your monitoring log and your enforcement history are the answer.

    9. Monitoring, enforcement and termination

    An agreement nobody enforces is evidence that you knew the risk and did nothing. Monitoring does not need to be elaborate. It needs to be regular, recorded and followed by action.

    A monitoring routine

    • At activation: review the first content before the link and code go live (Gate B).
    • Weekly, for new affiliates: check every approved channel for the first month.
    • Monthly, for everyone: check each active affiliate’s channels. Search your brand name, product names and every active code on the major platforms and in a search engine. Look for your codes on coupon sites.
    • Before each payout: a compliance check on the affiliate’s current content (Gate C).
    • On a signal: a sudden jump in one affiliate’s orders, a cluster of refunds or disputes, or a complaint. Look the same day.

    Log the date, what was checked, what was found and what you did. Screenshots matter, because posts get edited.

    An enforcement ladder

    What you findExampleResponse
    Disclosure faultDisclosure missing, buried or unclearWritten notice. Fix within a short fixed deadline. Hold pending commission until fixed. A second instance ends the relationship
    Process breachUnapproved channel, unapproved offer, code posted to a coupon siteDeactivate link and code until resolved. Reverse affected commission. Decide whether to continue
    Claims breachAny human-use, dosing, results or before-and-after contentDeactivate immediately. Demand removal in writing. Forfeit related commission. Terminate
    FraudSelf-referrals, fake orders, brand-bidding adsTerminate. Void commission. Keep the evidence

    Termination, step by step

    1. Deactivate the affiliate’s links and codes in the software.
    2. Send written notice citing the clause and the content, with a deadline for removal.
    3. Check that the content has come down. Where it has not, use the platform’s own reporting route for misuse of your brand.
    4. Settle or void commission as the agreement provides.
    5. Record everything: what was found, when, what you asked for, what happened.
    6. If the content could have reached your customers by email, review what your own list was sent. See peptide email marketing.

    10. How affiliate content reaches ad accounts and processors

    The regulatory risk is the serious one, but the commercial consequences usually arrive first.

    Ad accounts and Merchant Center

    Google’s Healthcare and medicines policy does not allow the promotion of a list of unapproved substances “regardless of any claims of legality”. The list includes products implied to work like prescription drugs, products that are not government approved but are marketed as safe or effective for a medical purpose, and products that have been the subject of any government or regulatory action or warning. The policy’s enforcement text says Google may review information from a variety of sources, including the ad, the website, accounts and third-party sources. Google’s Misrepresentation policy uses the same wording.

    The policy does not say how often third-party content is used or how much weight it carries, and we are not going to guess. The practical reading is simple. An affiliate video describing your product in terms of personal use is a public record that contradicts the RUO position your own site takes. If your account is ever under review, you want that record not to exist. If you already have a suspension or product disapprovals, clear up affiliate content before you appeal. Our Merchant Center recovery page and our Google Ads suspension playbook cover that process.

    Affiliates running their own ads create a second problem. Ads that point at your domain, or that use your brand name, tie their ad copy to your site. That is why the agreement bans paid media without written permission. If you do allow it, the terms in our peptide keyword guide apply to them as much as to you.

    Payment processors

    Processors publish lists of businesses they will not serve, and marketing practice is on them. Stripe’s prohibited and restricted businesses list includes pseudo-pharmaceuticals that are not safe or make harmful claims, incorrectly labelled research chemicals, and businesses that make outrageous claims or use deceptive or fake testimonials. PayPal’s Acceptable Use Policy prohibits transactions involving products that present a risk to consumer safety. Neither list names peptides. Whether a given store fits is the provider’s decision, made by its own risk team, and specialist high-risk processors apply their own underwriting.

    What a risk reviewer can see includes your affiliates. Search results for your brand name that show use claims and testimonials are easy to find. Affiliate traffic also affects the numbers processors watch. Buyers who were sold on an expectation the product cannot lawfully meet are the buyers who dispute charges. Hold commissions past your refund and dispute window, and track refunds and disputes by affiliate so you can see which partner is sending you problems. More on this in our guide to chargebacks and processor redundancy and on our peptide payment processing page.

    11. FAQ

    Can an RUO peptide brand run a peptide affiliate program at all?

    Nothing in the FTC’s rules stops a business from paying commission for referrals. The constraint is content. Affiliates may only say what the brand itself may say, they must disclose the relationship, and the brand must instruct and monitor them. If the only partners available promote personal use, the programme is not workable.

    Is the brand responsible for what an affiliate says?

    Yes. The FTC’s Endorsement Guides say advertisers are subject to liability for misleading or unsubstantiated statements made through endorsements and for undisclosed connections, and that good-faith efforts are not a safe harbour. The affiliate can be liable as well. Liability is not transferred by contract or by using an agency.

    What disclosure should an affiliate use?

    Plain words placed with the recommendation, such as the FTC’s own example: “I get commissions for purchases made through links in this post.” The FTC says “affiliate link” on its own is not adequate, that a disclosure in a profile or at the end of a post is easy to miss, and that in video it should be in the video itself.

    Does a “for research use only” line in an affiliate’s post make it compliant?

    No. A disclaimer does not cancel a claim. FDA has said in a 2026 warning letter that research-use statements did not control where other content showed intended use in people, and the FTC says a disclosure cannot contradict a claim. The content itself has to be free of use, dosing and results claims.

    Should affiliates get a coupon code or a referral link?

    Usually both, with the order credited once. Links cost you only the commission but lose tracking across devices and declined cookies. Codes track anywhere, including video, but cost a discount and leak to coupon sites. A code still needs a disclosure, because the FTC treats discount codes as a connection to disclose.

    What commission rate and cookie window should we set?

    There is no reliable public benchmark for this category, so set them from your own margin. Work out the most you can pay per order after costs, refunds and the code discount, and stay below it. Choose a cookie window you can explain, write it into the agreement, and avoid volume bonuses that reward aggressive selling.

    Can affiliates run Google or Meta ads for our store?

    Not without written permission, and in most cases the answer should be no. Ads placed by an affiliate that use your brand name or send traffic to your domain connect their ad copy to your site, and you have no control over what they write. Ban paid media and brand bidding in the agreement.

    What should we do when an affiliate makes a banned claim?

    Deactivate their link and code straight away, send a written removal demand citing the agreement, forfeit the related commission and end the relationship. Check that the content has come down, keep screenshots, and record what you did. A documented response is part of what the FTC describes as a reasonable programme.

    Planning an affiliate programme?

    Get the rules right before the first link goes out

    Peptide Marketing works only with research-use-only peptide brands. We can help you decide whether a programme fits your store, choose the software, set commission terms and build the vetting and monitoring routine around it. We do not write health or use claims, and we do not help brands make through affiliates what they cannot say themselves.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is general information for businesses selling research-use-only products. It is not legal, regulatory or tax advice. Sources were read on 16 November 2026. Regulations, platform policies and software features change, and rules differ by country and state. Check the linked pages and take professional advice before you act. Naming a software product here is not an endorsement, and we have no affiliate relationship with any vendor listed.

  • Conversion Tracking for Peptide Stores: GA4, Enhanced Conversions and Server-Side

    Peptide conversion tracking fails more often than tracking on an ordinary store, and for reasons that have little to do with the tag itself. Research-use-only (RUO) peptide stores tend to take payment through redirect checkouts, bank transfer or crypto, and many of the orders that matter are paid somewhere your tag never loads. This guide is for owners and marketers of RUO peptide stores. It explains where the data is lost, how to set up GA4 and the Google Ads purchase conversion properly, and how to recover the orders a browser tag cannot see, without sending personal data that a visitor has not agreed to share. It is general information, not legal advice.

    Key takeaways
    • Most lost conversions are lost at payment. If the buyer pays on another domain, or pays later, the thank-you page may never load and the browser tag never fires.
    • Decide what a “purchase” is before you tag it. For stores with delayed payment, a paid order and a placed order are different events. Pick one definition and use it everywhere.
    • Send a unique transaction ID with every purchase. Google Ads uses it to recognise duplicates, which is what lets a browser tag and an upload coexist.
    • Enhanced conversions and offline imports use customer data. They require Google’s customer data terms and, where the law asks for it, the buyer’s consent. Consent mode carries that choice to Google. It does not replace asking.
    • Server-side tagging improves control and reliability. It does not remove consent requirements and it is not a way around a visitor’s refusal.
    • Bidding learns from what you report. Smart Bidding and Performance Max optimise towards the conversions and values in your account. Missing or duplicated orders steer the budget in the wrong direction.

    1. Why tracking breaks on peptide stores

    A standard conversion tag works when a buyer clicks an ad, pays on your domain and lands on your order-confirmation page in the same browser. Peptide stores break that chain in three places.

    Off-site and redirect checkouts

    Many processors that accept this category host the payment page themselves. The buyer leaves your domain, pays, and is sent back. Two things go wrong.

    • The buyer does not come back. They see the processor’s own receipt and close the tab. Your thank-you page never loads, so no purchase event is sent.
    • The buyer comes back as a “referral”. Analytics sees a visit arriving from the processor’s domain. Google’s unwanted referrals page uses third-party payment processors as its example of this problem.

    Google’s cross-domain measurement can join two domains into one session, but it needs the same Google tag on every domain involved. You rarely control a processor’s hosted page, so for most stores the practical tools are the unwanted-referrals list and a confirmation page on your own domain. For how processor choice shapes the checkout, see peptide payment processing and our guide to chargebacks and processor redundancy.

    Crypto, bank transfer and other delayed payments

    With crypto, bank transfer, e-check or an emailed invoice, the order is created now and paid later, sometimes hours or days later, often from another device or app. No browser is on your site when the money arrives. If your tag fires when the order is placed, you count orders that are never paid. If it fires only on a paid confirmation page, you miss most of them.

    Consent banners

    Where the law requires consent for analytics and advertising storage, visitors who decline are not measured in the normal way. That is the banner doing its job. The UK regulator’s guidance says non-essential cookies cannot be set before the user has consented, and that the rules apply to storing or accessing information on a device “by any method”. The right response is a well-built banner and consent mode, covered in section 5. It is never to track people who said no.

    A category note

    Google’s personalised advertising policy lists health and restricted drug terms among its sensitive interest categories, and says advertiser-curated audiences such as Customer Match and “your data” segments are not supported for them. Conversion measurement is a separate thing from audience targeting, but the two share plumbing. Build tracking to measure sales. Do not plan on it as a source of remarketing lists, and take advice on how these policies apply to your catalogue. Our Google Ads for peptides page covers the wider policy picture, and the RUO website compliance checklist covers the site itself.

    2. The data flow from checkout to Google Ads

    Before changing any tags, draw where an order can go. The diagram below shows the three payment paths most RUO stores have, which collector can see each one, and where the data ends up.

    Infographic: from checkout to Google Ads

    Checkout to Google Ads: the data flow

    Read top to bottom. On a phone the columns stack, and each box says where its data goes next.

    1Click and visit

    Ad click lands on your storeThe click ID arrives in the URL. With consent, the Google tag stores it in a first-party cookie. Your order system can also save it against the cart.

    2Cart and checkout on your domain

    GA4 events fire in the browserview_item → add_to_cart → begin_checkout → add_payment_info

    3Payment: three paths

    A. On-site cardBuyer pays without leaving your domain and sees your confirmation page.↓ Seen by: browser tag
    B. Redirect / hosted pageBuyer pays on the processor’s domain. May or may not return to your site.↓ Seen by: browser tag only if they return. Otherwise server or upload.
    C. Crypto, transfer, invoiceOrder placed now, paid later, outside the browser session.↓ Seen by: server or upload only

    4Collectors

    Browser tagGoogle tag or Tag Manager web container on the confirmation page. Sends purchase with transaction ID, value, currency, items.
    Server container (optional)Receives events on your own subdomain, or a paid-order webhook from the store, and forwards them.
    Paid-order exportOrder ID, paid time, value, click ID and, with consent, hashed email. Sent on a schedule.
    Consent check: the visitor’s consent state travels with every hit and every upload

    5Destinations

    GA4purchase event. Reporting, funnels, key events.
    Google Ads conversionPurchase conversion action, plus enhanced conversions data where permitted.
    Google Ads Data ManagerImports paid orders that no browser saw.
    Google Ads matches the same order by transaction ID, counts it once, and passes conversions and values to Smart Bidding and Performance Max

    Two design decisions fall out of the diagram. First, one order ID has to travel down every path, so the same order arriving twice is recognised. Second, the definition of a purchase has to be the same in every collector. If the browser tag fires on “order placed” and the export sends “order paid”, you are counting two different things under one name.

    3. GA4 e-commerce events and the Google Ads purchase conversion

    The events

    Google’s GA4 e-commerce documentation lists the recommended events. For a store, the working set is:

    • view_item_list, select_item, view_item
    • add_to_cart, view_cart, remove_from_cart
    • begin_checkout, add_shipping_info, add_payment_info
    • purchase and refund

    The purchase example in that documentation carries transaction_id, value, currency, tax, shipping, coupon and an items array. The documentation says to set currency at the event level whenever you send a value, and each item needs an item_id or item_name, with both recommended. add_payment_info takes a payment_type. For a peptide store that parameter is worth the effort, because it lets you see card, redirect and crypto orders separately in the funnel.

    Keep event parameters to product identity and order facts. Do not put names, emails or anything describing a use into event names, item names or custom parameters. Product names that reach GA4 come from your catalogue, so the wording rules in our product page template apply here too.

    Fixing the redirect in GA4

    Add your processor’s payment domains under Admin > Data collection and modification > Data streams > your web stream > Configure tag settings > Show all > List unwanted referrals. Google says Analytics then ignores that referrer for attribution. Sessions that arrived from the domain before you listed it keep their original attribution, so expect old reports to stay as they were.

    The Google Ads purchase conversion

    There are two ways to get a purchase into Google Ads, and Google supports both.

    ApproachHow it worksStrengthsWatch for
    Google Ads conversion tagA conversion action in Google Ads, fired by the Google tag or Tag Manager on your confirmation pageDirect. Supports enhanced conversions and transaction ID deduplicationA second thing to maintain alongside GA4
    GA4 key event imported to Google AdsMark purchase as a key event in GA4 and create the Google Ads conversion from itOne source for both tools. Google says this reduces the risk of data discrepanciesInherits any GA4 gap, including consent and redirect losses

    Whichever you choose, make exactly one purchase action the primary one. Google’s conversion goals page explains that primary actions are used for bidding, while secondary actions are excluded from the “Conversions” column and kept for observation. Running a tag-based purchase and an imported GA4 purchase both as primary double-counts every order.

    Send a transaction ID with every purchase. Google’s transaction ID page says it must be unique for each transaction, may be up to 64 characters, and must not contain personal data. A static or repeated ID causes undercounting, because Google Ads may process only the first instance. Your store’s order number is the natural choice.

    WooCommerce and Shopify

    WooCommerceShopify
    Where tags runIn your theme and plugins, or through Tag Manager. You control the page.Through app pixels and custom pixels, which Shopify says run in a sandbox and cannot read the page by DOM scraping
    Google integrationGoogle for WooCommerce connects the store to Merchant Center and Google AdsThe Google & YouTube channel syncs products to Merchant Center and links to conversion tracking settings
    ConsentDepends on your banner plugin. Check that it sets consent defaults before any Google tag loads.Shopify says web pixels run only when visitors have given the required permissions, and new pixels need Marketing and Analytics permissions by default
    Typical peptide-store gapGateway plugins that mark an order “on hold” or “pending” and skip the standard thank-you pageManual or off-site payment methods where the buyer does not reach the confirmation page
    What to verifyWhich order status triggers the purchase event, and whether it can fire twice on reloadWhich app or pixel sends purchase, and that only one does

    Neither platform’s integration page describes exactly what it sends for every payment method, so do not assume. Place a test order through each payment option you offer and watch what arrives. Section 8 has the checklist. If you run Shopping campaigns, the same order data feeds the reporting described on our Google Shopping for peptides page and in our product feed guide.

    4. Enhanced conversions

    Google describes enhanced conversions as a feature that supplements your existing conversion tags by sending hashed first-party customer data, such as an email address, name, home address or phone number. The data is hashed with SHA256 before it is sent, and Google matches it against signed-in accounts to attribute conversions that cookies alone would miss.

    There are two forms: enhanced conversions for web, for sales that happen on the site, and enhanced conversions for leads, for sales completed off-site. Google’s help pages note that as of April 2026 the two are combined into a single setting in the account.

    Setting it up for web

    Google’s setup page for the Google tag puts the switch under Goals > Settings in Google Ads. You turn the feature on, accept the customer data terms, and choose how the data is collected:

    1. Automatic detection, where the tag looks for matching data on the page.
    2. CSS selectors or JavaScript variables that you specify.
    3. A code snippet that passes the fields directly. Google says data from the snippet is always prioritised.

    Google says collection will not begin until the terms are accepted, that diagnostics appear around 72 hours after setup, and that impact results take about 30 days. On a store with a redirect checkout, the code or variable method is usually more dependable than automatic detection, because the email is not on the confirmation page unless you put it in the data layer.

    Consent and customer data

    Enhanced conversions send personal data, in hashed form, to Google for advertising measurement. Hashing does not make it anonymous. Tell buyers about it in your privacy notice, and where consent is legally required, send the data only for buyers who gave it. In consent mode this is the job of the ad_user_data signal, which Google defines as consent for sending user data to Google for advertising purposes. Google’s own commitments on the data are set out in how Google uses enhanced conversion data.

    Google’s consent mode is not a banner. It is the mechanism that passes the choice your banner collects to Google’s tags, which then adjust what they do. There are four signals:

    • ad_storage: advertising cookies and identifiers
    • analytics_storage: analytics cookies
    • ad_user_data: sending user data to Google for advertising purposes
    • ad_personalization: personalised advertising

    Google’s developer guide says the last two were added in November 2023. Its EEA update page says advertisers must follow the EU user consent policy, which covers end users in the European Economic Area, the UK and Switzerland, and must share consent signals to keep using measurement and personalisation features for those users.

    Basic consent modeAdvanced consent mode
    Before the visitor choosesGoogle tags are blockedGoogle tags load with your default consent state
    If consent is deniedGoogle says no data is transferred to it at allTags send cookieless pings without advertising or analytics cookies
    Conversion modellingA general modelAn advertiser-specific model, subject to data thresholds
    Question to settle firstIs the banner blocking tags reliably?Are cookieless pings acceptable under the law that applies to your visitors?

    The second question in the last row is a legal one, and it is yours to answer with your adviser, not Google’s. If in doubt, basic mode is the conservative choice.

    Implementation points that are often missed

    • Set the default first. Google’s developer guide says the default consent command must run on every page before any command that sends measurement data, and that defaults will not work if the code is called out of order.
    • Update on choice, and remember it. Consent mode does not store the visitor’s decision. Your banner has to persist it and send the update on later pages.
    • Use region settings deliberately. Defaults can be set per region. Decide which visitors get which default on the basis of the law that applies to them.
    • Include uploads. Google’s offline import template has “Ad User Data” and “Ad Personalization” columns. Consent applies to data you upload, not only to tags.
    • Design the banner honestly. Declining should be as straightforward as accepting. A banner built to manufacture consent is a legal risk and produces data you cannot rely on.

    6. Server-side tagging basics

    In a standard setup the browser sends data straight to Google. With server-side tagging, the browser sends events to a server container that you run, and that container forwards them. Google lists three benefits: better page performance, more detailed user privacy controls and better data quality. The container can be hosted on Google Cloud or a platform of your choice, and Google recommends serving it from your own domain to get the full benefit.

    What it gives a peptide store

    • A place to receive paid-order events. A webhook from your store or processor, fired when payment is confirmed, can reach the server container even though no browser is open. That covers paths B and C in the diagram.
    • Control over what leaves. You can strip fields before data is forwarded, which is useful for keeping anything descriptive of use out of your tracking.
    • Fewer scripts in the page. Less third-party code at checkout.

    What it does not give you

    • An exemption from consent. Moving the request from the browser to your server changes the route, not the rules. Forward a visitor’s data only in line with the consent state that came with it.
    • A fix for bad events. A purchase that fires twice in the browser fires twice through the server.
    • Free running. It is infrastructure. Someone has to host, monitor and pay for it.

    Two related Google products are worth knowing by name. Google tag gateway for advertisers, announced in May 2025, serves Google tags through your own site’s infrastructure, with a Cloudflare integration and no change to existing tag code. The GA4 Measurement Protocol sends events to Analytics from a server. Google says it is meant to supplement tagging, not replace it, that purely server-to-server setups may get only partial reporting, and that new server-to-server integrations should use the Data Manager API.

    Start small

    Most stores do not need a server container on day one. Fix the confirmation page, the transaction ID and the consent defaults first, then add an offline import for delayed payments. Move to server-side tagging when you have a specific gap it closes and someone to own it.

    7. Offline conversion import for orders paid outside the site

    For crypto, bank transfer and invoice orders, the dependable route is to upload paid orders to Google Ads after the money arrives. The naming has changed, so check which page you are reading.

    • Google now labels the click-ID file upload “legacy” and says you should import conversions using Google Ads Data Manager.
    • Enhanced conversions for leads is described as an upgraded version of offline conversion import that uses user-provided data such as email addresses. Google says to include click IDs whenever possible.
    • The same page says that from 15 June 2026 these uploads move to the Data Manager API and are blocked in the Google Ads API. If a developer or a plugin built your upload before then, confirm which API it uses.

    How it works for a store

    1. Capture at order creation. When the order is placed, save the Google click ID from the landing URL against the order, along with the consent state at that moment. Only store the click ID where the visitor’s consent allows it.
    2. Wait for payment. The order moves to “paid” when the transfer or the on-chain payment is confirmed.
    3. Upload paid orders. Send the order ID, the conversion time, the value and currency, the click ID and, where the buyer has consented, the hashed email. Set the consent columns for each row.
    4. Use the same order ID as the tag. That is how an order that was also seen by the browser is recognised and not counted twice.

    Limits to plan around

    Google’s offline import FAQ says a conversion with a click ID can be uploaded as long as the click is no more than 90 days old, and gives 63 days for uploads that rely on user-provided data. After creating a new conversion action, wait 4 to 6 hours before the first upload. Processing can take 24 to 48 hours. Adjustments, for example for an order that is later refunded, are allowed for up to 55 days.

    Placed or paid?

    If a meaningful share of your transfer and crypto orders is never paid, count the conversion when payment is confirmed and send it by upload. If nearly all are paid within a day, firing at order placement and adjusting the few that fail is simpler. Either works. Mixing the two under one conversion action does not. The follow-up that turns unpaid orders into paid ones belongs in your email flows. See peptide email marketing.

    8. Checking data quality

    The test of a tracking setup is whether Google Ads and your order system tell the same story. Run this check at launch and again after any change to theme, checkout, gateway or banner.

    Data-quality checklist
    1. Place a test order through every payment method you offer, on a phone and on a desktop. Note the order ID for each.
    2. Confirm one purchase per order. Check GA4’s real-time and debug views and Tag Assistant. Reload the confirmation page and confirm it does not fire again.
    3. Check the payload. Transaction ID equals your order number. Value and currency match the order. Items are present.
    4. Decide what “value” includes. With or without tax and shipping, the same in the tag and the upload.
    5. Test the redirect. Pay on the hosted page and return. The session should keep its original source, not the processor’s domain.
    6. Test the non-return. Pay on the hosted page and close the tab. Confirm the order reaches Google Ads by server event or upload.
    7. Test declined consent. Reject on the banner, place an order, and confirm no advertising or analytics cookies were set and no customer data was sent.
    8. Test granted consent. Accept, place an order, and confirm the consent state shows as granted in Tag Assistant.
    9. Check primary and secondary. Exactly one purchase action is primary in the Purchase goal.
    10. Read the diagnostics. Open the conversion action in Google Ads and review its status and the enhanced conversions diagnostics once they appear.
    11. Reconcile weekly. Compare paid orders in the store with purchases in GA4 and conversions in Google Ads, by day and by payment method. Investigate the method with the biggest gap first.
    12. Check refunds and cancellations. Decide whether they are sent as GA4 refund events and Google Ads adjustments, and do it consistently.
    13. Write it down. One page that says what counts as a purchase, which tag or upload sends it, and who owns it.

    Do not expect the numbers to match exactly. Declined consent, ad-click attribution windows and time-zone settings all produce honest differences between a store’s order count and Google Ads. What you are looking for is a gap that is stable and explainable. A gap that jumps after a plugin update, or that is concentrated in one payment method, is a fault.

    9. How tracking quality affects Performance Max and Smart Bidding

    Google describes Smart Bidding as bid strategies that use Google AI to optimise for conversions or conversion value in every auction, and says conversion tracking must be enabled before you can use one. Performance Max works the same way: you define the conversion actions you care about and their values, and it bids on conversion probability. The conversion data is the instruction you give the system. Our Performance Max guide for peptide brands covers the campaign side.

    That has specific consequences for a peptide store.

    • Missing payment methods bias the bidding. If card orders are tracked and crypto orders are not, campaigns learn to find card buyers and under-value everyone else.
    • Double-counting inflates everything. Two primary purchase actions make every campaign look twice as good, and targets set on that basis will overspend.
    • Unpaid orders teach the wrong lesson. Counting placed-but-never-paid orders trains bidding towards people who abandon at payment.
    • Values matter as much as counts. Google’s Target ROAS page says you need to set values for the conversions you track, and asks for at least 15 conversions in the past 30 days for Search and Shopping campaigns. A wrong or missing value makes the target meaningless.
    • Volume affects stability. Google recommends judging Smart Bidding over periods that contain at least 30 conversions, or 50 for Target ROAS. Recovering untracked orders is often the quickest way to reach that.
    • Delayed uploads delay learning. Upload paid orders daily, not monthly, so bidding sees them while they are still useful.

    Google’s conversion goals page puts it directly: misconfiguring these settings can prevent Smart Bidding from optimising effectively. Good tracking does not make a campaign eligible or compliant. Product and account approval is a separate matter, covered on our Merchant Center recovery page and, for Google Ads accounts, in our suspension appeal playbook. What good tracking does is make sure that whatever budget you are allowed to spend is steered by real orders.

    10. FAQ

    Why is peptide conversion tracking less reliable than on other stores?

    Because payment often happens away from the site. Redirect checkouts send the buyer to a processor’s domain, and crypto or bank-transfer orders are paid later. In both cases the order-confirmation page may never load in the buyer’s browser, so a browser tag has nothing to fire on.

    Should the purchase conversion fire when an order is placed or when it is paid?

    Choose one and apply it everywhere. If many delayed-payment orders are never paid, count the conversion on payment and send it by upload. If nearly all are paid quickly, firing at order placement and adjusting the exceptions is simpler. Do not mix both under one conversion action.

    Do I need both GA4 and a Google Ads conversion tag?

    You need GA4 for reporting and one primary purchase conversion in Google Ads for bidding. That conversion can be a Google Ads tag or a GA4 key event imported into Google Ads. Running both as primary actions double-counts orders.

    Are enhanced conversions allowed for an RUO peptide store?

    Enhanced conversions is a measurement feature available in Google Ads accounts, subject to Google’s customer data terms and policies. It sends hashed customer data, so it also falls under privacy law. Disclose it, and where consent is required send the data only for buyers who gave it.

    Does server-side tagging get around consent banners?

    No, and it should not be used to try. Server-side tagging changes where data is processed, not whether you are allowed to collect it. The visitor’s consent state should travel with each event, and the server should forward data only in line with it.

    How do I track crypto and bank-transfer orders in Google Ads?

    Save the Google click ID against the order when it is placed, where consent allows. When payment is confirmed, upload the paid order through Google Ads Data Manager with the order ID, time, value and currency. Google’s FAQ says click-ID uploads are accepted for clicks up to 90 days old.

    Why do Google Ads conversions not match my store’s orders?

    Some difference is normal. Visitors who decline consent, orders that did not start from an ad click, attribution windows and time zones all create gaps. A gap that is stable and explainable is fine. One that is concentrated in a single payment method, or that appears after a site change, points to a fault.

    How many conversions does Smart Bidding need?

    Google asks for at least 15 conversions in the past 30 days to use Target ROAS on Search and Shopping campaigns, and recommends evaluating Smart Bidding over periods with at least 30 conversions, or 50 for Target ROAS. Check Google’s pages for the current figures for your campaign type.

    Not sure what your account is counting?

    Have your tracking checked against your orders

    Peptide Marketing works only with research-use-only peptide brands. We will trace one order through each of your payment methods, compare what reaches GA4 and Google Ads with what your store recorded, and tell you what to fix first. We do not help bypass consent or work around platform policies.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is general information for businesses selling research-use-only products. It is not legal, privacy or regulatory advice. Sources were read on 16 November 2026. Google’s features, names and requirements change, and privacy law differs by country and state. Check the linked pages and take professional advice before you act.

  • Peptide Product Page Template: COAs, Trust Signals and Conversion

    A peptide product page is read by three audiences at once: the buyer deciding whether to trust you, Google’s systems checking it against your product feed, and anyone assessing what your store intends its products to be used for. This guide is for owners and marketers of research-use-only (RUO) peptide stores. It sets out what the page should contain and in what order, from the title and certificate of analysis to reviews, Product schema and mobile layout. It is general information, not legal or regulatory advice.

    Key takeaways
    • Describe the material, not a use. Identity, purity, form, quantity and storage belong on the page. Effects, dosing and human-use language do not.
    • Put the batch evidence next to the buy button. A lot number, a stated purity and a link to that lot’s certificate of analysis (COA) do more for trust than any badge.
    • The page and the feed must agree. Google checks the landing page for title, description, image, price, currency, availability and a buy button, and compares them with your product data.
    • Policies are part of the product page. Shipping costs, returns and contact details have to be easy to find before purchase. Google treats leaving them out as misrepresentation.
    • Reviews are your content once you publish them. Moderate for human-use statements with a written rule applied to positive and negative reviews alike, and never write or buy reviews.
    • A good page is necessary, not sufficient. Google restricts unapproved pharmaceuticals in Shopping. No template guarantees approval.

    1. What the page has to do

    Most product page advice assumes one reader. An RUO peptide page has three, and each reads for something different.

    • The buyer wants to confirm what the material is, how pure this lot is, what it costs delivered and whether the supplier is real.
    • Google wants the page to match the product data you submitted. Its landing page requirements list the key elements it expects: title, description, image, price, currency, availability and a buy button. The same page says all the information in the data source will be verified.
    • Regulators and payment underwriters read the page as evidence of intended use. Under 21 CFR 201.128, intended use can be shown by labelling claims, advertising matter, or oral or written statements, and by the circumstances surrounding distribution.

    The third reader is not hypothetical. FDA warning letters to peptide sellers, including TXP Innovations (24 August 2026), Prime Sciences (31 March 2026) and Summit Research Peptides (10 December 2024), each say that website evidence established intended human drug use despite research-use labelling. The evidence they quote is mostly the sellers’ own product-page text. The TXP and Prime Sciences letters also point to bacteriostatic water sold alongside the products, and in one case a kit with a syringe. Our RUO website compliance checklist covers what those letters flag across the whole site.

    The limit of this guide

    A template cannot make a product eligible. Google’s Shopping ads and listings policies place unapproved pharmaceuticals and supplements under restricted healthcare content and say some content may not be listed anywhere. Google’s healthcare and medicines policy for ads does not allow certain products regardless of any claims of legality. Neither page mentions research use only as an exception. Build the page to be accurate. Do not build it to look like something it is not.

    2. The page order, with an annotated wireframe

    Order matters because most buyers decide from the first screen, and because Google’s crawler reads the same page. The principle is simple: identity and evidence first, policies before the purchase, long-form detail below.

    #ElementWhereWhy it sits there
    1Product titleTop of the buy boxMust describe the same product as the feed title
    2Main image and galleryTop left, or first on mobileGoogle expects an image on the landing page. The buyer checks it against the label
    3Identity lineUnder the titleForm, quantity per vial, CAS number where one exists, catalogue number
    4Purity and batch stripUnder the identity lineStated purity, current lot number, link to that lot’s COA
    5Price, variants, quantity breaksBuy boxPrice and currency must be clearly shown and match the feed
    6AvailabilityNext to priceGoogle checks that availability is clearly shown
    7RUO statement and add to cartBuy boxThe statement is read at the moment of purchase
    8Shipping and returns summaryDirectly under the buttonCosts and conditions disclosed before purchase
    9Description and specification tableBelow the first screenFull identity data for buyers who read on
    10COA panel and testing methodBelow the descriptionThe document itself, with the lab’s name
    11Storage and handlingBelow the COALaboratory storage conditions for the material
    12ReviewsNear the bottomService and quality feedback, moderated
    13Business detailsFooterLegal name, address, contact route, policy links

    Infographic: annotated product page wireframe

    RUO peptide product page wireframe

    Numbers match the table above. On a phone the blocks stack top to bottom, image first.

    2Main imageActual vial and label. No overlays, borders or watermarks.
    1TitleName, quantity, form, “for research use only”
    3Identity lineCAS no. · catalogue no. · lyophilised powder
    4Purity and batchPurity (HPLC) · Lot no. · View COA for this lot
    5Price and quantity breaksOne clear price in feed currency. Break table below it.
    6AvailabilityIn stock / out of stock, in text
    7RUO statementNot for human or veterinary use
    Add to cart
    8Shipping and returnsCost, dispatch time, returns link
    9Description and specification tableSequence, molecular formula and weight, appearance, quantity per vial. No effects, no dosing.
    10COA panelLot-specific PDF, test methods, laboratory name, test date
    11Storage and handlingStorage temperature, light and moisture, laboratory handling
    12ReviewsService, packaging, documentation. Moderated for human-use statements.
    13Footer: business detailsLegal name · address · contact · shipping, returns, terms, privacy
    Everything a visitor sees here should match the product feed and the structured data.

    3. Title and description

    The on-page title and the feed title do not have to be identical. Google’s title attribute page says they should refer to the same product. In practice we keep them the same, because it removes one source of mismatch.

    Title

    Google allows 1 to 150 characters for a feed title and says not to include promotional text or capital letters for emphasis. Price, sale and delivery information do not belong in a title either. A workable pattern for an RUO page is:

    [Compound name] [quantity per vial] [form], for research use only

    Put the most identifying words first, because Google says it will truncate titles that do not fit.

    Description

    Google’s description attribute page allows up to 5,000 characters, asks you to describe only the product itself, and says not to include promotional text, links to your store or other sites, or comparisons with other products. That suits an RUO page well. Write the description around four things:

    • Identity. Chemical name and synonyms, sequence, molecular formula, molecular weight, CAS number where one is assigned.
    • Purity. The figure for the current lot and the method used to measure it.
    • Form. Physical form, appearance, quantity per vial, container type.
    • Storage. Recommended storage conditions for the material as supplied.
    Page elementWrite thisNot this
    TitleCompound, quantity, form, RUOOutcome words, prescription brand names, “best”, “sale”
    Opening lineWhat the material is and its stated purityWhat it “does”, who it is “for”, or what studies “suggest” it may treat
    QuantityMass per vial“Doses per vial”, “weeks of supply”
    HandlingStorage temperature, protection from light and moistureReconstitution-for-injection steps, calculators, injection supplies
    Related productsOther catalogue items by category“Stacks”, kits with syringes, “frequently used with”
    Image alt text“[Compound] 10 mg vial, lot label”Body-part or outcome descriptions

    The “not this” column is drawn from the kind of text the FDA letters quote. The Prime Sciences letter cites a product title that paired a prescription brand name with “Weight Loss Supplement” and an “Application” line about disease treatment. A research-use footer did not outweigh either. For a wider treatment of site wording, our Google Ads for peptides page covers how page text and ad text are reviewed together. For feed titles specifically, see our guide to peptide product feed optimization, and for choosing the words themselves, peptide keyword research.

    4. COAs, batch data and third-party testing

    A certificate of analysis is the strongest trust signal an RUO page can carry, and it is also plain product information. How it is presented decides whether a buyer believes it.

    Make it lot-specific

    • Show the current lot number near the buy button, and link it to the COA for that lot. A single undated PDF reused across every batch tells the buyer nothing about the vial they will receive.
    • Match the label. The lot number on the page, the COA and the vial should be the same string.
    • Keep an archive. List previous lots with their COAs on the page or in a COA library, so a customer holding an older vial can find its document.
    • Update on changeover. When stock moves to a new lot, change the page figure and the linked document together.

    What a buyer looks for on the document

    • Product name, lot number and quantity tested
    • Test date and the date of the report
    • Methods, for example HPLC for purity and mass spectrometry for identity
    • Results as numbers, with the chromatogram or spectrum where the lab supplies one
    • The name of the laboratory that ran the tests, and a report or sample reference

    Third-party testing

    If you say “third-party tested”, the page should name the laboratory and say which tests it ran on which lot. If testing was done in-house or by the manufacturer, say that. The accurate statement is the safe one: Google’s misrepresentation policy does not allow inaccurate claims, and a purity figure the document does not support is an inaccurate claim.

    Do not over-read the COA

    A COA reports what was measured on a sample of a lot. Present it as that. Do not describe the material as “pharmaceutical grade”, “sterile”, “safe” or “clinically tested” unless a document you hold says exactly that, and be aware that such words also describe a use. Purity is a quality statement about a research material. It is not a suitability statement.

    5. Images that meet Google’s image rules

    Google’s image link attribute page sets the rules for the main feed image, and the same image normally leads the product page.

    • Show the exact item. The primary image must clearly display the item being sold. No placeholders, generic images or graphics that do not show the product.
    • No overlays. No promotional elements, watermarks or graphic stamps on the main image. That rules out purity badges and “lab tested” seals placed over the photo. Put those facts in text beside the image.
    • No borders.
    • Size. At least 500 x 500 pixels, with around 1500 x 1500 or above recommended. Google’s page says enforcement of the 500 x 500 minimum for all product images begins on 31 January 2027.

    Beyond Google’s rules, the picture is also a statement about use. A photograph of the sealed vial with a legible label, including the research-use statement and lot number, supports the page. Syringes, needles, alcohol swabs, body imagery, gym or clinic settings and before-and-after pictures contradict it. Keep them out of the gallery, the lifestyle banners and the category thumbnails. Use secondary images for the label close-up, the packaging and a thumbnail of the COA.

    Image handling in the feed is covered in more depth on our Google Shopping for peptides page, and creative for ads in our Performance Max for peptides guide.

    6. Pricing, quantity breaks, shipping and returns

    One clear price

    Google’s landing page requirements say to clearly show the price, in the currency of the product data, and to not change displayed product information after initial loading. Its mismatched price page says the prices in the page HTML need to match exactly the prices uploaded to Merchant Center, and that Googlebot reads structured data to verify pricing.

    For an RUO store this has three practical consequences.

    • The default price is the feed price. Whatever variant loads first should show the price submitted for that variant’s feed item.
    • Quantity breaks go in a table. Show the single-unit price as the main price and list the breaks beneath it, for example by number of vials and price per vial. Do not display the lowest tier as the headline figure if a buyer of one unit pays more.
    • No surprises at checkout. Google’s checkout requirements say the price must not increase at checkout and that mandatory fees must be clearly shown. Card surcharges and handling fees added at the last step fall foul of that.

    Shipping

    Google lists not disclosing all applicable shipping costs as a misrepresentation issue. State the cost or the rule for calculating it, the free-shipping threshold if you have one, the dispatch time and the regions you ship to, in two lines under the buy button with a link to the full policy. Shipping rates in Merchant Center may be overestimated, as long as they are not higher on your store at checkout.

    Only promise dispatch times you can meet. The FTC’s Mail, Internet, or Telephone Order Merchandise Rule guide says a seller must have a reasonable basis for any shipping time it states or implies, and for shipping within 30 days where no time is stated, and sets out delay notices and refunds when that is missed.

    Returns

    Google’s return policy page asks for clear and conspicuous refund and return information on the website, reachable without logging in and consistent with what you enter in Merchant Center. It should state the time frame, the method and any fees, and address ordinary change-of-mind cases as well as defective items. Many RUO stores do not accept opened material back. That can be a legitimate position, but it has to be written down, disclosed before purchase and applied as written. Google lists denying a refund that your own policy allows as an unacceptable practice.

    Clear terms also reduce disputes. See peptide payment processing for how processors read the same pages, and our guide to chargebacks and processor redundancy.

    7. The RUO acknowledgement and reviews

    The acknowledgement

    State the research-use condition in three places: in the title or first line, beside the add-to-cart button, and as a tick-box the buyer must accept at checkout that links to your terms. Keep the wording short and literal, for example that the product is sold for laboratory research use only and is not for human or veterinary use.

    Two cautions apply.

    • The statement does not carry the page. Each of the FDA letters cited above reached its conclusion despite a research-use statement, because the rest of the site said otherwise. The acknowledgement is consistent with a compliant page. It does not create one.
    • Do not hide the product behind it. A full-page gate that keeps the title, price, availability or buy button from loading until a visitor clicks through works against Google’s requirement that the landing page show those elements and not change them after loading. Place the acknowledgement at add-to-cart or checkout. Show Google’s crawler exactly what a visitor sees. Serving it something different is cloaking, and we do not do that.

    Reviews

    None of the three FDA letters we read cites customer reviews. The evidence quoted is the sellers’ own copy, product names, bundled items and, in one letter, social media posts. Even so, a review you choose to display is text published on your product page, and 21 CFR 201.128 looks at written statements and the circumstances of distribution. Our working rule is that reviews describing personal use, dosing or outcomes should not appear on an RUO product page.

    That has to be done without distorting the reviews themselves.

    • Publish a moderation rule. Say that reviews mentioning human or animal use, dosing or health outcomes are not published, whatever the star rating.
    • Apply it to content, never to sentiment. A one-star review about slow delivery stays up. A five-star review describing personal results does not.
    • Ask about what you can stand behind. Prompt reviewers on packaging, delivery, documentation and support.
    • Never write, buy or seed reviews. The FTC’s Consumer Reviews and Testimonials Rule, in effect since 21 October 2024, covers fake reviews, incentives conditioned on a particular sentiment and undisclosed insider reviews, and allows civil penalties for knowing violations. It also has provisions on review suppression. Read the FTC’s questions and answers, and take advice, before you finalise moderation rules.
    • Edit nothing. Publish a review as written or do not publish it. Rewriting a customer’s words to remove a claim makes it your statement.

    8. Product schema, page speed and mobile layout

    Product structured data

    Google’s merchant listing documentation is the reference for pages where a shopper can buy. In summary it asks for a Product with a name, an image and an Offer, and for the Offer to carry a price above zero and a currency. Availability, identifiers, shipping details and a return policy are recommended additions. Check the current property tables before you build, because they change.

    Three rules from Google’s general structured data guidelines matter most here.

    • Mark up only what is visible. Structured data must be a true representation of the page content. The price, availability and rating in the markup have to be the ones on screen.
    • No fake or misleading content. That includes reviews. Google’s review snippet guidelines also say not to include fake or undisclosed incentivised reviews in the page or the markup.
    • No guarantee. Google does not promise that valid markup will produce a rich result.

    Keep the schema description as clean as the visible one. Markup is marketing text too.

    Page speed

    Google recommends achieving good Core Web Vitals. The thresholds published on web.dev are a Largest Contentful Paint within 2.5 seconds, an Interaction to Next Paint of 200 milliseconds or less and a Cumulative Layout Shift of 0.1 or less, measured at the 75th percentile of page loads on mobile and desktop. On a product page the usual causes of a poor score are an oversized main image, review and chat widgets that load before the content, and price or stock blocks that appear late and push the layout down. That last one is also a Merchant Center risk, because displayed product information should not change after loading.

    Mobile layout

    Google says it uses the mobile version of a site’s content for indexing and ranking, and asks that mobile and desktop carry the same content and structured data. So the phone layout is the page of record.

    • Stack in the wireframe’s order: image, title, identity, purity and lot, price, availability, RUO statement, button, shipping summary.
    • Keep the COA link and lot number above the fold or one short scroll below it. Do not bury them in a collapsed tab that a buyer never opens.
    • Let specification tables scroll sideways inside their own box, so the page itself never scrolls horizontally.
    • Do not remove the specification table, storage section or policy links on small screens to save space.

    9. Merchant Center approval, conversion and a pre-launch checklist

    Merchant Center reviews a product by reading its landing page. Most of the avoidable problems are mismatches: a feed price that differs from the page, availability that is not stated, a link that lands on a category, a main image with a badge on it, or policies a visitor cannot find. Google’s checkout page says plainly that omission of relevant information is considered a misrepresentation, and its misrepresentation policy says some practices can lead to suspension without prior warning. If you are already there, see Merchant Center recovery, and if the Google Ads account is affected, our suspension appeal and recovery playbook.

    On conversion, we do not publish benchmark figures for this category, because we have none we could source and stand behind. What we can say is what the page changes for a buyer: whether they can confirm identity and purity for the lot in stock, see the delivered cost before checkout, and find a real business behind the store. Those are the same things Google’s policies ask for. Measure the effect in your own analytics, one change at a time. The buyers the page does win are worth keeping in touch with on the same terms. See peptide email marketing.

    Pre-launch checklist
    1. Title names the compound, quantity and form, includes the research-use statement, and describes the same product as the feed title.
    2. Description covers identity, purity, form and storage only. No effects, conditions, dosing or audiences.
    3. Lot number on the page matches the linked COA and the vial label.
    4. COA is lot-specific, dated, names the laboratory and the methods, and opens on a phone.
    5. Testing claims say who tested what. “Third-party” is used only where it is true.
    6. Main image shows the actual product at 500 x 500 pixels or more, with no overlay, watermark or border.
    7. Gallery contains no syringes, needles, body imagery or before-and-after pictures.
    8. Price and currency on first load match the feed and the structured data. Quantity breaks are in a table beneath.
    9. Availability is stated in text and matches the feed.
    10. Checkout is on HTTPS, adds no undisclosed fees, and the price does not increase.
    11. Shipping cost, dispatch time and returns are summarised under the button and linked in full, readable without logging in.
    12. RUO acknowledgement appears beside the button and as a checkout tick-box. It does not block the page from loading.
    13. Related products include no injection supplies, kits or “stacks”.
    14. Reviews follow a published moderation rule applied regardless of rating. None are written, bought or edited by the business.
    15. Product schema validates and matches what is visible, including price, availability and any rating.
    16. Mobile page shows the same content as desktop, in order, with no horizontal scroll.
    17. Core Web Vitals have been checked on the live template, and price and stock do not shift after load.
    18. Footer shows the legal business name, address and a working contact route.

    10. FAQ

    What should a peptide product page include?

    A title naming the compound, quantity and form, a description limited to identity, purity, form and storage, the current lot number with its certificate of analysis, an image of the actual product, a clear price and availability, shipping and returns information, a research-use statement, and business contact details.

    Does a research-use-only disclaimer make a product page compliant?

    No. FDA warning letters to peptide sellers in 2024 and 2026 concluded that website evidence established intended human use despite research-use labelling. The statement has to be consistent with everything else on the page, including titles, descriptions, images and related products.

    Will a well-built product page get my peptides approved in Google Merchant Center?

    Not on its own. Google restricts unapproved pharmaceuticals and supplements in Shopping and says some content may not be listed anywhere. An accurate page that matches the feed removes avoidable disapprovals such as price or availability mismatches. It does not change whether a product is eligible.

    Where should the certificate of analysis go on the page?

    Put the stated purity, the current lot number and a link to that lot’s COA close to the buy button, then show the document and test methods in a panel below the description. Keep an archive of earlier lots so customers can find the document for a vial they already hold.

    Can I put a purity badge or “lab tested” seal on the product image?

    Not on the main image used in your product feed. Google’s image rules do not allow promotional elements, watermarks, graphic stamps or borders on it. State the purity and testing details in text next to the image.

    How should an RUO store handle customer reviews?

    Publish a written moderation rule and apply it to content, not to star rating. Reviews about service, packaging and documentation are fine. Reviews describing personal use, dosing or outcomes should not be displayed. Never write, buy or edit reviews. The FTC’s Consumer Reviews and Testimonials Rule has applied since 21 October 2024.

    Should the page be hidden behind an age gate or RUO pop-up?

    We advise against a gate that stops the title, price, availability or buy button from loading. Google expects those elements on the landing page and says displayed product information should not change after loading. Place the acknowledgement at add-to-cart or checkout, and show crawlers the same page visitors see.

    What structured data does a peptide product page need?

    Product markup with a name, an image and an Offer carrying the price and currency, following Google’s merchant listing documentation. Add availability and other recommended properties where you can. The markup must match what is visible on the page, and valid markup does not guarantee a rich result.

    Want a second pair of eyes?

    Have your product page template reviewed

    Peptide Marketing works only with research-use-only peptide brands. We will go through one of your product pages against your feed, your structured data and the checklist above, and tell you what to change first. We do not help disguise products or work around platform policies.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is general information for businesses selling research-use-only products. It is not legal or regulatory advice. Sources were read on 16 November 2026. Google’s policies and enforcement change. Check the linked pages and take professional advice before you act.

  • Chargebacks and Processor Redundancy for Peptide Stores

    Peptide chargebacks are the most common reason a research-use-only (RUO) peptide store loses its ability to take cards. A few dozen disputes in a month can move a small merchant from normal processing to a reserve, a monitoring programme or a closed account. This guide is for owners and marketers of RUO peptide stores. It explains why the category is underwritten as high risk, how the Visa and Mastercard monitoring programmes count disputes in 2026, what causes disputes, how to prevent and contest them, and how to build a backup payment stack that every provider knows about. It is general information, not financial or legal advice.

    Key takeaways
    • The networks count, they do not judge. Visa and Mastercard programmes are triggered by ratios and counts. Winning a dispute later does not remove it from the count.
    • Visa now counts fraud reports too. The Visa Acquirer Monitoring Program (VAMP) adds fraud reports and disputes together. The merchant “Excessive” line is 1.5% in the US, Canada, the EU and Asia Pacific since 1 April 2026.
    • Mastercard’s line is also 1.5%, with at least 100 chargebacks in the month, measured against the previous month’s transactions.
    • Your processor will act long before the network does. Most small stores never reach the network minimums. They meet their processor’s own risk limits first.
    • Most prevention is plain operations: a recognisable descriptor, prompt order and shipping emails, a refund policy people can find, and fast refunds.
    • A backup processor is sensible. A hidden one is not. Every provider should get the same accurate description of what you sell.

    1. Why peptide merchants are underwritten as high risk

    A payment processor is financially responsible for the merchants it boards. If a store cannot cover its chargebacks or network assessments, the processor and its acquiring bank pay. Underwriters therefore price two things: how likely disputes are, and how likely the business is to breach a rule the processor answers for. RUO peptides score poorly on both.

    • The product category is written into restricted lists. Stripe’s restricted businesses list does not name peptides, but it prohibits incorrectly labelled research chemicals, card-not-present prescription-only products and pharmaceuticals, and pseudo-pharmaceuticals that are unsafe or make harmful claims. PayPal’s Acceptable Use Policy prohibits products that present a risk to consumer safety. Shopify Payments lists pseudo-pharmaceuticals. An underwriter reads your site and decides which side of those lines you fall on.
    • The card networks treat nearby categories as high risk. Visa’s Merchant Data Standards Manual lists card-absent merchants under the drug category codes 5122 and 5912 as high-integrity risk. Mastercard’s Security Rules and Procedures require acquirers to register non-face-to-face pharmaceutical merchants. Neither document mentions research peptides. The point is that acquirers are cautious about anything that sits close to those categories.
    • Regulatory action is visible. The FDA has sent warning letters to peptide sellers in 2026, and processors read the same letters you do. Our RUO website compliance checklist summarises what those letters cited.
    • Sales are card-not-present and shipped. Every order can be disputed as fraud or as not received.
    What this means in practice

    Expect a longer application, requests for supplier documents and certificates of analysis, a review of your website, higher fees than a low-risk store pays, and possibly a reserve. Those terms are the cost of an account that knows what you sell. An account opened under a vaguer description is cheaper only until its first review.

    2. How Visa and Mastercard monitoring works in 2026

    Both networks run programmes that identify merchants with too many disputes. They work differently, and both changed recently.

    Visa: the Visa Acquirer Monitoring Program (VAMP)

    Visa’s VAMP fact sheet describes one global programme that consolidates the earlier Visa Dispute Monitoring Program and Visa Fraud Monitoring Program. Three features matter to a merchant.

    • One combined ratio. The VAMP ratio is the count of fraud reports (which Visa calls TC40) plus the count of disputes (TC15), divided by the count of settled card-not-present transactions. It is based on counts, not value.
    • Fraud is counted even without a chargeback. A fraud report from an issuer adds to the numerator on its own. Stripe’s documentation notes that a payment with both a fraud report and a dispute is counted twice.
    • The merchant line dropped in 2026. A merchant is “Excessive” at a ratio of 1.5% or more with at least 1,500 fraud reports and disputes in the month. In the US, Canada, the EU and Asia Pacific that line was 2.2% until 1 April 2026.

    VAMP also measures the acquirer’s whole portfolio. Visa’s fact sheet sets “Above Standard” at 0.5% and “Excessive” at 0.7% for acquirers. This is why your processor cares about your ratio long before you reach 1,500 items: every dispute you receive counts against its own number. Stripe’s documentation, for example, describes a lower tier at a ratio of 0.5% that may attract fees.

    Visa’s fact sheet says disputes resolved through pre-dispute solutions are excluded from the ratio. Processors describe the details differently, so ask yours exactly which resolutions it excludes. Visa does not publish its fees in the fact sheet. Checkout.com’s VAMP article reports a fee of USD 8 per fraud or dispute item for Excessive merchants. Your own processor’s pass-through may differ.

    Mastercard: the Excessive Chargeback Program (ECP)

    Mastercard’s Security Rules and Procedures define the ratio: chargebacks received in a month divided by Mastercard transactions in the preceding month. Mastercard keeps the thresholds in a manual that is not public, so the figures below come from Stripe’s documentation.

    Programme and tierRatioMinimum monthly countWhat is counted
    Visa VAMP, merchant Excessive (US, Canada, EU, Asia Pacific, Latin America)1.5% or more1,500 fraud reports plus disputesFraud reports plus disputes, over settled card-not-present transactions in the same month
    Visa VAMP, merchant Excessive (Central Europe, Middle East and Africa)2.2% or more150, and at least USD 75,000As above
    Mastercard Excessive Chargeback Merchant (ECM)1.5% to 2.99%100 to 299 chargebacksChargebacks this month over transactions in the previous month
    Mastercard High Excessive Chargeback Merchant (HECM)3% or more300 or more chargebacksAs above
    Mastercard Excessive Fraud Merchant (EFM)Fraud chargebacks above 0.50%1,000 e-commerce transactions and more than USD 50,000 in fraud chargebacksFraud chargebacks only, where few payments use 3-D Secure

    Sources: Visa VAMP fact sheet and Stripe monitoring programmes documentation, read 16 November 2026. Some countries have different figures. Confirm the current numbers with your processor.

    Stripe’s page lists Mastercard assessments that start at USD 1,000 in the second month in the programme and rise the longer a merchant stays. It also says a merchant leaves after three consecutive months below the thresholds, and that refunds and dispute wins do not reduce the count.

    A change to watch

    A Checkout.com merchant notice dated 19 August 2026 says Mastercard will introduce a Global Merchant Audit Program on 1 April 2027, with new dispute monitoring for merchants. We did not find a public Mastercard document confirming the detail. Ask your processor what will apply to your account.

    The MATCH list

    If an acquirer closes your account for certain reasons, it must add you to Mastercard’s MATCH Pro database. The Security Rules say acquirers must check it before signing a merchant, and that records stay for five years. Excessive chargebacks is one listing reason. Transaction laundering is another. A listing makes a new card account very hard to get, which is the practical reason to manage disputes early.

    3. What causes chargebacks in this category

    In the US, a cardholder can dispute a billing error within 60 days of the statement, and the FTC’s consumer guidance lists goods not delivered as agreed as one such error. Network rules give issuers longer. Stripe says networks typically allow 120 days. Most peptide disputes fall into three groups.

    Unclear billing descriptors

    The buyer sees a name on the statement that they do not connect with your store. This often happens when the legal entity name differs from the brand, or when a store deliberately uses a vague name. The buyer, or a partner who shares the account, reports it as fraud. Under VAMP that single event can produce a fraud report and a dispute.

    Shipping delays and silence

    Stock gaps, cold-chain holds, customs and carrier delays are routine in this category. A late parcel becomes a dispute when the buyer hears nothing. The FTC’s Mail, Internet, or Telephone Order Merchandise Rule also applies to US sellers: you need a reasonable basis for your stated shipping time, or for shipping within 30 days if you state none, and if you cannot ship on time you must tell the buyer and offer a cancellation and refund.

    Friendly fraud

    Friendly fraud is a dispute from the real cardholder for a purchase they made. Causes include buyer’s remorse, a forgotten order, a family member’s purchase, or a wish to avoid the return process. Buyers in this category may also be reluctant to explain a purchase to someone else who sees the statement, which makes “I don’t recognise this” an easy answer.

    True fraud and card testing

    Stolen cards are used on any store with high-value, easily resold goods. Card testing, where a bot runs many small authorisations, is tracked separately by Visa as enumeration.

    4. Prevention: descriptors, emails, refunds, alerts and 3-D Secure

    Use a descriptor the buyer recognises

    Stripe’s statement descriptor rules are a good reference even if you use another processor: 5 to 22 characters, reflecting the name you do business as, because clear descriptors can reduce chargebacks. Use your store’s brand name, and add a support phone number or URL where the processor allows it. Repeat the descriptor in the order confirmation email: “This charge will appear on your statement as…”.

    A descriptor that hides the business from the cardholder or the bank causes disputes and is a form of misdescription. Do not use one.

    Send order and shipping emails that answer questions before the bank does

    • Order confirmation within minutes: items, total, descriptor wording, expected dispatch date and a reply-to address someone reads.
    • Dispatch email with carrier and tracking link.
    • Delay email as soon as you know, with a new date and a one-click option to cancel for a refund.
    • Delivery confirmation, with the support contact repeated.

    These are transactional messages and should stay free of product claims. Our peptide email marketing page covers how we build these flows within RUO framing.

    Publish a refund policy people can find, and honour it quickly

    State what can be returned or refunded, in what condition, within how many days, and how to ask. Link it in the footer, at checkout and in the confirmation email. When a customer is clearly heading for a dispute, a prompt refund is usually cheaper than the dispute: Stripe’s US pricing, for example, charges USD 15 for a dispute received and a further USD 15 if you contest it, and the dispute counts toward your ratio whether or not you win.

    Use alert and order-detail tools

    • Verifi Rapid Dispute Resolution (RDR) is a Visa service that automatically refunds a pre-dispute according to rules you set, before it becomes a chargeback.
    • Verifi Order Insight shares order details with the issuer so the cardholder can recognise the purchase.
    • Ethoca Alerts, from Mastercard, notifies the merchant of a dispute early so it can refund first.
    • Ethoca Consumer Clarity shows recognisable purchase details in banking apps.

    These tools cost money per alert and they trade a dispute for a refund. Check with your processor whether it supports them, and which resolutions it excludes from your VAMP count.

    Turn on 3-D Secure where it makes sense

    3-D Secure asks the issuer to authenticate the cardholder. Stripe’s documentation says that when an authenticated payment is disputed as fraudulent, liability typically shifts to the issuer. It does not cover other reasons, such as a product not received. Stripe also notes that Mastercard still counts liability-shifted chargebacks in its programme ratios. 3-D Secure adds a step at checkout, so many stores apply it by risk rule, for example to first orders above a set value.

    Screen for obvious fraud

    Require the card security code, use address verification, review orders where billing and shipping addresses differ, limit repeated attempts from one device, and consider signature on delivery for high-value parcels.

    Marketing affects disputes too

    A buyer who was promised an outcome and did not get it is a dispute waiting to happen, and outcome claims are a compliance problem in their own right. Accurate, claim-free product pages and ads produce buyers who know what they ordered. See our pages on Google Ads for peptides and Google Shopping for peptides, and Merchant Center recovery if a listing problem is already affecting orders. Earlier guides in this series cover claim-free product feed titles and recovering a suspended Google Ads account.

    5. How to fight a dispute with evidence

    Contesting a dispute means sending evidence through your processor to the cardholder’s bank. Stripe’s description of the process is typical: you usually have 7 to 21 days to respond, you get one submission, and the outcome is at the discretion of the cardholder’s bank. Deadlines vary by processor and network, so use the date shown on the dispute itself.

    Match the evidence to the reason given. Stripe’s dispute categories guide recommends:

    Dispute reasonEvidence that answers it
    Product not receivedShipping address that matches a verified billing address, carrier name, tracking number, shipping date and delivery confirmation. Or proof that a refund was already issued.
    FraudulentAddress and security-code match results, delivery proof and signature, and a history of earlier undisputed orders from the same customer.
    Credit not processedThe refund policy text, how it was shown before purchase, and why the customer was not entitled to a refund. Or proof the refund was sent.

    Visa Compelling Evidence 3.0

    For Visa fraud disputes, Visa’s merchant readiness document sets out a specific test. You show two earlier transactions from the same customer, each between 120 and 365 days old and neither reported as fraud. At least two data elements must match the disputed order, from user ID, IP address, shipping address and device ID, and one of the two must be the IP address or device ID. Stores with customer accounts and repeat buyers can meet this if they log those fields. Visa’s fact sheet says fraud reports that qualify are excluded from the VAMP ratio.

    Practical rules

    • Keep the response short and factual. A one-page summary followed by labelled evidence.
    • Send only your own records. Never alter a document or invent a delivery record.
    • Do not contest what you cannot evidence. If the parcel was lost, accept the dispute.
    • Do not refund a payment after it has been disputed unless your processor tells you to. The bank has usually already returned the money.
    • Log every dispute by reason, product, carrier and traffic source. The pattern is more useful than any single win.

    6. Rolling reserves and what they do to cash flow

    A reserve is money the processor holds back to cover future disputes and refunds. Stripe’s reserves FAQ describes it as a temporary hold on part of a business’s funds and lists reasons that include long delivery windows, elevated dispute activity and sudden unexplained growth in volume.

    PayPal’s reserves article explains the common types:

    • Rolling reserve. A percentage of each day’s sales is held and released on a schedule. PayPal’s example is 10% held for 90 days.
    • Minimum reserve. A fixed balance must be kept. PayPal’s example is 5% of daily volume until USD 5,000 is reached.

    Those are illustrations, not quotes for your account. High-risk agreements often carry larger percentages or longer periods, and the terms are set in the merchant agreement.

    Planning for a reserve

    Read the reserve clause before you sign: the percentage, the hold period, whether the processor may raise it without notice, and how long funds are held after the account closes. Model your cash flow with the reserve in place, including the cost of inventory you must buy while money is held. A sudden jump in sales after a promotion is a common trigger, so tell your processor before a large campaign.

    7. Building a backup payment stack, honestly disclosed

    No processor is permanent in this category. A portfolio review, a change of acquiring bank or a policy update can end an account that has done nothing wrong. Redundancy means a second account is already approved when that happens.

    One accurate business description, given to every provider:
    what you sell, RUO terms, website, volumes, dispute history
    Store checkoutOne brand, one descriptor family, one refund policy
    1. Primary processor
    Card acquiringHigh-risk account underwritten for RUO peptides
    • Takes most card volume
    • Alerts and 3-D Secure enabled
    • Reserve terms known
    2. Backup processor
    Card acquiringSecond approved account with a different acquiring bank
    • Takes a steady share of volume
    • Told that a primary exists
    • Ready to take more
    3. Alternative rails
    Non-card paymentsEach within the provider’s own terms
    • ACH or bank transfer
    • Invoice for lab accounts
    • Crypto, where permitted
    Monitor each account separately: dispute ratio, fraud reports, refund rate, reserve balance

    How to build it

    • Apply to the backup while the primary is healthy. An application made after a termination is weaker, and you must answer truthfully if asked about one.
    • Use a different acquiring bank. Two sales agents that board to the same bank are one point of failure.
    • Tell both processors. Disclose that you hold another account and how you split volume. Give both the same product list, website and processing history.
    • Keep the backup active. Route a steady, modest share through it. An account that goes from nothing to full volume overnight invites a review and a reserve.
    • Do not use a second account to dilute a problem. Each merchant account is measured on its own. Fix the cause of the disputes.

    Alternative rails

    • ACH or bank transfer. There is no card chargeback, but ACH debits can be returned. Nacha’s rules set an unauthorised return rate threshold of 0.5%, so ACH has its own monitoring.
    • Invoicing for institutional buyers. Labs and universities often prefer purchase orders and bank payment.
    • Cryptocurrency. The FTC notes that crypto payments are typically not reversible. That removes chargebacks but also removes a protection buyers expect, so your refund policy carries more weight. Use a provider whose terms allow your business, and take tax and legal advice.
    What we will not help with

    Describing the business to a processor as something else, such as supplements or cosmetics. Running sales through another company’s merchant account or a separate “clean” website. Splitting one business across shell entities to reset a dispute count. Mastercard’s rules require a merchant to submit only its own transactions, Visa’s Acceptance Risk Standards define transaction laundering as an unknown business using an approved merchant’s credentials, and MATCH has a listing code for it. These routes end in terminated accounts, held funds and a five-year listing. Our peptide payment processing page describes how we approach applications openly.

    8. The monthly chargeback checklist

    Run this every month
    1. Calculate both ratios per account. Visa: fraud reports plus disputes, divided by settled transactions this month. Mastercard: chargebacks this month divided by last month’s transactions.
    2. Compare against your processor’s limits, not only the network thresholds. Ask for those limits in writing if you do not have them.
    3. Sort disputes by reason. Fraud, not received, not as described, credit not processed.
    4. Check the descriptor. Look at a real statement or a test charge and confirm it shows your brand and a contact.
    5. Test the emails. Place an order and confirm that the confirmation, dispatch and delay emails send, and that replies reach a person.
    6. Measure support response time and refund turnaround. Set a target and record misses.
    7. Review late shipments. Confirm every delayed order received a notice with a cancellation option.
    8. Review alert and 3-D Secure performance. How many alerts arrived, how many were refunded in time, and what authentication did to approval rates.
    9. Reconcile the reserve. Confirm amounts held and released match the agreement.
    10. Check the backup. Confirm it processed volume this month and that its details on file are current.
    11. Confirm disclosures are still accurate. If your catalogue, website or volumes changed, tell each processor.
    12. Write down one cause to fix before next month, with an owner.

    9. FAQ

    What chargeback rate is too high for a peptide store?

    Visa’s merchant Excessive threshold is 1.5% of card-not-present transactions, counting fraud reports and disputes together, in most regions. Mastercard’s Excessive Chargeback Merchant tier starts at 1.5% with at least 100 chargebacks. Processors usually set stricter limits of their own, so ask yours.

    Why are peptide chargebacks treated more seriously than in other niches?

    Processors already classify the category as high risk because it sits close to restricted product lists and has seen regulatory action. A dispute ratio that a low-risk store might survive can prompt a reserve or a closure for a peptide merchant.

    Does winning a dispute remove it from my ratio?

    No. Stripe’s documentation on the network programmes says refunds and dispute wins do not reduce the counts. Prevention and pre-dispute resolution matter more than representment for staying under thresholds.

    Does 3-D Secure stop chargebacks?

    It typically shifts liability for fraud disputes to the card issuer on authenticated payments. It does not cover disputes such as product not received, and Mastercard still counts liability-shifted chargebacks toward its programme ratios.

    What is a rolling reserve?

    A processor holds a percentage of each day’s sales and releases it after a set period. PayPal’s published example is 10% held for 90 days. Your percentage and period are set in your merchant agreement.

    Can I have two payment processors at the same time?

    Yes, and it is sensible in this category. Tell each processor about the other, give both the same accurate description of the business, and keep real volume on both. Do not use a second account to hide or dilute disputes.

    Can I describe my store as supplements to get approved?

    No. Misdescribing the business breaches the merchant agreement and can lead to termination, held funds and a MATCH listing that lasts five years. We do not assist with it.

    Is this guide financial or legal advice?

    No. It is general information about card-network programmes and processor policies. Thresholds and fees change, and your merchant agreement governs your account. Take advice from a qualified professional.

    Need a second opinion?

    Talk through your dispute numbers and payment setup

    Peptide Marketing works only with research-use-only peptide brands. We will look at your dispute reasons, your descriptor and order emails, and the marketing that brings in your buyers, and tell you what to fix first. We do not help misdescribe a business to a processor.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is general information for businesses selling research-use-only products. It is not financial, legal or regulatory advice. Sources were read on 16 November 2026. Card-network thresholds, fees and processor policies change, and your merchant agreement governs your account. Check the linked pages and take professional advice before you act.

  • Peptide Keyword Research: Safe Terms, Risky Terms and a Negative Keyword List

    Choosing peptide keywords for Google Ads is less about finding volume and more about deciding which searches a research-use-only (RUO) store should appear for at all. The same list drives your SEO page titles, so a poor choice shows up twice. This guide is for owners and marketers of RUO peptide stores. It sorts terms into lower-risk, caution and avoid groups, explains what Google’s policies say about keywords, and covers match types, ad group structure, a starter negative keyword list and a weekly search-term review. It is general information, not legal or regulatory advice.

    Key takeaways
    • Keywords are inside Google’s policy. Google says it restricts prescription drug terms in ads, landing pages and keywords. Keyword-targeting those terms needs a certification built for pharmacies, telemedicine providers and manufacturers.
    • Lower risk means brand, category, quality and lab-supply terms. Your own name, “research peptides”, purity and certificate-of-analysis (COA) terms, and business-to-business supply terms.
    • Avoid human-use intent. Dosing, weight loss, conditions, prescription-drug brand names and “no prescription” terms describe a use your store says it does not sell for.
    • Negative keywords do most of the work. They do not match synonyms or plurals, so the list has to be built by theme and maintained.
    • Review search terms weekly. Close variants cannot be switched off, so even exact match keywords pick up queries you did not choose.
    • Keywords do not fix a site. Google reviews the destination and the products. A careful keyword list on a non-compliant site is still a non-compliant account.

    1. Why keyword choice matters more for RUO peptide stores

    In most niches a bad keyword wastes money. In this one it can also be read as a statement about what you sell and to whom. Three things make that true.

    Google’s policy names keywords

    Google’s restricted drug terms policy says: “Google restricts the use of prescription drug terms in ads, landing pages, and keywords.” For campaigns targeting the US, Canada or New Zealand, the page allows promotional use under local law but requires certification to keyword-target those terms. Google’s October 2025 policy update names online pharmacies, telemedicine providers and pharmaceutical manufacturers as business types that need certification. An RUO supplier is none of those, and we know of no certification route designed for one. Confirm your own position with Google before you assume otherwise.

    This matters because several compounds that RUO stores list share a name with the active ingredient of an approved prescription medicine. Semaglutide and tirzepatide are the obvious examples. Google links a non-exhaustive list of prescription drugs from the update.

    The unapproved substances policy applies to the product

    Google’s healthcare and medicines policy does not allow certain products “regardless of any claims of legality”. Its examples include products that are not government approved and imply they are safe or effective for treating a condition, products subject to government or regulatory action or warning, and products with names confusingly similar to an unapproved product. The same page does not allow promotion of speculative or experimental medical treatments. Google’s list of unapproved pharmaceuticals and supplements describes itself as not exhaustive. When we read it, it named no peptides, which means the absence of a compound from that list tells you nothing.

    Regulators read marketing text as evidence of intended use

    The FDA’s 2026 warning letters to peptide sellers, including TXP Innovations (24 August 2026) and Prime Sciences (31 March 2026), say that website evidence established human drug use despite “research use only” labelling. The evidence quoted is product-page text. In the Prime Sciences letter it includes a page title that paired a prescription brand name with the words “Weight Loss Supplement”. A page title is exactly what keyword research produces. An earlier letter to Summit Research Peptides also quoted Facebook posts.

    None of the three letters we read cites a keyword list, a metatag or a hashtag. We are not claiming the FDA audits Google Ads accounts. The practical point is narrower: the words you choose to rank and advertise for end up in headlines, titles and descriptions, and those are marketing text.

    The limit of this guide

    Keyword choice does not make a non-compliant site compliant. Google’s policy overview applies its rules to ads, assets and destinations. If product pages carry outcome claims, dosing language or reconstitution calculators, a clean keyword list changes nothing about them. Fix the site first. Then build keywords that describe it accurately. Our RUO website compliance checklist covers what to change.

    2. How to research peptide keywords without inventing numbers

    We do not quote search volumes in this guide. We have no reliable volume data for this category to publish, and Google’s own tool is limited here: the Keyword Planner help page says keywords with very low volume or sensitive keywords cannot be discovered or forecast, and that its policies often prevent results for sensitive categories such as health. Treat any third-party volume figure for a peptide term as an estimate from a model, and check how it was produced.

    Use sources that reflect your own store instead.

    • Your search terms report. The best list of real queries is the one your account already has. Section 8 covers how to read it.
    • Google Search Console. The queries report shows what your pages already appear for, with impressions and clicks from your own site.
    • Keyword Planner, for what it will show. Category and lab-supply terms usually return estimates. Use them to compare terms with each other, not as forecasts.
    • Your own site search and support inbox. The words buyers type into your search box and emails are the words they use.
    • Supplier and laboratory vocabulary. Purity, HPLC, mass spectrometry, lyophilised, COA, lot number, CAS number. Researchers and procurement staff search with these.
    • Search results pages. Autocomplete and related searches show how a query is commonly completed. They are also the fastest way to find negative keywords, because most completions are consumer-use phrases.

    Record every term in one sheet with four columns: the term, the intent you believe is behind it, the page on your site that honestly answers it, and its group from the next section. A term with no honest landing page does not belong in the account.

    3. The three groups: lower risk, caution, avoid

    Google publishes no list of approved peptide keywords. The grouping below is our working judgement, built from the policies and letters cited above. “Lower risk” does not mean approved. Any ad can still be limited or disapproved on review of the product and the destination.

    Lower risk

    • Your brand. Store name, domain and common misspellings of them.
    • Category terms with research framing. “Research peptides”, “peptides for research”, “research peptide supplier”, “laboratory peptides”.
    • Quality and documentation terms. “HPLC tested peptides”, “peptide certificate of analysis”, “third-party tested peptides”, “peptide purity testing”, “lyophilised peptides”.
    • Lab-supply and business terms. “Custom peptide synthesis”, “bulk research peptides”, “peptide supplier for laboratories”, “wholesale research peptides”.

    These describe what an RUO store is: a supplier of documented material to people doing laboratory work. They also bring fewer buyers who expect a consumer product.

    Caution

    • Generic buying terms. “Buy peptides”, “peptides for sale”, “peptides online”. The query does not say who is buying or why, and much of the traffic is consumer intent.
    • Compound names that are not approved medicines. The name alone is not a claim, but search intent around many compounds is about personal use, and Google’s unapproved substances policy is applied to products, not only to wording.
    • “Research chemicals”. Accurate for some catalogues, but the phrase also attracts searches for unrelated substances.
    • Laboratory water and supplies. The FDA letters above treated bacteriostatic water as a drug where it was sold alongside injectable products or in a kit with a syringe.
    • Competitor names. Google’s trademarks policy does not restrict trademarks as keywords, and limits them in ad text after an owner’s complaint. Policy allows the bid. Whether it is worth it is a commercial question, and you inherit that competitor’s audience and its intent.
    • “Reviews”, “best”, “legit”. Often useful brand modifiers, but check each query: “results” and “before and after” sit one step away.

    If you run caution terms, use exact or phrase match, give them their own ad group, and review their search terms every week.

    Avoid

    • Human-use and dosing terms. Dosage, dose, how to inject, how to take, cycle, protocol, side effects.
    • Outcome and condition terms. Weight loss, fat loss, muscle growth, anti-ageing, healing, and any disease or condition name. Google’s policy overview lists unrealistic weight-loss claims as an example of misrepresentation.
    • Prescription drug terms. Brand names of approved medicines, and the generic names of their active ingredients, unless your business holds the certification Google requires for keyword targeting.
    • Access terms. “For sale no prescription”, “without a prescription”, “online pharmacy”, “telehealth”, “compounded”.
    • Consumer forms and audiences. Pills, capsules, nasal spray, pens, “for men”, “for women”, “for dogs”.

    Every term in this group describes a use that an RUO store states it does not sell for. Bidding on it contradicts the label.

    Do not disguise terms

    Code names, deliberate misspellings and spaced-out letters are not a fourth group. Google’s abusing the ad network policy covers manipulating text to bypass detection, and its circumventing systems policy covers cloaking and opening new accounts after a suspension. Google treats circumvention as egregious and can suspend without warning. The Prime Sciences letter also shows the FDA identifying products sold under abbreviated names. We do not build campaigns this way.

    4. Infographic: the keyword traffic-light chart

    Peptide keyword traffic-light chart

    Read by label and shade. White is lower risk, grey is caution, black is avoid.

    Lower riskWhite · build here first
    • Your brand and domain
    • “Research peptides”
    • Purity, HPLC and COA terms
    • Third-party testing terms
    • Custom synthesis, bulk, wholesale
    • Laboratory supplier terms
    Action: exact and phrase match, own ad groups
    CautionGrey · test narrowly
    • “Buy peptides”, “peptides for sale”
    • Compound names that are not approved medicines
    • “Research chemicals”
    • Laboratory water and supplies
    • Competitor names
    • “Reviews”, “best”, “legit”
    Action: exact match only, weekly review
    AvoidBlack · add as negatives
    • Dose, dosage, inject, cycle
    • Weight loss, muscle, anti-ageing
    • Disease and condition names
    • Prescription drug brand names
    • “No prescription”, pharmacy, telehealth
    • Pills, sprays, “for men”, “for dogs”
    Action: do not target, exclude
    No column makes a non-compliant site compliant. Fix the site, then choose keywords.

    5. Match types and why broad match needs care

    Google’s keyword matching options page defines three match types. Negative keywords use the same names but behave differently, which catches many advertisers out.

    Match typeAs a keyword you bid onAs a negative keywordUse in an RUO peptide account
    Exact [research peptides]Searches with the same meaning or intent as the keywordBlocks only that exact query, same order, no extra wordsDefault for brand, category and every caution term
    Phrase “research peptides”Searches that include the meaning of the keywordBlocks queries containing those words in that order, with extra words allowedGood for lower-risk terms once negatives are in place. The usual choice for multi-word negatives
    Broad research peptidesRelated searches, including ones that do not contain the keyword’s literal meaningBlocks queries containing all the words, in any orderRisky as a keyword in this niche. The usual choice for single-word negatives such as “dosage”

    Source: Google Ads Help, keyword matching options and about negative keywords, read 16 November 2026.

    Two details from Google’s pages shape how we set accounts up.

    • Broad match reads more than the keyword. Google says broad match may also use the person’s recent searches, the content of the landing page and assets, and the other keywords in the ad group. In a category where most related searches are about personal use, “related” is the problem. Google also says Smart Bidding is critical with broad match. If you test broad match, do it on lower-risk terms only, with conversion tracking, Smart Bidding and a full negative list already in place.
    • Close variants cannot be switched off. Google’s close variants definition includes misspellings, plurals, reordered words, synonyms and same-intent queries, and says there is no way to opt out. Exact match is therefore not a guarantee. It is a narrower starting point that still needs the review in section 8.

    6. Ad group structure and your business name in headlines

    Group keywords by intent, and give each group a landing page that answers that intent in RUO terms. Small, tightly themed ad groups make the search terms report readable and stop one risky query from being hidden among hundreds.

    Ad groupExample keywordsLanding pageHeadline theme
    Brand[your store name], “your store name peptides”Home pageBusiness name, official site, RUO supplier
    Category[research peptides], “peptides for research”Catalogue or category pageResearch peptides, for laboratory use only
    Quality and COA“HPLC tested peptides”, “peptide certificate of analysis”Testing or COA library pageBatch COAs, third-party tested, stated purity
    Lab supply“custom peptide synthesis”, “bulk research peptides”Wholesale or enquiry pageBulk supply, purchase orders, documentation
    Caution terms (optional)[buy peptides], one compound per ad groupThe matching category or product pageSame RUO wording, no outcome language

    Writing the ads

    A responsive search ad takes 3 to 15 headlines of up to 30 characters and 2 to 4 descriptions of up to 90 characters. Google recommends including at least one keyword in the headlines. Because Google assembles combinations, every headline must be acceptable next to every other. Write each one so it is accurate on its own, and keep outcome words out of all of them.

    Pinning fixes a headline to a position. Google says pinning is not recommended for most advertisers and can lower Ad Strength. In this category we still pin an RUO statement such as “For Research Use Only” to a headline position, and accept the lower score, because we would rather every impression carry it.

    Using an approved business name

    If your verified business name or domain contains the word “peptides”, that name is yours to use. There are two legitimate places for it.

    • The business name asset. Google’s business information page requires completed advertiser verification, and says a business name that does not exactly match the verified domain or verified legal name is not approved. After advertiser verification, your name and location also appear in ad disclosures.
    • Headlines and brand keywords. Use the name exactly as verified, in a headline and as exact and phrase match keywords in the Brand ad group.

    This is accurate identification of the advertiser. It is not a route around review. Ads that use the name are still reviewed, and the name does not carry over to claims or to other terms. Do not rename a business or register a domain to place a restricted term in ad text.

    For how this fits a whole account, see our Google Ads for peptides page. If an account has already been suspended, start with our suspension appeal and recovery guide.

    7. A starter negative keyword list by theme

    Negative keywords tell Google which searches not to show your ads for. Three rules from Google’s negative keywords page decide how to build the list.

    • Negatives are literal. Google says negative keywords will not match close variants or other expansions. Add singular and plural forms and synonyms by hand: “dose”, “doses”, “dosage”, “dosing”. Google says casing and misspellings are handled automatically.
    • Choose the match type on purpose. A single word as a broad negative blocks any query containing it. A multi-word broad negative blocks only queries containing all of its words, so use phrase match for strings such as “weight loss”.
    • There are limits. Google’s negative keyword lists page allows up to 5,000 keywords per list, up to 20 lists per account, and 1,000 account-level negative keywords. One shared list per theme stays manageable.

    The list below is a starting point. Read every word against your own catalogue before you add it. A negative that matches a product you legitimately sell will stop its ads.

    Starter list

    1. Dosing and administration
    dose, doses, dosage, dosing, inject, injection, injections, injectable, “how to take”, “how to use”, “how much”, cycle, stack, protocol, calculator, syringe, needle

    2. Outcomes and conditions
    “weight loss”, “lose weight”, “fat loss”, slimming, diet, obesity, diabetes, muscle, bodybuilding, “anti aging”, healing, injury, pain, tanning, libido, treatment, therapy, cure, benefits, results, “before and after”, “side effects”

    3. Prescription drug terms
    The brand names of approved medicines related to anything in your catalogue, and the generic names of their active ingredients. Build this theme from Google’s prescription drug list and your product list.

    4. Access and prescribing
    prescription, “no prescription”, “without prescription”, pharmacy, pharmacies, doctor, clinic, telehealth, compounded, compounding, insurance, coupon, “near me”

    5. Consumer forms
    pills, tablets, capsules, oral, gummies, drops, “nasal spray”, pen, pens, supplement, supplements

    6. People and animals
    “for men”, “for women”, “for seniors”, “for kids”, “for dogs”, “for cats”, “for horses”, pets, human, humans

    7. Cosmetic and food peptides
    serum, cream, moisturiser, moisturizer, skincare, “skin care”, lip, shampoo, hair, collagen, protein, drink

    8. Low-intent and off-topic
    free, sample, samples, jobs, salary, course, definition, meaning, wiki, reddit, forum, “how to make”, diy

    Themes 1 to 6 remove searches that contradict RUO framing. Themes 7 and 8 remove waste: “peptide” is also a skincare and food-supplement word, and those shoppers are not looking for laboratory material.

    Shopping and Performance Max

    Shopping and Performance Max campaigns have no keywords to bid on, so negatives are the only keyword control. Google says Performance Max negative keywords apply to Search and Shopping inventory, and that account-level negatives apply automatically across Search and Shopping inventory, including Performance Max. Put themes 1 to 4 at account level. Feed titles also act as targeting, so the same word rules apply to them; our product feed guide covers titles, and our Performance Max guide covers asset groups. Google’s Shopping policies overview lists unapproved pharmaceuticals and supplements under restricted healthcare content. See Google Shopping for peptides, and Merchant Center recovery if products are already disapproved.

    8. The weekly search-term review routine

    The search terms report shows the searches that triggered your ads, and its match type column flags close variants. Google omits terms without enough activity, to keep with its data privacy standards, so the report is always incomplete. Some of your spend will go to queries you cannot see. That is one more reason to block by theme and not only by individual query.

    Run this every week
    1. Open the search terms report for the last 7 days, for every Search, Shopping and Performance Max campaign. Add the Keyword and Match type columns.
    2. Sort by impressions, then by cost. A risky query matters when it shows, even if nobody clicks.
    3. Label each new term lower risk, caution or avoid, using section 3.
    4. Add every avoid term as a negative in the matching themed list. Add its plural and obvious synonyms in the same step.
    5. Look for the pattern. If three queries share a word, add the word. If a whole theme is new, start a new list.
    6. Trace it back. Find which keyword matched the query. If one keyword keeps producing avoid terms, tighten its match type or pause it.
    7. Promote good terms. Add lower-risk queries that converted as exact match keywords in the right ad group.
    8. Check that nothing useful is blocked. Compare this week’s negatives against your product list and brand terms.
    9. Read policy notices. Check the policy manager for limited or disapproved ads and keywords. Fix the cause. Do not resubmit the same thing reworded.
    10. Log the changes with a date: what was added, what was paused, and why.

    For a new account or a new campaign, run the first four steps daily for two weeks. Most of the negative list is found in that period.

    9. Using the same research for SEO

    Organic search has no ad review, which makes it easier to drift. The same three groups apply, because titles, headings and meta descriptions are published marketing text.

    • Map lower-risk terms to pages. Category terms go to category pages. Quality terms go to a testing page and a COA library. Lab-supply terms go to a wholesale or enquiry page.
    • Write informational content about the material, not its use. Storage and handling in a laboratory setting, how purity is measured, how to read a COA, what lyophilisation is. These match what a researcher or buyer asks, and they stay inside RUO framing.
    • Leave avoid terms unranked. A page targeting a dosing or weight-loss query is a human-use page, whatever its footer says. That includes blog posts, FAQ entries, image alt text and page titles.
    • Keep ads and pages consistent. Broad match can draw on landing page content, so the words on the page influence which searches your ads reach.

    The same vocabulary should carry through to email. Our peptide email marketing page covers that. Processors read your site too, and their underwriters notice human-use language. See peptide payment processing.

    10. FAQ

    What are the safest peptide keywords for Google Ads?

    No keyword is guaranteed safe. The lower-risk groups are your brand name, category terms with research framing such as “research peptides”, quality terms about purity and certificates of analysis, and lab-supply terms such as custom synthesis and bulk supply.

    Can I bid on prescription drug names if I sell RUO versions?

    Google says it restricts prescription drug terms in ads, landing pages and keywords, and requires certification to keyword-target them. That certification is aimed at online pharmacies, telemedicine providers and pharmaceutical manufacturers. We treat these terms as avoid, and add them as negatives.

    Does a careful keyword list make my store compliant?

    No. Google reviews ads, assets and destinations, and regulators look at the website as a whole. Keywords should describe a compliant site accurately. They cannot correct product pages that carry outcome claims or dosing language.

    Should I use broad match for peptide campaigns?

    Usually not at the start. Broad match reaches related searches and can draw on landing page content, and most related searches in this category are about personal use. Begin with exact and phrase match and build the negative list first.

    How many negative keywords do I need?

    There is no correct number. Google allows up to 5,000 keywords per list, 20 lists per account and 1,000 account-level negatives. Build by theme, add plurals and synonyms by hand, and keep adding from the weekly search-term review.

    Do you have search volumes for peptide keywords?

    No, and we do not publish estimates. Google’s Keyword Planner says it often cannot return results for sensitive categories such as health. Use your own search terms report and Search Console data.

    Can I use misspellings or code names to get restricted terms approved?

    No. Google’s policies cover manipulating text to bypass detection and treat circumvention as egregious, with suspension possible without warning. We do not build campaigns that way.

    Do negative keywords work in Shopping and Performance Max?

    Yes. Google says Performance Max negative keywords apply to Search and Shopping inventory, and account-level negatives apply automatically across Search and Shopping inventory, including Performance Max.

    Want a second pair of eyes?

    Have your keyword and negative lists reviewed

    Peptide Marketing works only with research-use-only peptide brands. We will look at your search terms, ad groups and negative lists alongside the pages they point to, and tell you what to change first. We do not help disguise restricted terms or work around platform policies.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is general information for businesses selling research-use-only products. It is not legal or regulatory advice, and the keyword groups are our opinion, not a Google classification. Sources were read on 16 November 2026. Google’s policies and enforcement change. Check the linked pages and take professional advice before you act.

  • Peptide Product Feed Optimization: Titles, Categories and Disapproval Fixes

    A peptide Google Shopping feed is judged twice. Google’s systems check it as product data, the way they check any store’s feed. They also check it against the healthcare policies that apply to what a research-use-only (RUO) peptide store sells. Most feed guides only cover the first check. This one is for owners and marketers of RUO peptide stores and covers both: how to write each attribute in Google Merchant Center, which settings sit around the feed, how to read an item disapproval, what a feed fix can and cannot make eligible, and what to look at every week. Policy statements link to the Google or FDA page they come from, checked in November 2026.

    Key takeaways
    • Accurate data fixes data problems, not policy problems. Merchant Center’s Unapproved substances rule applies “regardless of any claims of legality”. No title, category or rule makes a listed substance eligible.
    • Write titles for the first 70 characters. Google allows 150 and says shoppers usually notice only the first 70 or fewer.
    • Never invent a GTIN. If you make and sell your own-label products, Google says to use the store name as brand and an MPN of your own.
    • Google assigns the product category itself. Use product type for your own structure and custom labels for bidding and reporting.
    • Feed images show the product as sold. No overlays, watermarks, borders or placeholder images.
    • Fix before you request review. You may get one chance to disagree with an issue, and failed reviews can start a cool-down.
    • Never re-list a disapproved product under a new ID or an altered name. Google does not allow retailers to bypass its review processes.

    1. What a feed decides, and what it cannot

    Your feed, which Merchant Center now calls a product data source, decides three things: whether a product can show at all, which searches it is matched to, and how it looks next to competing listings. Shopping ads and feed-based Performance Max campaigns can only serve products that Merchant Center has approved. If that is new to you, start with our overview of Google Shopping for peptides.

    The feed does not decide what Google permits. Merchant Center’s Healthcare and medicines policy has an Unapproved substances section. It says Google does not allow listing certain products “regardless of any claims of legality”. The list includes:

    • Everything on Google’s list of unapproved pharmaceuticals and supplements, plus substances with a similar chemical composition.
    • Non-government-approved products marketed as safe or effective for treating a disease.
    • Products that have been subject to government or regulatory action or warning.
    • Products with names confusingly similar to an unapproved product or a controlled substance.

    Google describes that list page as examples of what is not allowed in Shopping ads and free listings. When we checked, it did not name the peptides commonly sold by research suppliers. That is not an approval. The policy’s other bullets, especially the regulatory one, reach further than the list. The FDA’s page on bulk drug substances that may present significant safety risks in compounding names several peptides that appear in research catalogues. That page is about compounding, not RUO sales, but it shows that regulators have written about these names.

    The same policy has a section for prescription drugs. It allows some prescription drugs in the United States and Canada, only from online pharmacies that hold a recognised accreditation and are certified by Google. An RUO store is not a pharmacy, so that route does not apply.

    The honest position

    Feed optimization for a peptide store has two honest goals. The first is to stop losing eligible products to avoidable data errors. The second is to describe every product accurately, so a review is decided on what the product is. It is not a way to get refused products through. Where this guide says “fix”, it means correcting data and pages, not disguising them.

    2. Titles and descriptions

    Titles

    Google’s title attribute page sets a limit of 150 characters and tells you to put the most important details first, because users usually notice only the first 70 or fewer. It does not allow promotional text, prices, sale or delivery dates, shipping information, your company name as promotion, capital letters for emphasis, or gimmicky symbols.

    A title structure that works for RUO products:

    Brand + accurate product name + quantity + form + pack size

    • Use the accurate name. The name on the label, the landing page and the certificate of analysis should be the same name in the title.
    • Add what distinguishes the variant. Quantity, form and pack size. Google asks for the detail that separates one variant from another.
    • Leave out outcomes. No benefit, effect or use words. They are not product details, and they are what the policy calls marketing a product as safe or effective.
    • Leave out sales language. “Best”, “sale”, “free shipping” and “#1” are all disallowed promotional text.
    • Do not respell or split a name. An altered name is misleading product data, and it reads as an attempt to get past review.

    Descriptions

    The description attribute allows 5,000 characters. Google says to describe only the product itself and to put the most important details in the first 160 to 500 characters. It does not allow promotional text, links, comparisons, details of other products, or business history and policies.

    For an RUO product, a good description is short and factual: what the item is, quantity and form, purity as stated on its documentation, storage conditions as supplied, what documentation ships with it, and a plain statement that it is sold for laboratory research use. Do not include dosing, administration, effects, or comparisons with any medicine. Keep the description consistent with the landing page. If the page says one thing and the feed another, you have created a mismatch for a reviewer to find.

    AttributeGoogle’s ruleOur standard for RUO stores
    Title1 to 150 characters. Important details first. No promotional text or capitals for emphasisBrand, accurate name, quantity, form, pack size. Key facts inside 70 characters
    Description1 to 5,000 characters. Product only. No links, comparisons or promotionFactual specification and a research-use statement. No use or outcome language
    Google product categoryOptional. Assigned automatically. Overrides accepted in limited casesCheck the assigned category. Do not use an override to look like something else
    Product typeOptional. Up to 750 characters. Your own taxonomyOne value, two or three levels, mirroring site navigation
    BrandRequired where a brand is clearly associated. 1 to 70 charactersYour store name if you make and sell your own label
    GTINRecommended when the manufacturer assigned one. Never made upLeave empty unless a real GTIN exists
    MPNRequired for products without a manufacturer-assigned GTIN. 1 to 70 charactersYour own stable part number if you are the manufacturer
    Image linkClean product image. No overlays, watermarks, borders or placeholdersThe product as sold, plain background, 1500 x 1500 pixels or larger

    3. Product category, product type and custom labels

    Google product category

    Google’s product category page says every product is automatically assigned a category from Google’s taxonomy, and the attribute is optional. You can submit your own value, but Google says it will only accept an override in specific cases, such as categories with their own attribute requirements. If you do submit one, use one value, the most specific that fits.

    The practical points for a peptide store:

    • Look at what Google assigned. A catalogue of research compounds can land in a health or supplement category, which tells you how your titles, descriptions and pages are being read.
    • Fix the cause, not the label. If the data and the page describe a laboratory product accurately and without use language, that is the correction available to you.
    • Do not submit a category you know is wrong in order to change how the product is reviewed. That is misleading product data.

    Product type

    Product type is your own taxonomy. It is optional, allows up to 750 characters, and uses > between levels. Google says only the first value is used to organise bidding and reporting in Shopping campaigns, so submit one. Mirror your site navigation, for example Research Supplies > Peptides > Lyophilized. Build the structure by category and format. A product type per compound adds nothing you can use.

    Custom labels

    Google provides five custom labels, custom_label_0 to custom_label_4, each up to 100 characters. They are not shown to shoppers. They exist so you can filter, report and bid on groups of products in Shopping and Performance Max. Useful labels for a peptide store are margin band, best seller or long tail, promotion name, and policy status. A “policy status” label lets you see at a glance which products have ever been limited or disapproved.

    4. Identifiers: GTIN, MPN and brand

    Identifier warnings are among the most common avoidable feed issues, and peptide stores hit them because most sell their own label with no barcode. Google’s rules are clear once you know which situation you are in.

    Your situationBrandGTINMPN
    You make or label the product and are its only sellerYour store nameLeave empty unless you have registered real onesA unique number you assign. Keep it stable
    You resell another manufacturer’s product that has a GTINThe manufacturer’s brandThe manufacturer’s GTIN, exactlyThe manufacturer’s MPN
    You resell a product with no GTINThe manufacturer’s brandLeave emptyThe manufacturer’s MPN. Do not create one

    The sources for each cell:

    • GTIN. Google’s GTIN page recommends it for products that have one assigned by the manufacturer, and says not to guess or make up a value.
    • MPN. The MPN page requires it for products without a manufacturer-assigned GTIN, and says not to use a value you created unless you are the manufacturer.
    • Brand. The brand page says that if you are the manufacturer and sole seller, you should use the store name as the brand and include an MPN of your choice.
    • Identifier exists. This attribute is set to no only when you are certain a product has no GTIN, MPN or brand. An own-label store with a brand and its own MPNs does not need it.

    One more identifier matters more than the others: the product id. Google’s tips for keeping products approved say not to change it, because a changed ID is treated like a new product and can take up to 3 business days to be approved again. Pick an ID scheme once, usually the SKU, and leave it alone.

    5. Images, shipping and returns

    Images

    Google’s image link page requires an image for every product. It does not allow promotional elements or overlays, which covers calls to action, price or shipping text, watermarks and added logos. It also rules out placeholders, generic images and borders. The page recommends 1500 x 1500 pixels or above and states a minimum of 500 x 500 pixels beginning January 31, 2027. Files can be up to 16MB. Google’s crawlers, Googlebot and Googlebot-image, must be allowed to reach the image URL.

    For a peptide store that means the feed image is a clean photograph of the item as it is sold, with its real label, on a plain background. A purity badge or “lab tested” stamp placed over the image is an overlay. So is a sale banner. If one image template is used for every product, check that it is not a generic placeholder with only the text changed.

    Feed images and ad creative are different things

    The feed image must show the product. The images, logos and videos you upload yourself to Search and Performance Max campaigns are a separate matter, and our standard there is brand-led creative with no product shots. Our guide to Google Ads for peptides covers that side, and our guide to Performance Max for peptide brands covers asset groups in detail.

    Shipping

    Google’s shipping attribute page lists the United States among the countries where shipping costs are required for Shopping ads and free listings. It says to use account shipping settings in Merchant Center first and the shipping attribute only as a last resort, and to match or slightly overestimate the cost customers would pay. Set up one account-level shipping policy that reflects your real checkout: flat rate, free-shipping threshold, handling time and transit time. If you ship cold-pack or express on some items, model that too. A feed that shows a lower shipping cost than the checkout is a mismatch.

    Returns

    Google’s return policy page presents return settings as something you may choose to provide. You enter a return policy URL, the countries it covers and whether you accept returns. “No, I don’t accept returns” is one of the options. If you provide nothing, Google may show a general policy collected from your site. Our advice is to set it explicitly, so that what Google displays is what your policy page says.

    Price and availability

    These two attributes cause the most routine disapprovals. Google’s availability page says a mismatch between feed and landing page will trigger a product disapproval, and its price mismatch page says mismatches may lead to an account suspension. Automatic item updates are on by default and correct price and availability from your site’s structured data. Google is explicit that they are not a replacement for regular feed updates. Keep them on, and fix the cause of every mismatch. Checkout and currency changes are a frequent cause, so re-check prices after any change covered in our payment processing guide.

    6. Infographic: a feed row, before and after

    One product, attribute by attribute. The dashed side is the kind of row we find in audits. The solid side is the corrected row. “[Product name]” stands for the accurate name on the label.

    7. Supplemental sources and attribute rules

    Most peptide stores feed Merchant Center from a store plugin or app, and the plugin’s output is rarely what you want. Two Merchant Center features let you improve it without editing the store. Both require the “Advanced data source management” add-on, which you enable under Settings > Add-ons.

    Supplemental data sources

    Google’s page on creating a product data source explains the split. Primary sources are the only type that can add or remove products. A supplemental source cannot add or remove products or stand alone. It adds or updates attribute values for products that already exist in a primary source, matched on the product ID, and can be a file, a Google Sheet or the API.

    A Google Sheet with an id column is the simplest version. Good uses:

    • Corrected titles and descriptions for the products where the plugin output is wrong.
    • Product type and custom labels, which most plugins do not fill.
    • Brand and MPN for own-label products.
    • excluded_destination for products you have decided not to advertise.

    Attribute rules

    Feed rules are now called attribute rules. They live under Data sources > Product sources > your primary source > Attribute rules, and they transform values as the feed is processed. Operations include Set to, Prepend, Append, Find & Replace, Extract and Clear. Google’s own examples include building a title from brand plus title and clearing “n/a” from the brand field. Rules can be saved as a draft and tested before they are applied.

    Rules worth having:

    • Prepend the brand to titles that lack it.
    • Find and replace promotional phrases the plugin adds, such as “Buy” or “On Sale”.
    • Set product type from the store’s own category field.
    • Set a custom label from price or from a tag in the store.
    Where the line is

    Use these tools to make data more accurate. Do not use them to make it less accurate. A Find & Replace that swaps a product’s real name for a coded or respelled one is misleading product data. Google’s Shopping policies include “Abusing the Shopping network”, which does not allow retailers who try to bypass its review processes. We do not write rules like that, and we advise clients not to.

    Taking a product out of ads cleanly

    When you decide a product should not be advertised, there are documented ways to do it. The excluded destination attribute prevents a product appearing in chosen destinations, such as Shopping_ads or Free_listings. The pause attribute is for short breaks: Google says to pause a product for 14 days or less. For a permanent decision, remove the product from the primary source.

    8. Diagnosing item disapprovals

    Google’s issues page describes four levels. Warnings leave products showing with possibly limited performance. Disapprovals stop a product showing. Preemptive item disapprovals are applied as a precaution after price or availability mismatches. Suspensions take the whole account offline. Account-level issues always come first, and our Merchant Center recovery guide covers those.

    How to read the damage

    1. Open Products > Needs attention. Read account-level and setup or policy issues before any item issue.
    2. Export or list the affected products and group them by issue name. You fix reasons, not SKUs.
    3. Copy each issue name exactly as shown. Peptide stores usually see healthcare labels such as “Unapproved substances” or a prescription or restricted drug label. Wording varies between Merchant Center and the Google Ads Products page, so work from your own account.
    4. For each group, compare three things side by side: the feed row, the landing page, and the policy section named.
    5. Decide per group: fix, remove, or request review. Then log it.

    What can and cannot be made eligible

    What you seeUsual causeCan it become eligible?Action
    Price or availability mismatchFeed and page disagreeYesFix the data or the page’s structured data. Keep automatic item updates on
    Image issueOverlay, watermark, border or placeholderYesReplace with a clean product image
    Identifier warningMissing brand or MPN, invalid GTINYesApply the table in section 4
    Missing shippingNo shipping policy for the countryYesAdd an account shipping policy that matches checkout
    Healthcare issue caused by how the product is marketedUse, benefit or dosing language in the feed or on the pageSometimes. Only if the product itself is not covered by the policyCorrect feed and page, then request review once
    Healthcare issue because of what the product isOn Google’s list, similar in composition to a listed item, or subject to regulatory action or warningNoRemove from the feed or exclude from ads. Do not rename
    Prescription drug issueThe product is, or is named as, a prescription medicineNot for an RUO store. That route is for certified pharmaciesRemove from the feed
    Name confusingly similar to an unapproved productThe product name itselfNo. A new name on the same product is a bypass attemptRemove from the feed

    Requesting a review

    Google’s page on requesting a review gives two routes from the Needs attention tab: “I fixed the issue” and “I disagree with the issue”. Three details on that page should shape how you use them:

    • You may only have one chance to disagree with an issue.
    • If issues are not resolved by the second review attempt, a one-week cool-down may begin. It may increase with each unsuccessful review, and Google support cannot shorten it.
    • Reviews may take up to 7 business days, and the same page also mentions up to 2 weeks. Approved products become eligible to show within 24 hours.

    So request review only for products you believe comply, after the feed and the page are both corrected. For Unapproved substances, the policy page says violations will not lead to immediate account suspension without prior warning, and that a warning is issued at least 7 days before any suspension. Its fix section says warning emails give 7 or 28 calendar days. Treat that as a deadline.

    What not to do

    Do not delete a disapproved product and upload it again under a new ID. Do not respell, abbreviate or split its name. Do not point the feed at a cleaner page than buyers see. Each of these is an attempt to bypass review, and it puts the whole account at risk for the sake of one product. If a Google Ads account has already been suspended, our suspension appeal and recovery playbook covers what to do next.

    9. The weekly feed check

    A feed drifts. Plugins update, prices change, stock runs out, someone edits a product page. Fifteen minutes a week catches most of it before it costs eligible products.

    Weekly checklist
    1. Account issues. Open Needs attention. Any account-level or policy warning is the first job of the week. Note its deadline.
    2. Counts. Record approved, limited and disapproved product totals. Compare with last week.
    3. New disapprovals. Group by issue name. Classify each group with the table in section 8.
    4. Price and availability. Check for mismatches and for products automatic item updates had to correct. Fix the cause.
    5. Feed fetch. Confirm the primary source updated on schedule and the product count is what you expect.
    6. Stock. Out-of-stock items should show as out of stock in the feed, not sit as in stock.
    7. New products. Check each new row against section 6 before it goes into a campaign.
    8. Edited pages. Re-read any product page changed this week for use or outcome language.
    9. Rules and supplemental sheet. Confirm rules still do what you intended and no supplemental row points at an ID that no longer exists.
    10. Reviews. Check the status of open review requests and whether a cool-down is active. Do not stack requests.
    11. Google Ads side. Compare the Products page in Google Ads with Merchant Center, so campaigns are not built around items that cannot serve.
    12. Change log. Date, product or rule, old value, new value, reason.

    A feed will not carry every product a research supplier sells, and some of the catalogue will never be eligible. That is a reason to build channels that do not depend on product review. Your customer list is the obvious one, and our guide to peptide email marketing covers it within RUO framing.

    10. FAQ

    Can an RUO peptide store run a Google Shopping feed?

    A store can submit a feed, and products that comply with Google’s policies can be approved. Merchant Center’s Unapproved substances rule applies regardless of any claims of legality, so a research-use-only statement does not make a non-allowed product eligible.

    What should a peptide product title look like in the feed?

    Brand, the accurate product name, quantity, form and pack size, with the key facts in the first 70 characters. Google allows 150 characters and does not allow promotional text or capital letters for emphasis. Leave out any use or outcome wording.

    Do peptide products need a GTIN?

    Only if the manufacturer assigned one. Google says not to guess or make up a GTIN. If you are the manufacturer and sole seller, Google says to use your store name as the brand and include an MPN of your choice.

    Which Google product category should I choose?

    Google assigns a category to every product automatically and accepts an override only in limited cases. Check the assigned category in Merchant Center. Use product type for your own structure and custom labels for bidding and reporting.

    Why are my products disapproved for Unapproved substances?

    Either the product itself is covered by Google’s policy, or the feed and landing page market it in a way the policy does not allow, such as implying it is safe or effective. Compare the feed row, the landing page and the policy section to see which applies.

    Can I rename a disapproved product and submit it again?

    No. Google’s Shopping policies do not allow retailers who try to bypass its review processes. An altered name or a new ID for the same product is misleading product data, and it risks the whole account.

    How long does a Merchant Center product review take?

    Google’s review page says reviews may take up to 7 business days and also mentions up to 2 weeks. If issues are not resolved by the second review attempt, a one-week cool-down may begin, and it can increase with each unsuccessful review.

    Do I need the Advanced data source management add-on?

    Yes, if you want supplemental data sources or attribute rules. Google says the supplemental sources tab is visible only when the add-on is enabled, and attribute rules require it too. You enable it under Settings, then Add-ons.

    Want your feed looked at?

    Get a feed audit before you spend more

    Peptide Marketing works only with research-use-only peptide brands. We will go through your Merchant Center issues, group them by cause, and tell you plainly which products can be fixed, which should come out of the feed, and what to change first. We do not disguise product names, re-list disapproved items or cloak pages.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is marketing and platform-policy information for businesses selling research-use-only products. It is not legal or regulatory advice. Policies change; check the linked pages before you act.

  • The RUO Website Compliance Checklist: What FDA Warning Letters Actually Flag

    RUO peptide website compliance is usually treated as a wording question: which disclaimer to use and where to put it. The FDA warning letters sent to peptide sellers in 2026 show that the question is wider. In each one the agency acknowledged the research-use-only (RUO) label, then quoted the seller’s own website to show what the products were intended for. This guide is for owners and marketers of RUO peptide stores. It summarises what those letters cited, sets out what ad platforms and payment processors read on the same pages, and ends with a 25-point site audit. It is marketing and policy information, not legal advice.

    Key takeaways
    • The website was the evidence. All six 2026 letters we read rest on text and products found on the seller’s own site.
    • The disclaimer was noted and set aside. Each letter records the research-use wording, then says the site shows the products are intended as drugs for people.
    • Research framing did not protect a claim. Lines built on “studied for” or “research shows” were quoted as evidence of intended use.
    • Supplies counted. Bacteriostatic water sold next to peptides was cited in five of the six letters, and charged as a drug in four.
    • Some things were not cited. None of the six letters quotes a testimonial, an image or a social post. US and UK rules still reach them.
    • Platforms and processors read the same pages and apply their own rules, whatever the label says.
    • An audit makes the site match the business. It does not make a business selling for personal use compliant.

    1. Why the website is the evidence

    Under US law, whether a product is a drug depends on its intended use, not on what the label calls it. The regulation the 2026 letters cite is 21 CFR 201.128. It says intended use means the objective intent of the people responsible for the product. That intent can be shown by what they say, by the design or composition of the product, and by the circumstances in which it is distributed. The regulation gives labeling claims, advertising matter, and oral or written statements as examples.

    A website is all of those at once. Product pages, comparison articles, the navigation menu, the items in the catalogue and the tools on the site are statements made by the seller. A reviewer does not need inside information. They need a browser and a date.

    That is how the 2026 letters were built. Each one says the FDA reviewed the firm’s website in a stated month, lists product page URLs, and quotes text from them. None of the six relies on an inspection, a test purchase or a lab result.

    Who else reads the site

    The same pages are read by Google’s ad and Merchant Center review, by your payment processor’s risk team, and, if you sell to the UK, by the MHRA and the ASA. Their rules differ, but they share one feature: none of them accepts the seller’s label as the last word.

    2. What the 2026 FDA warning letters cited

    We read six warning letters that the FDA’s Center for Drug Evaluation and Research sent to peptide sellers in 2026. Four are dated 24 August 2026, which we confirmed on fda.gov. Each of those four says the firm’s website was reviewed in July 2026. The other two are dated 31 March and 17 June 2026. All six came from the Office of Unapproved Drugs and Labeling Compliance. There may be other 2026 letters we have not read.

    The charge is the same in each. The products are drugs because of their intended use, they are new drugs without an approved application, and introducing them into interstate commerce violates the Federal Food, Drug, and Cosmetic Act. Each firm was asked to reply within fifteen business or working days, and warned that failure to correct violations could lead to legal action, including seizure and injunction.

    LetterDateSite evidence the FDA cited, in our words
    Gram Peptides31 March 2026Product-page text on appetite, body weight, glucose and lipids. Bacteriostatic water sold alongside peptides that need reconstitution, and charged as a drug.
    Wholesale Peptide17 June 2026Product-page text naming prostate conditions, with benefits introduced by “research shows”. Text on testosterone production and cancer research.
    Peak Performance Peptides24 August 2026Product-page lines framed as “studied for” or “investigated for” effects on glycemic control, appetite and fat distribution. Bacteriostatic water charged as a drug.
    Peptide Partners LLC24 August 2026Product-page summaries of studies suggesting benefits for bone, kidney and brain health. A “reconstitution solution” charged as a drug.
    Royal Peptides LLC24 August 2026Comparison pages with benefit lists and clinical results, including the phrase “Once-weekly injection for convenience”. A mixed multi-pack kit and a blend. Bacteriostatic water marketed beside a peptide guide and a peptide calculator.
    TXP Innovations LLC dba Tex Peptides24 August 2026Product-page text on supporting weight loss and managing type 2 diabetes and obesity. Bacteriostatic water marketed as a solvent for the site’s products, and charged as a drug.

    The patterns across the six letters

    • Product-page claims are the core. Every letter quotes product or comparison pages. Statements about weight, appetite, blood sugar, named diseases or body function are treated as evidence of intended use.
    • Research phrasing did not change the reading. Several of the quoted lines are written as descriptions of studies. The FDA quoted them anyway.
    • Reconstitution supplies are evidence. Five letters cite bacteriostatic water or a reconstitution solution sold next to the peptides. Four charge the water itself as an unapproved drug, reasoning that the pairing shows it is meant for injection.
    • Tools and bundles appear. One letter cites a peptide guide and calculator, a mixed kit and a blend.
    • The catalogue repeats. Semaglutide, retatrutide, tesamorelin, PT-141 and SS-31 are named in all four August letters, and tirzepatide in three.
    • The disclaimer is acknowledged in a footnote. Section 3 covers this.
    What the letters did not cite

    None of the six letters quotes a customer testimonial or review, describes an image, or cites a social media account, hashtag, email or discount code. None mentions syringes. The reviews covered websites. This matters for accuracy: articles that say the FDA “flagged testimonials and Instagram” in these letters are not describing these letters. Sections 5 and 8 explain why those areas still belong in an audit.

    3. Why a disclaimer alone is not enough

    Every one of the six letters records that the firm’s labeling marketed the products for research use only and not for human consumption, or close variants of that wording. Each then says that the evidence from the website establishes the products are intended to be drugs for human use. The disclaimers were present and the FDA saw them. They did not decide the outcome.

    The FDA has said the same thing to consumers. Its page on unapproved GLP-1 drugs, updated on 1 October 2026, says the agency has warned companies selling certain products it describes as “falsely labeled” for research purposes or as not for human consumption, and that these were sold directly to consumers for human use with dosing instructions.

    The reasoning follows from section 1. A disclaimer is one statement. Intended use is judged on all the statements and circumstances together. If a footer says “for laboratory research only” and the product page above it describes appetite and body weight, the two conflict, and the reviewer goes with the weight of the page.

    What a disclaimer is for

    A research-use statement is worth having when it is true. It tells a genuine research buyer what the product is and is not, and it should appear on the product page, the label, the checkout and the terms of sale. It works as a summary of how the business operates. It does not work as a correction to the rest of the site.

    The same logic limits what an audit can do. Removing claims from a site that still sells to people buying for personal use changes the wording and leaves the circumstances of distribution untouched, and the regulation counts those circumstances too. This guide is about making a site consistent with a real research-supply business. We do not help disguise human-use sales, and no wording would do that reliably anyway.

    4. Product copy, comparison pages and blog content

    Product pages

    The quoted text in the letters has a common shape: it tells the reader what the compound does in a body, or which condition it relates to. A research supplier’s page has a different job. It identifies the material and documents its quality. The table shows the difference by area.

    Area of the pageReads as intended for human useConsistent with a research-supply business
    Product nameNames built around a drug class or an outcomeThe compound’s accurate chemical or common name, matching the label and certificate of analysis
    DescriptionEffects on weight, appetite, sleep, recovery, ageing or a named conditionIdentity, sequence or formula, molecular weight, quantity, form, stated purity
    Study summariesBenefit lists drawn from trials, whatever phrase introduces themNone on the sales page. Analytical data for the batch instead
    Usage informationAmounts, schedules, routes, or mixing steps for useStorage and handling as supplied, and safety data sheet information
    DocumentationA purity badge with nothing behind itA batch-specific certificate of analysis and the test method
    Research-use statementA footer line that contradicts the page above itA statement on the page, label and checkout that matches everything else

    Two details from the letters are worth applying directly. First, phrases such as “studied for” and “research shows” did not turn a benefit statement into something else. Second, one letter quoted text under a heading about advanced research use that listed anti-ageing and neuroprotection. A research heading over an outcome list is still an outcome list.

    Comparison pages and blog content

    One August letter cites two comparison pages by URL. One address contains a weight-loss phrase, and the quoted text includes benefit lists and trial results. They sit outside the shop section, like blog posts. The lesson is that everything on the domain counts, not just product pages.

    For a blog on an RUO store, our standard is:

    • No articles that compare compounds by outcome for a person, or that explain how to choose between them.
    • No articles on protocols, cycles, schedules or results.
    • No outcome or condition words in URLs, page titles or meta descriptions. They are statements too.
    • Topics that fit the business: analytical methods, how to read a certificate of analysis, storage and stability, shipping and documentation.
    • Old posts get the same review as new ones. An archived article is still published.

    5. Testimonials, reviews, images and social links

    These areas were not cited in the six letters. They are still statements or circumstances connected to the seller, so they fall inside the intended-use regulation, and other reviewers name them directly. The MHRA’s guidance, covered in section 8, lists websites, social media and customer reviews among the things it looks at.

    Testimonials and reviews

    A review that describes a personal result is a human-use statement displayed on your product page. You did not write it, but you chose to publish it. For a research supplier, reviews that make sense are about the things a lab buyer can judge: documentation, packaging, delivery time and service. If your review tool imports text automatically, moderate it against a written rule, and apply the rule to every review, not only to the ones that look risky. Do not write, buy or edit reviews.

    Images

    Images make claims without words. Body or before-and-after imagery, lifestyle photography, and pictures of injection equipment or a product being prepared for use all say who the product is for. An accurate photograph of the item as sold, with its real label, says what it is. Check alt text and file names as well, because they are published text.

    Social links

    A social icon in the footer joins that account to the site. If the account, its bio, its hashtags or its reposts talk about personal use or results, a reviewer following the link will read them as the seller’s statements. The same applies to affiliates and anyone paid to promote the store: what they say for you is said on your behalf. Link only to accounts you would be content to have read alongside your product pages.

    6. Dosing language, calculators and bundled supplies

    This is the area where the 2026 letters are most specific.

    • Bacteriostatic water. Five of the six letters cite it. Four go further and charge the water as an unapproved drug, on the reasoning that selling it to reconstitute the site’s peptides shows it is intended for injection.
    • Calculators and guides. One letter notes the water was marketed alongside a “peptide guide” and a “peptide calculator”.
    • Kits and blends. The same letter cites a mixed multi-pack of two compounds and a pre-combined blend.
    • Dosing language. The FDA’s consumer page describes these products as sold with dosing instructions. One letter quotes a line about weekly injection.

    Read together, these describe what regulators call the circumstances of distribution. A catalogue of single-use retail vials, a mixing liquid, a tool that converts amounts, and a multi-pack is a picture of a consumer product, whatever each page says. The letters also explain why the FDA cares: they note that injectable products are delivered directly into the body and bypass its natural defences.

    Our position

    An RUO site should carry no dosing, administration or reconstitution-for-use content, no calculators, and no bundles assembled around personal use. Whether to sell ancillary supplies at all is a business and legal decision for the owner and their counsel. We will not suggest moving these items to a second domain or a hidden page. The letters show how such supplies are read, and relocating them does not change what they are sold for.

    7. What ad platforms and payment processors look at

    Google Ads and Merchant Center

    Google’s Healthcare and medicines policy for ads has an Unapproved substances section that applies “regardless of any claims of legality”. Its list includes non-government-approved products marketed as safe or effective for a disease, products that imply they work as well as prescription drugs, products with names confusingly similar to an unapproved pharmaceutical or controlled substance, and products that have been subject to government or regulatory action or warning. Merchant Center’s Healthcare and medicines policy uses the same wording for product listings.

    Three practical points follow:

    • The landing page is reviewed, not only the ad. The policy refers to landing pages and websites throughout. A clean ad pointing at a page with outcome claims is a page problem.
    • A warning letter is itself a policy trigger. The regulatory-action bullet means that compounds named in FDA letters carry extra risk in ads and feeds.
    • Review must see what buyers see. Google’s Abusing the ad network policy does not allow ads, content or destinations that try to trick or circumvent its review processes. Showing reviewers a different page from the one customers get is a violation in its own right.

    Google’s Misrepresentation policy also covers unreliable claims, meaning inaccurate claims or ones that present an improbable result as likely. For the campaign side, see our guides to Google Ads for peptides and Google Shopping for peptides. If your account already has a suspension, start with Merchant Center recovery. Earlier guides in this series cover appealing a Google Ads suspension and setting up Performance Max with policy-safe creative.

    Payment processors

    Processors publish their own lists, and they read your site when you apply and again when they review the account. Two public examples:

    • Stripe’s prohibited and restricted businesses list prohibits “Incorrectly labeled research chemicals”, along with pseudo-pharmaceuticals that are not safe or make harmful claims. It restricts card-not-present sales of pharmaceuticals and prescription-only products.
    • PayPal’s Acceptable Use Policy prohibits transactions involving products that present a risk to consumer safety, and requires pre-approval to sell products that need a prescription.

    Neither page names peptides. Both are written broadly enough that the outcome depends on what an underwriter concludes from your website and your description of the business. That description must be accurate. Telling a processor you sell something else is misrepresentation and puts funds at risk. Our peptide payment processing guide covers how to approach this openly.

    Email

    Emails are written statements by the seller, and they get forwarded. Hold campaigns, flows and subject lines to the same standard as product pages. Our peptide email marketing guide covers this within RUO framing.

    8. A short UK note: ASA and MHRA

    If you sell to UK customers or run a UK company, two bodies matter.

    The MHRA decides what is a medicine. The Human Medicines Regulations 2012 define a medicinal product in two ways: by presentation, as something presented as preventing or treating disease, and by function, as something that may be administered to modify a physiological function through pharmacological, immunological or metabolic action. The MHRA’s borderline products guidance says it looks at explicit and implicit claims, the properties of the ingredients, how consumers would use the product, and how it is presented, including websites, social media and customer reviews. The page does not say that a disclaimer settles the question. Regulation 279 prohibits advertising a medicinal product that has no marketing authorisation.

    The ASA regulates advertising. Section 12 of the CAP Code allows medicinal claims only for licensed products and bars advertising prescription-only medicines to the public. The Code’s scope covers a company’s own website and, for UK-registered marketers, its non-paid social media. CAP’s advice on prescription-only medicines, dated 30 September 2026, says almost any reference to such a medicine is likely to be treated as promoting it, that landing pages count, and that references in posts, images and hashtags can count too. Several catalogue names in the US letters are prescription-only medicines in the UK, so product naming is an advertising question there.

    9. The 25-point site audit

    The infographic groups the audit by area. Each point is a question to answer with yes or no about your live site.

    RUO website audit: 25 points in 6 areas

    A. Product pages

    1Product names are the accurate compound names and match the label and certificate of analysis.
    2Descriptions give identity, quantity, form and purity, with no effect or outcome statements.
    3No disease, condition or body-function wording, including under “studied for” or “research shows”.
    4No study or trial summaries on sales pages.
    5A batch-specific certificate of analysis is available for each product.

    B. Blog and site content

    6No comparison articles that rank compounds by outcome.
    7No protocol, schedule, cycle or results content, including old posts.
    8URLs, page titles and meta descriptions contain no outcome or condition words.
    9FAQ and help pages answer supply questions only, not use questions.

    C. Reviews and images

    10Published reviews cover service, delivery and documentation, not personal results.
    11A written moderation rule exists and is applied to every review.
    12No reviews are written, bought or edited by the business.
    13Images show the product as sold. No body, lifestyle or injection imagery.
    14Alt text and image file names contain no use or outcome wording.

    D. Catalogue and supplies

    15No dosing, administration or reconstitution-for-use instructions anywhere on the domain.
    16No calculators or conversion tools.
    17No kits, stacks or bundles assembled around personal use.
    18The decision on ancillary supplies has been taken with legal advice and recorded.

    E. Off-site and channels

    19Every linked social account, bio and hashtag set meets the same standard as the site.
    20Affiliate and partner content has written rules and is checked.
    21Emails, flows and subject lines carry no claims or use language.
    22Ads, feed data and landing pages say the same thing, and reviewers see what buyers see.

    F. Statements and operations

    23The research-use statement appears on the page, label, checkout and terms, and nothing contradicts it.
    24The business description given to processors and platforms is accurate.
    25There is a dated change log, a named owner for site content, and a repeat audit on the calendar.
    A “no” is a page to fix. A site that passes describes the business accurately. It is not legal clearance.

    How to run it

    Audit steps
    1. Read the primary sources first. Open two or three of the FDA letters linked above and read the quoted site text yourself.
    2. List every published URL. Use your sitemap and a crawl. Include blog posts, category pages, PDFs, old landing pages and anything not linked from the menu.
    3. Go through the 25 points page by page. Record yes or no, with the URL, for each one.
    4. Search the site for outcome and use words. Search for condition names, body-function words and use verbs. Check page titles, meta descriptions and alt text as well as body copy.
    5. Check what is connected to the site. Social profiles, review widgets, email templates, affiliate pages and any marketplace listings.
    6. Fix the page, not its visibility. Correct or remove the content for all visitors. Do not hide it from reviewers, and do not move it to another domain.
    7. Align the channels. Update the product feed, ad copy and email flows so they match the corrected pages.
    8. Take the legal questions to a lawyer. Catalogue decisions, supplies, terms of sale and any regulator correspondence need an attorney who works in FDA or UK medicines law.
    9. Log and repeat. Keep a dated record of each change. Re-run the audit every quarter and after any redesign, plugin change or new product launch.

    10. FAQ

    What is RUO peptide website compliance?

    It means the whole website is consistent with a business that supplies materials for laboratory research. Product copy, blog content, reviews, images, supplies and linked accounts are all read as evidence of intended use, so compliance covers all of them, not just the disclaimer.

    Is a “research use only” disclaimer enough to protect a peptide site?

    No. Each of the six 2026 FDA warning letters we read notes the seller’s research-use labeling, then says website evidence shows the products are intended as drugs for human use. A disclaimer is one statement among many and is weighed with the rest of the site.

    What did the August 2026 FDA warning letters to peptide sellers cite?

    The four letters dated 24 August 2026 cite product-page and comparison-page text about effects on the body, and bacteriostatic water or a reconstitution solution sold alongside the peptides. One also cites a peptide guide, a calculator, a mixed kit and a blend.

    Did the FDA letters cite testimonials or social media?

    Not in the six letters we read. None quotes a testimonial, describes an image or cites a social account. Those areas can still count as evidence of intended use under 21 CFR 201.128, and the MHRA’s UK guidance lists social media and customer reviews by name.

    Can we keep health claims if we write “studies suggest” in front of them?

    The letters indicate not. Several of the lines the FDA quoted were framed as “studied for”, “investigated for” or “research shows”. The agency treated them as evidence of intended use regardless of the framing.

    Should an RUO store sell bacteriostatic water?

    That is a decision to take with legal advice. Five of the six letters cite it as evidence, and four charge it as an unapproved drug because it was sold to reconstitute the site’s peptides. Moving it to another domain does not change that reading.

    Do Google and payment processors accept the RUO label?

    Not on its own. Google’s Unapproved substances policy applies regardless of any claims of legality, and it reviews landing pages. Stripe prohibits incorrectly labeled research chemicals. Both judge what the site shows.

    Does passing this audit mean the site is legal?

    No. The audit checks that the site describes a research-supply business accurately and consistently. It is marketing and policy information, not legal advice, and it cannot make a business that sells for personal use compliant.

    Want a second pair of eyes?

    Have your site read the way a reviewer reads it

    Peptide Marketing works only with research-use-only peptide brands. We will go through your site against the 25 points, show you which pages a regulator, ad platform or processor would quote, and tell you plainly what to change first. We do not cloak pages, disguise product names or hide content from reviewers.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is marketing and platform-policy information for businesses selling research-use-only products. It is not legal or regulatory advice. Sources were read in November 2026. Laws, letters and policies change, so check the linked pages and take advice from a qualified attorney before you act.

  • Performance Max for Peptide Brands: Setup, Assets and Policy-Safe Creative

    Most advice you find when you search “performance max peptides” is generic e-commerce advice with the word peptide added. That is a problem, because Performance Max (PMax) puts one set of assets in front of Google’s reviewers for Search, Shopping, YouTube, Display, Discover, Gmail and Maps at once, and a research-use-only (RUO) peptide catalogue sits right on top of Google’s healthcare policies. This guide is for owners and marketers of RUO peptide stores. It covers when PMax is worth running, what has to be in place first, how to structure campaigns and asset groups, which creative passes review, and how to scale without inviting a policy problem. Policy statements are linked to the Google page they come from, checked in November 2026.

    Key takeaways
    • PMax does not change what is allowed. Google’s Unapproved substances policy applies to ads and to Merchant Center listings “regardless of any claims of legality”. A campaign type cannot make a disapproved product eligible.
    • Sort out the feed and tracking first. A feed-based campaign needs a linked Merchant Center account with eligible products, and Google says you should use conversion tracking with PMax.
    • Advertise the brand and the offer. Our standard is no vials, syringes, product-in-hand or human-use imagery in any uploaded asset, and no compound names or outcome language in text.
    • Upload your own video in all three orientations. If you do not, Google says videos may be auto-generated from your other assets.
    • Raise optimization score with assets, not budget. Dismissing a recommendation also moves the score, so a low score is not a reason to accept a spend increase.
    • Change slowly. Google recommends running a new campaign for at least 6 weeks and avoiding frequent budget and bid changes in that time.

    1. When Performance Max makes sense for an RUO store

    Google describes Performance Max as a campaign type that reaches all Google Ads inventory from a single campaign, including YouTube, Display, Search, Discover, Gmail and Maps. You supply assets, a goal and a budget. Google’s systems decide where and to whom the ads show.

    For a peptide store that reach cuts both ways. One approved asset group can serve everywhere. One flagged asset is also reviewed for everywhere, and you give up most of the placement control you have in a Search campaign.

    SituationIs PMax a fit?Why
    Account in good standing, products eligible in Merchant Center, purchases trackedYesThe campaign has clean inputs and a real conversion signal to optimise toward
    Brand Search already running and profitable, you want more reachYes, alongside itPMax adds non-search inventory. Keep the brand campaign separate so you can read results
    Most products disapproved or “Not eligible” in Merchant CenterNot yetA feed campaign can only serve eligible products. Fix the feed first
    No purchase conversion tracking, or it double countsNot yetAutomated bidding optimises to whatever it is told. Bad data produces bad spend
    Active warning or strike for Unapproved substancesNoClear the violation before adding a campaign type that widens exposure
    Account suspendedNoAppeal the existing account. Do not start a new one
    The honest position

    Google’s Healthcare and medicines policy does not allow promotion of certain products “regardless of any claims of legality”. The list includes non-government-approved products marketed as safe or effective, products subject to any government or regulatory action or warning, and products with names confusingly similar to an unapproved pharmaceutical. No campaign type, asset trick or disclaimer changes that. What follows is how to run PMax well for the parts of your business Google will accept, not how to get refused products through.

    If you are new to the channel, start with our overview of Google Ads for peptides, which covers account structure across Search, Shopping and PMax.

    2. Prerequisites: feed, tracking and brand

    Three things decide whether a PMax campaign can work before a single asset is uploaded.

    An approved Merchant Center feed

    Google’s Performance Max specs page says retailers can attach a Merchant Center feed to a PMax campaign to serve Shopping ads. The campaign creation steps for product feeds add two practical points: the Google Ads account must be linked to the Merchant Center account, and you cannot change the Merchant Center account after the campaign is created.

    Merchant Center has its own Healthcare and medicines policy, with an Unapproved substances section that mirrors the Ads one and adds substances with a similar chemical composition to those on Google’s list. The same page says violations of that section do not lead to immediate account suspension without prior warning, and that a warning is issued at least 7 days before any suspension. Treat a warning as a deadline, not as a buffer.

    So before you build the campaign, open Merchant Center and write down how many products are eligible, how many are disapproved and why. If the eligible list is short, that is your PMax catalogue. Our guides to Google Shopping for peptides and Merchant Center recovery cover the feed side in detail.

    A feed is not mandatory. PMax can run on uploaded assets alone, pointed at a brand or category page. The same policies apply to those assets and to the landing page.

    Conversion tracking you trust

    Google’s campaign creation guide says you should use conversion tracking with Performance Max. It notes that campaigns can run without it but spend may be limited, and that new conversion actions need 24 to 48 hours to update. For a store, that means:

    • One primary purchase conversion action that records order value.
    • Add-to-cart, begin-checkout and page views set as secondary, so bidding does not chase them.
    • A test order checked end to end. Count and value in Google Ads should match the store.
    • Agreement with whoever owns tracking before anything is changed. Checkout and payment changes are a common reason tracking breaks, so re-test after any change covered in our payment processing guide.

    A business name and logo Google accepts

    Google now manages business names and logos through brand guidelines at campaign level. The creation guide says the business name should match your verified legal name or your domain name to avoid disapproval, and the specs page caps it at 25 characters. Use a wordmark logo, the same one that appears on your site. An approved brand name is the lowest-risk asset a peptide advertiser has, so get it settled first.

    Pre-launch checklist
    1. No open policy warning or strike in the Google Ads account.
    2. Merchant Center linked, with a written list of eligible products.
    3. No disapproved product re-listed under a new ID or an altered name.
    4. Primary purchase conversion recording correct value. Test order verified.
    5. Business name matches the domain or legal name. Wordmark logo uploaded in 1:1 and 4:1.
    6. Landing pages free of dosing, administration, outcome and personal-use language, with clear research-use positioning.
    7. Offer on the page matches the offer in the ad, including the end date.
    8. Images ready in 1.91:1, 1:1 and 4:5. Videos ready in 16:9, 1:1 and 9:16.
    9. A daily budget ceiling agreed with whoever signs off spend.
    10. A change log started, with launch as its first entry.

    3. Campaign and asset-group structure

    Keep the structure small enough that each part gets enough conversions to learn from. For most RUO stores that means one or two PMax campaigns.

    Campaign level

    • One main campaign for the eligible catalogue, bidding to purchase value.
    • A second campaign only with a reason. For example a different budget for a different margin band, or a capped campaign for a seasonal promotion.
    • Brand Search kept separate. Google’s brand settings page says brand exclusions stop a PMax campaign serving on queries for the brands you list, on Search and Shopping inventory. If you run a brand Search campaign, excluding your own brand from PMax lets you see what PMax earns on its own. Google also warns that brand settings limit reach, so use them deliberately.
    • Negative keywords. Google’s PMax negative keywords page says they apply to Search and Shopping inventory only. Google raised the limit to 10,000 per campaign in 2025. Use them to remove human-use and medical queries you do not want to appear on.

    Asset-group level

    An asset group is one theme: a final URL, a set of text, image, logo and video assets, and optional signals. Build asset groups around things that are safe to say out loud:

    • Brand and trust. Who you are, documentation, service, shipping.
    • Category. Research supplies by category page, not by individual compound.
    • Promotion. One group per offer with a start and end date. Pause it on the end date instead of deleting it, so its history is there next season.

    If a feed is attached, you can split products between asset groups with listing groups so each product sits with the creative that matches it. Do not create an asset group per compound. That structure pushes compound names into headlines, search themes and image text, which is exactly where review problems begin.

    What an asset group needs

    These figures come from Google’s specs page. “Required” there means required to publish an asset group without a feed.

    AssetLimitGoogle’s recommendation
    Headlines30 characters. 3 to 1511 or more, at least one of 15 characters or fewer
    Long headlines90 characters. 1 to 52 or more
    Descriptions90 characters. 2 to 54 or more
    Business name25 charactersMatch the domain or legally verified name
    Images, 1.91:1 and 1:1Up to 20 each4 or more each, 1200 x 628 and 1200 x 1200
    Images, 4:5Up to 20, optional2 or more, 960 x 1200
    LogosUp to 5 each of 1:1 and 4:11 of each
    VideosUp to 15, each 10 seconds or more1 each of 16:9, 1:1 and 9:16

    Google notes that a feed-only campaign can launch with no extra creative but may show a Poor ad strength rating. For a peptide store there is a second reason to supply your own: you decide what appears.

    4. Infographic: anatomy of an asset group

    Each box is one slot in a PMax asset group. The solid half shows the brand-led material we use. The dashed half shows what we see flagged or what we keep out as a standard.

    5. Audience signals and search controls

    Google’s page on audience signals for Performance Max describes them as optional suggestions that help its AI optimise toward your goal. It also says PMax may show ads to relevant audiences outside your signals when they are likely to convert. A signal steers. It is not a targeting fence.

    The signal types Google lists are your data (website visitors, customer lists, video viewers), custom segments built from keywords and URLs, demographics, and Google’s own segments such as in-market and affinity.

    Read this before uploading a customer list

    Google’s personalized advertising policy says advertisers promoting products in sensitive interest categories cannot use advertiser-curated audiences. Customer Match, your data segments and lookalike segments are listed as not supported, while Google’s predefined audiences remain available. Health is one of those categories. Google’s description covers health conditions, products that treat or manage chronic conditions, and invasive medical procedures including injections. It does not mention research peptides, and neither page mentions Performance Max by name. Whether your account is treated as sensitive is Google’s call. If your own lists are restricted, accept it and use predefined and custom segments. That is one more reason to keep health language and injection imagery out of the site and the ads.

    A sensible signal set for an RUO store:

    • Custom segment: people searching your brand name and research-supply category terms.
    • Google segments: laboratory and scientific equipment, business and industrial interests. Leave health, fitness and weight-related segments out.
    • Your data, where Google permits it: past purchasers and site visitors, built from properly consented data. The same list is the base for peptide email marketing, which does not depend on ad review.

    Search themes

    Search themes tell PMax which queries matter to you. Google’s search themes page suggests adding up to 50, and the PMax overview says they carry the same priority as phrase and broad match keywords. Write them the way you write headlines: brand, research supplies, laboratory categories. A compound name in a search theme is still a compound name submitted to Google.

    New versus existing customers

    Google’s customer lifecycle goals offer two acquisition modes. “New Customer Value” bids higher for new customers and requires a purchase conversion goal. “New Customer Only” bids only for new customers, and Google recommends it only if you have a strict acquisition budget or non-purchase goals. For most stores the first mode is the better default, because repeat buyers stay reachable. Both modes need first-party data to define existing customers, so the audience restriction above can apply here too.

    6. Creative that passes review

    Google’s healthcare policy has no rule that says “no vials”. It does not need one. The policy is about what a product is and how it is marketed, and images and video are part of the marketing. A syringe in an image says human use more clearly than any sentence. Our working standard, applied to every peptide account, is therefore stricter than the letter of the policy: advertise the brand and the offer, not the compound.

    AssetBrand-led: what we useWhat we keep out
    ImagesWordmark and offer graphics, clean lab settings with no product in frame, branded shipping boxes, certificates of analysis shown as documentsVials, syringes, powders, product in hand, body or physique imagery, before and after
    VideoA presenter explaining the company, its documentation and service. Offer slides. End card with logo and “For research use only”Product footage, preparation or use scenes, any description of what a compound does
    LogoText wordmark, identical on site, feed and adsVial, needle or molecule-in-syringe icons
    Headlines and descriptionsBrand, category, offer, documentation, shipping, supportCompound names, prescription drug terms, outcomes, dosing, “patients”, “treatment”, “therapy”
    Landing pageResearch-use positioning, accurate product names, documentation, same offer as the adUse instructions, benefit statements, reviews describing personal use

    Video: upload your own, in every orientation

    Google’s specs page says that if you do not add a video to an asset group, one or more videos may be auto-generated from its assets, and that you need to upload horizontal, square and vertical video to reach Excellent ad strength and avoid AI-generated videos. For a peptide store, an auto-generated video is one you did not review before it ran. Make three short videos once and reuse them in every asset group.

    You do not need a production budget. The video creation tool in the Google Ads asset library builds a video from a logo, approved images and a few lines of text. Use the wordmark, an offer image and a closing slide with the brand and “For research use only”.

    Check what Google adds for you

    In 2025 Google added image controls to PMax: a landing page images option that sources images from your site, which you can view, remove or opt out of, and image enhancements that create cropped versions of your images. If your landing pages carry product photography, review what has been pulled in, or opt out, so that your asset group contains only images you chose.

    Feed images are a separate matter

    Product images in the feed follow Merchant Center’s image link rules. The main image must give an unobstructed, clean view of the item, and promotional text, overlays, watermarks and superimposed logos are not allowed. So an eligible product’s feed image shows the product as sold. The brand-led rule above is about the assets you upload to the asset group.

    Wording that works

    Headline patterns we use: “[Brand] Research Supplies”, “Documentation With Every Order”, “Fast, Tracked Shipping”, “[Brand] Seasonal Sale Ends Friday”. Each one is true of the business and names no compound. If you state that products are third-party tested, publish the documents on the landing page. Google’s Misrepresentation policy covers claims a business cannot evidence.

    7. Optimization score hygiene

    Google defines optimization score as an estimate of how well your account is set to perform, from 0% to 100%. Two details on that page matter. Google states the score is not used by Quality Score. And both applying and dismissing a recommendation change the score, so 100% can be reached by dismissing everything.

    That makes the score a to-do list, not a grade. Google’s recommendation categories include Ads and assets, Bidding and budgets, Keywords and targeting, Repairs and Measurement. We sort them like this:

    RecommendationOur defaultReason
    Add videos, images, logos, headlines, descriptionsApply, with brand-led assetsComplete asset groups are eligible for more formats
    Fix a disapproved or limited assetApply by replacing the assetA flagged asset should not stay in the group
    Repairs and measurement fixesApply after checking with the tracking ownerThey affect the data bidding relies on
    Add audience signalsApply within the limits in section 5Signals speed up learning
    Raise budgetDismiss unless the owner agreesBudget is a business decision, not a hygiene item
    Set or loosen a ROAS or CPA targetDismiss unless your own numbers support itTargets should follow results
    Broaden targeting or add automatically created assetsReview case by caseMore automation means more content you did not write

    We keep auto-apply off in peptide accounts. Every change to assets or spend should be made by a person who has read the policy.

    Google’s PMax optimization tips suggest aiming for Good or Excellent ad strength, with at least 20 text assets, 7 images and 1 video. Fill those slots with brand-led material. Never fill them with compound names to reach a rating.

    8. Budgets and scaling rules

    Start with what Google documents. Its optimization tips say to run new campaigns for at least 6 weeks, to avoid frequent changes to budget, bid strategy or status during that period, and to allow 1 to 2 weeks, or one full conversion cycle, after a significant change. The creation guide says to set an adequate daily budget, avoid overly restrictive targets and adjust targets gradually. Google does not publish a dollar figure.

    The rules below are our own working rules for RUO peptide accounts. They are judgement, not Google policy. Adjust the thresholds to your account and write your own numbers down.

    1. Compliance before scale. No budget increase while any asset, product or landing page in the campaign is limited or disapproved.
    2. Launch capped. Start on Maximize conversion value with a daily budget you can sustain for 6 weeks without touching it.
    3. Add a ROAS target later. We wait for about 30 purchases, then set the target a little below the return the campaign has actually achieved.
    4. Judge PMax without brand. If your brand is not excluded, part of the reported return is brand demand you would have captured anyway.
    5. Raise in small steps. No more than about 20% per week, and only when the campaign is limited by budget and is meeting its return target.
    6. One change at a time. Budget, target or assets, then 7 days before the next change.
    7. Fund increases from weak spend first. Move money from campaigns that are not paying back before adding new money.
    8. Grow reach through approved inputs. More eligible products, complete assets and new promotional asset groups. Not broader matching on sensitive terms.
    9. Stop quickly on a bad signal. A day of normal spend with zero purchases means check policy status and tracking before bids.

    Use the channel performance report to see where the campaign serves. It breaks results out by Search, Display, YouTube, Discover, Maps, Gmail and Search partners, and shows a status for each, including Eligible (Limited) and Missing required assets. Read it before cutting anything.

    Why slow is safer here

    A policy-limited campaign that receives more budget spends it through whatever assets are still approved. That is rarely your best creative. Fix the limit first, then scale.

    9. Common disapprovals and how to handle them

    These are the policy outcomes peptide advertisers meet most often in PMax.

    What you seeUsual causeWhat to do
    Asset disapproved: Unapproved substancesA compound name or use language in a headline, image text or video, or on the final URLRemove the asset. Fix the landing page. Replace with brand-led creative
    Asset limited or disapproved: prescription drug termsA catalogue name shared with a prescription medicine. Google restricts these terms in ads, landing pages and keywordsTake the term out of assets and search themes. Decide whether that product should be advertised at all
    Product disapproved in Merchant CenterThe Merchant Center Unapproved substances sectionLeave it out of the campaign. Request review only if the listing is actually compliant
    Business name or logo disapprovedName does not match the domain or legal nameCorrect the brand guidelines so name and logo match the site
    Audience not eligibleSensitive-category restriction on your own listsRemove the list. Use predefined or custom segments
    Misrepresentation flagUnclear business identity or claims without evidencePublish business details and documentation. Remove what you cannot evidence
    Video stuck under reviewReview queueWait. Do not upload copies of the same video

    Fix, then appeal once

    Google’s page on fixing a disapproved ad says an edited ad or asset is reviewed again automatically. If you believe a decision is wrong, you can appeal in the account, either disputing the decision or stating that you made changes to comply. Each ad is limited to 3 appeals, and Google asks you to wait at least 24 hours between appeals. Since July 21, 2026, decisions more than 6 months old cannot be appealed in the account and go through Google Ads support.

    What turns a disapproval into a suspension

    Unapproved substances is covered by Google’s repeat-violation strike system: one warning, then a 3-day hold, then a 7-day hold if the same policy is violated within 90 days, then suspension on a third strike. A disapproved asset is a signal to act on, not something to leave in the account.

    The faster route to suspension is trying to get around a decision. Google’s Circumventing systems policy lists creating variations of disapproved ads or content, and showing Google different content from what users see, as examples. Respelled compound names, a product photo swapped in after approval, or a duplicate site for the same catalogue all fall there. We do not do any of it, and we advise clients not to.

    10. FAQ

    Can RUO peptide stores run Performance Max?

    Yes, if the account is in good standing and the content complies with Google’s policies. Performance Max is a campaign type, not an exemption. Google’s Unapproved substances policy applies regardless of any claims of legality, so only compliant products, assets and landing pages can serve.

    Do I need a Merchant Center feed for Performance Max?

    No. A feed lets the campaign serve Shopping ads for eligible products, and the Google Ads account must be linked to Merchant Center to use one. Performance Max can also run on uploaded assets alone. The same policies apply either way.

    Can I use product photos of vials in Performance Max assets?

    Google publishes no rule that names vials, but its policies judge how a product is marketed, and images are part of that. Our standard is to keep vials, syringes and product-in-hand shots out of every uploaded image, logo and video, and to use brand, offer and lab-setting visuals.

    What happens if I do not upload a video?

    Google says one or more videos may be auto-generated from the assets in your asset group. To avoid that and reach Excellent ad strength, upload horizontal, square and vertical videos of at least 10 seconds each.

    Does a low optimization score hurt my ads?

    Google describes the score as an estimate of how well the account is set to perform and says it is not used by Quality Score. Applying or dismissing recommendations both change it. Use it as a list of asset gaps to close, and decide budget recommendations on your own numbers.

    Can I use my customer list as an audience signal?

    Only if Google does not treat your products as a sensitive interest category. For sensitive categories, which include Health, Google does not support Customer Match, your data segments or lookalike segments, while its predefined audiences remain available.

    How long should I wait before judging a Performance Max campaign?

    Google recommends running a new campaign for at least 6 weeks and avoiding frequent changes to budget, bid strategy or status in that time. After a significant change to an existing campaign it suggests 1 to 2 weeks, or one full conversion cycle.

    What should I do when an asset is disapproved?

    Remove or edit the asset and fix the landing page if it is the cause. Edited assets are reviewed again automatically. Appeal only if you believe the decision is wrong, and do not resubmit variations of the same content, which Google lists as circumventing systems.

    Want it checked before it goes live?

    Get your Performance Max setup reviewed

    Peptide Marketing works only with research-use-only peptide brands. We will look at your feed status, conversion tracking and asset groups, and tell you plainly what to fix before you spend more. We do not cloak pages, disguise product names or open replacement accounts.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is marketing and platform-policy information for businesses selling research-use-only products. It is not legal or regulatory advice. Policies change; check the linked pages before you act.

  • Google Ads Suspended for Peptides: The Appeal and Recovery Playbook

    If you are searching for “peptide Google Ads suspended“, you are probably looking at a red banner in your account and a store whose paid traffic has just stopped. This playbook is written for owners and marketers of research-use-only (RUO) peptide stores. It explains which suspension types peptide brands actually hit, how to tell them apart, what to fix on the site, feed and ads before you appeal, how to write the appeal, and what recovery realistically looks like. Every policy statement below is linked to the Google or FDA page it comes from, checked in November 2026.

    Key takeaways
    • Read the suspension reason first. Google suspends for policy violations, for billing and payment reasons, and for a few other causes. Each has a different fix and a different appeal.
    • “Unapproved substances” is a repeat-violation policy, not an instant ban. Google’s strike system gives one warning, then a 3-day hold, a 7-day hold, and suspension on the third strike.
    • “Circumventing systems” and “Unacceptable business practices” are egregious. Google suspends on detection, without warning.
    • Fix before you appeal. Google says accounts are reinstated only in compelling circumstances, and that too many appeals may not be processed.
    • Never open a new account. Google names this as an example of circumventing systems. It turns a fixable suspension into a far harder one.
    • You have at least 6 months from the suspension date to appeal. Use the first days for the fix, not for a rushed appeal.

    1. Why peptide accounts get suspended

    Google’s account suspensions overview says accounts may be suspended when Google finds violations of its policies or its Terms & Conditions. For most stores that is a remote risk. For a peptide store it is a standing one, because the catalogue sits directly on top of Google’s Healthcare and medicines policy.

    That policy has an “Unapproved substances” section. Google states it does not allow the promotion of certain products “regardless of any claims of legality”. Three of the listed items matter most to RUO sellers:

    • Non-government-approved products marketed in a way that implies they are safe or effective.
    • Products that have been subject to any government or regulatory action or warning.
    • Products with names confusingly similar to an unapproved pharmaceutical, supplement or controlled substance.

    Google’s list of unapproved pharmaceuticals and supplements does not name individual research peptides. Google describes that list as not exhaustive and as examples of the content it monitors, so a compound’s absence from it is not an approval.

    The “regulatory action or warning” bullet is where the FDA comes in. The FDA’s page on bulk drug substances that may present significant safety risks in compounding names several peptides commonly sold by research suppliers. Ipamorelin acetate appears in its current category 2 table. BPC-157, CJC-1295, AOD-9604, Melanotan II and a thymosin beta-4 fragment also known as TB-500 appear in a second table of substances that were previously in category 2 and whose nominations were withdrawn; that table still records potential significant safety risks for each. The page is about compounding, not about RUO sales, and it does not say these substances are illegal to sell. It does show that the names in a typical peptide catalogue are names regulators have written about, which is the kind of signal Google’s policy points to.

    The same policy also restricts prescription drug terms in ads, landing pages and keywords. A catalogue that includes compounds sharing a name with a prescription medicine carries that second risk as well.

    The honest position

    An RUO disclaimer does not exempt a store from these policies. Google’s wording is “regardless of any claims of legality”. What you control is how products are named, described and presented, whether your business identity is transparent, and whether your billing is clean. Those are the things an appeal is judged on.

    2. The four suspension types peptide brands hit

    The account banner and the suspension email name a reason. For peptide brands the four below are the ones to know.

    Unapproved substances (repeat violations)

    This is the policy peptide ads and landing pages are typically flagged under. It is not on Google’s list of egregious policies. It is covered by Google’s enforcement procedures for repeat violations, the strike system, which lists Unapproved substances by name. The sequence Google describes is:

    1. Warning. The first violation produces a warning by email. No strike is issued.
    2. First strike. If the violation continues, the account is placed on a temporary hold for 3 days.
    3. Second strike. A further violation of the same policy within 90 days of the first strike brings a 7-day hold.
    4. Third strike. A further violation within 90 days of the second strike brings account suspension.

    To come off a hold, Google says you must remove or fix all policy violations in the account and complete an acknowledgement form, or appeal the strike. The practical meaning: a suspension under this policy usually has a paper trail. There were disapproved ads, a warning email and one or two holds before it. That trail tells you what Google objected to.

    Circumventing systems

    Google’s Circumventing systems policy prohibits practices that circumvent or interfere with its advertising systems. The examples Google lists include creating variations of ads, domains or content that have been disapproved; creating new accounts to re-enter the system after a suspension; cloaking, meaning showing Google a compliant landing page while showing people different content; spreading violating ads across two or more accounts; and submitting false information in verification. Google classes this policy as egregious: suspension happens on detection, without prior warning, and Google states the advertiser will not be allowed to advertise again.

    Peptide brands reach this suspension through the workarounds that circulate in the industry: re-submitting disapproved products under altered names, a “clean” landing page for Google and a different one for buyers, a second domain for the same catalogue, or a replacement account after the first was suspended.

    Misrepresentation (Unacceptable business practices)

    Google’s Misrepresentation policy has ten sub-policies. Two are egregious: Unacceptable business practices and Coordinated deceptive practices. Unacceptable business practices covers, among other things, offering products or services you cannot deliver, including without the right licences or qualifications, and making it seem that you are supported by another brand, organisation or government entity when you are not. The non-egregious sub-policies that peptide stores also meet are Misleading representation (obscuring or omitting material information about identity, affiliations or qualifications) and Unreliable claims.

    For a peptide store, the likely triggers are an anonymous business, lab-testing or certification language that cannot be evidenced, and outcome claims on product pages.

    Suspicious payments and other billing suspensions

    Google’s billing and payment suspensions page lists four causes: an unpaid balance or concerns about future payments, suspicious payment activity, requesting a chargeback, and promotional code abuse. These are not about your products at all. They matter in this vertical because card and processor problems are a familiar part of running a peptide store, and an ad account funded with a card whose name and address do not match the business is exposed.

    Suspension typeWarning first?Usual peptide triggerWhat the appeal must show
    Unapproved substancesYes. One warning, then strikes with 3-day and 7-day holdsProduct names, benefit or use language in ads, feed and landing pagesThe flagged content is gone across ads, feed and site, and a review process exists
    Circumventing systemsNo. EgregiousCloaking, altered re-submissions, duplicate domains, replacement accountsThe practice has stopped, or it never happened and here is the evidence
    Unacceptable business practicesNo. EgregiousUnclear business identity, unevidenced claims about testing or statusWho the business is, what it can deliver, and proof
    Suspicious payment activity / billingNot specified by GoogleMismatched card details, declined payments, chargebacksPayment method verified and balance settled

    3. How to diagnose which one you have

    Do not guess from forum threads. Work from your own account. A suspended account is read-only with a few exceptions: Google confirms you can still view and download reports, appeal, complete advertiser verification, make payments and update security settings.

    1. Read the banner and the email word for word. Copy the exact policy name. “Unapproved substances”, “Circumventing systems” and “Suspicious payment activity” lead to three different playbooks.
    2. Open the policy and account status area. Google’s billing page notes this now sits under Admin > Policy > Account. Record any strike history and any verification task that is open.
    3. Search the admin inbox for earlier Google Ads emails. A warning or strike email in the weeks before the suspension confirms a repeat-violation path and usually names the ad or asset involved.
    4. Export ad and asset policy statuses. List every ad, asset and keyword that was Disapproved or Limited, with the policy named against it.
    5. Check Merchant Center separately. It is a different account with its own policies and its own review. A Shopping problem and an Ads suspension can be related or unrelated. Our Merchant Center recovery guide covers that side.
    6. Check billing. Look for declined payments, an outstanding balance, a recent change of card, or a chargeback request.
    7. List every related account. Google says accounts related to a suspended account may be suspended, and that all linked, previously linked and related accounts must comply before you appeal. Include old accounts, agency-created accounts and anything that shares your payment method or manager account.
    Check for a compromise too

    Google also suspends temporarily when it detects an unauthorised user trying to access an account, to protect against unauthorised charges. If you see campaigns, users or payment methods you did not add, treat it as a security incident first and use Google’s compromised-account route before any policy appeal.

    4. Infographic: the suspension decision tree

    Read each column top to bottom: the suspension reason, its usual cause, the fix, then what the appeal should say.

    5. What to fix before you appeal

    Google’s overview is blunt: accounts are reinstated only in compelling circumstances, such as a mistake. If the suspension was not a mistake, the compelling circumstance has to be that the cause no longer exists. Fix first, then appeal. Work through the list below in order.

    Pre-appeal checklist
    1. Freeze the account. Do not edit ads to “test” what gets through. Variations of disapproved ads are an example Google gives of circumventing systems.
    2. Remove human-use language sitewide. Dosing, administration instructions, outcome or benefit statements, before-and-after content and customer reviews describing personal use. Check product pages, blog posts, FAQs, image alt text and meta descriptions.
    3. Keep honest RUO positioning. State clearly that products are sold for laboratory research use. Do not use the disclaimer as cover for copy that says the opposite.
    4. Review every product name. Use the accurate name. Do not alter, abbreviate or split names to get a disapproved product back through review. Decide which products you will stop advertising altogether.
    5. Clean the feed to match the site. Titles, descriptions, images, price and availability must match the landing page. Remove products that were disapproved rather than re-listing them under new IDs.
    6. Rewrite ads and assets. Remove any headline, description, sitelink, image or video that was ever flagged. Build around brand, category, quality documentation and service.
    7. Make the business visible. Legal entity name, physical address, working email and phone, shipping, returns and privacy pages, all consistent with your Google payments profile.
    8. Evidence every claim. If the site says products are third-party tested, publish the documentation. Remove any wording that implies regulatory approval or endorsement.
    9. Use one page for everyone. Remove geo, device or referrer logic that changes what a product page shows, and any interstitial that blocks Google from seeing the page. Google allows slightly different content for language, special offers or location, but says the promoted product must be the same for everyone.
    10. Settle billing. Pay any outstanding balance, withdraw any chargeback against legitimate charges, and use a payment method in the business’s name.
    11. Complete advertiser verification if requested. Google says certain selected advertisers must verify successfully before they can appeal, and that if it cannot verify them after 3 attempts they will not be allowed to appeal. Submit accurate documents once, carefully.
    12. Bring related accounts into line. Every linked, previously linked or related account must comply before you appeal.
    13. Keep a dated change log. URL, what changed, when. It becomes the core of your appeal.

    If payment friction is part of the picture, read our guide to peptide payment processing. For how a compliant account should be structured once you are back, see Google Ads for peptides and Google Shopping for peptides.

    6. How to write the appeal

    Google’s process is short. In the suspended account, select the “Contact Us” link in the notification at the top of the screen, which opens the appeal form. A separate appeal is needed for each suspended account. When the appeal has been reviewed you receive the outcome by email. If it is rejected you can appeal again through the same route.

    Google’s own tips are to explain the situation for each policy you were found to violate, to follow the best practices on the relevant policy page, and to complete advertiser verification if it is requested. Build the appeal around that.

    A structure to follow

    1. Who you are. Legal entity, website, what you sell and to whom. Two sentences.
    2. What you understand the violation to be. Name the policy exactly as Google named it. Show you read it.
    3. What caused it. Be specific and factual. “Product pages for 14 items contained usage language written by a previous contractor” is useful. “We always follow all policies” is not.
    4. What you changed. A dated list with URLs: pages edited, products removed from the feed, ads and assets deleted, business information added.
    5. What stops it recurring. A named person who reviews copy before publishing, a written content standard, a feed rule.
    6. What you are asking for. A re-review of the account. Nothing else.
    Tone and length

    Write for a reviewer who is reading many of these. Plain sentences, no legal threats, no account of lost revenue, no argument that the policy is unfair. If you believe the suspension is an error, say so once and attach the evidence that shows it. If it was not an error, do not claim it was. A false statement in an appeal or in verification creates a new problem, since Google lists submitting false information in its verification programs as circumventing systems.

    What to attach or have ready

    • Business registration documents matching the name on the payments profile.
    • For billing suspensions, Google says it may ask you to verify your payment method through a verification code, a payment or documents, and may request details such as legal name, address, a government ID image, proof of address and an image of the payment method. Documents must be unexpired, legible and show all four corners.
    • Your change log.
    • A list of all accounts you own or have used, including suspended ones.

    7. What not to do

    A suspension under a repeat-violation or billing policy is fixable. The actions below are how it gets converted into an egregious one.

    • Do not create a new account. Google’s Circumventing systems policy names creating new accounts to re-enter the system after a suspension as a violation, and says existing suspensions need to be reinstated through the appeal process. Its billing page is more direct still: asked whether a suspended advertiser can set up other accounts, the answer is no, and it says any new accounts the advertiser tries to create will be suspended.
    • Do not borrow or buy an account. Running your ads through an account in someone else’s name misstates who the advertiser is and puts their account at risk. Related accounts may be suspended.
    • Do not cloak. Showing Google one page and buyers another is the textbook example in the policy. It is egregious, and Google says such advertisers are not allowed to advertise again.
    • Do not re-submit disapproved products under altered names. Google lists creating variations of ads, domains or content that have been disapproved as circumvention. A respelled compound name on a product that was already disapproved is that.
    • Do not move the same catalogue to a new domain to run the ads that were disapproved. Google lists creating new websites or accounts to show ads similar to ones already disapproved as an example.
    • Do not flood the appeal form. Google says that if you file too many appeals for the same suspension it may not process them, recommends one appeal at a time, and says misuse leads to processing of certain appeals being suspended for 7 days.
    • Do not file a chargeback for legitimate ad spend. It is itself a listed suspension cause.
    • Do not pay for “guaranteed reinstatement”. Nobody outside Google can guarantee an outcome, and services that work by supplying replacement accounts are selling the violation described above.

    8. Realistic timelines

    Google publishes few hard numbers for suspension appeals, so separate what is documented from what is experience.

    StageWhat Google documentsSource
    Window to appealAt least 6 months from the date of suspensionSuspensions overview
    Warning before a repeat-violation suspensionAt least 7 daysSuspensions overview
    Strike holds3 days (first strike), 7 days (second strike)Repeat violations
    Advertiser verification status updateUp to 5 business daysAdvertiser verification
    Payment method verification for a billing appealYou may be asked to verify within 30 daysBilling suspensions
    Appeal review timeNot stated. The outcome arrives by emailSuspensions overview
    Merchant Center account reviewTypically 7 business days, longer for complex reviewsMerchant Center Misrepresentation

    In November 2025 Google said, as reported by PPC Land, that it had reduced incorrect suspensions by more than 80% and that 99% of appeals were being resolved within 24 hours. Treat that as the speed of a decision, not the speed of a recovery. For a peptide store the slow part is the work before the appeal: auditing a catalogue, rewriting pages, getting a developer to change templates, and assembling documents.

    A sensible plan for an owner is to expect the fix to take days to a couple of weeks depending on catalogue size, a first decision after a complete appeal, and a real chance that the first answer is no and a second, better-evidenced appeal is needed. Plan cash flow on the assumption that paid search is off for the whole period.

    Changed in 2026

    Google’s page on fixing a disapproved ad or appealing a policy decision says that from July 21, 2026 the option to appeal a policy decision directly from your Google Ads account is not available for policy decisions made more than 6 months earlier; for those it directs advertisers to Google Ads support. The same page limits each ad to 3 appeals. That page concerns ad and asset decisions. Account suspension appeals follow the suspension overview. If old disapprovals are part of your clean-up, deal with them through support rather than expecting an in-account appeal button.

    9. After reinstatement, and if the appeal fails

    If you are reinstated

    Reinstatement returns the account, not the old way of running it. Restart slowly: brand and category campaigns first, with the cleaned site and feed. Review every new ad, asset and product against the content standard you described in your appeal. Watch policy status weekly, and treat any new warning email as urgent, since strikes follow a continued violation.

    If the appeal is rejected

    You can appeal again, but only with something new: a fix you had missed, a document you had not supplied, a related account you had not addressed. Re-sending the same text is how appeals stop being processed. Advertisers in the EU may also have additional redress options under the Digital Services Act, which Google notes on its suspensions page.

    Do not rebuild on one channel

    Whatever the outcome, a peptide store that depends on a single ad account is fragile. Owned channels are not subject to ad policy review in the same way. Start with the customer list you already have: our guide to peptide email marketing covers how to do that within RUO framing.

    10. FAQ

    Why was my peptide Google Ads account suspended without warning?

    Google suspends immediately, without warning, for policies it classes as egregious. Those include Circumventing systems and Unacceptable business practices. Unapproved substances is handled differently, through a warning and strikes, so a suspension with no prior warning usually points to one of the egregious policies or to a billing issue.

    Can I open a new Google Ads account after a suspension?

    No. Google lists creating new accounts after a suspension as an example of circumventing systems, and says any new accounts a suspended advertiser tries to create will be suspended. Appeal the original account instead.

    How long do I have to appeal a Google Ads suspension?

    Google states that all advertisers have at least 6 months from the date of account suspension to submit an appeal. A suspension is considered permanent unless an appeal is submitted and the account is successfully reinstated.

    How long does a Google Ads suspension appeal take?

    Google’s suspension page gives no review time and says you will be emailed the outcome. In November 2025 Google was reported as saying 99% of appeals were resolved within 24 hours. The preparation before the appeal usually takes much longer than the review.

    Does a research-use-only disclaimer protect my ads?

    No. Google’s Unapproved substances policy applies regardless of any claims of legality. A disclaimer does not offset product pages, ads or feeds that imply a product is safe or effective, or that carry use instructions.

    How many times can I appeal?

    Google sets no fixed number for account suspensions, but says that too many appeals for the same suspension may not be processed, recommends one appeal at a time, and says misuse leads to processing of certain appeals being suspended for 7 days.

    What is a suspicious payment activity suspension?

    It is a billing suspension applied when Google detects suspicious payment activity. Google may ask you to verify your payment method with a code, a payment or documents before it processes the appeal.

    Will my Merchant Center account be suspended too?

    Not automatically. Merchant Center is a separate account with its own policies and review. Its Unapproved substances policy says a warning is issued at least 7 days before any account suspension, so check its status and fix issues there in parallel.

    Need a second pair of eyes?

    Get your suspension diagnosed before you appeal

    Peptide Marketing works only with research-use-only peptide brands. We will look at the suspension reason, your site and your feed, and tell you plainly what has to change before an appeal has a chance. We do not open replacement accounts or cloak pages.

    Book a 15-min call

    Prefer email? Write to hello@peptidemarketing.info.

    Sources

    This guide is marketing and platform-policy information for businesses selling research-use-only products. It is not legal or regulatory advice. Policies change; check the linked pages before you act.